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This thesis aimed to study the association between nutritional status (both 
undernutrition and overnutrition) and the post-stroke outcomes. 
 
In the first study, the predictive validity of a nutrition screening tool was evaluated on 
hospitalised elderly and stroke patients. Patients identified as being nutritionally-at-
risk had a significantly increased rate of mortality and a tendency for a longer length 
of hospital stay, when compared to adequately nourished patients. 
 
In a second study, the association between Body Mass Index (BMI) and mortality 
after a first-ever stroke was explored, using data provided by the South London Stroke 
Register (which covers a multiethnic population of 234,533 inhabitants in South 
London). After adjusting for possible confounders and having the normal weight 
category as reference group, the risk of mortality (up to 8 years) was higher for the 
underweight and lower for the overweight category. 
 
In the third study, the relationship between BMI, central obesity, nutrition risk 
categories and outcomes at 6 months post stroke was prospectively analysed. 550 
patients were recruited on admission after stroke to two London-based hospitals. The 
higher the BMI, and the waist circumference (WC) quartile, the lower the rate of 
mortality, and there were no significant associations between BMI and WC with 
stroke recurrence. Patients at high risk of malnutrition had significantly higher risk of 
mortality, length of hospital stay and hospitalisation costs. Further research is needed 
to determine whether nutritional support (and which type) improves patients’ 
outcomes. 
 
A systematic review entitled “Oral nutritional supplements (ONS) in patients at risk of 
malnutrition who have had a stroke” was also conducted (as part of a review of 
clinical guidelines on stroke care) and it was concluded that there is a lack of good 
quality evidence supporting the role of ONS in the management of patients at risk of 
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1.1 – Malnutrition 
 
 
1.1.1 – Definition 
 
Malnutrition can be defined as a “state of nutrition in which a deficiency or excess (or 
imbalance) of energy, protein, and other nutrients causes measurable adverse effects 
on tissue/body form (body shape, size and composition) and function, and clinical 
outcome” (Elia, 2000). 
In other words, malnutrition relates to all deviations from adequate nutritional status, 
which includes energy undernutrition and overnutrition (obesity is a form of 
malnutrition) (Shetty, 2003). Overnutrition implies a positive nutrient balance and 
undernutrition a negative nutrient balance (Meijers et al., 2010). 
Malnutrition arises from deficiencies of specific nutrients; for example, anaemia and 
xerophthalmia are symptoms of malnutrition caused by inadequate intake of iron and 
vitamin A.  
The term “undernutrition” is used to refer to generally poor nutritional status, but also 
implies underfeeding. It is caused primarily by an insufficient energy intake, 
regardless of whether any other specific nutrient is a limiting factor (Shetty, 2003). 
 
For the purposes of this thesis, undernutrition will be defined as malnutrition and 
overnutrition will be defined as obesity and/or overweight, as usually referred in the 
literature. 
   
 
1.1.2 – Malnutrition (as undernutrition) 
 
The World Health Organisation (WHO) defines nutrition as “the intake of food 
considered in relation to the body’s dietary needs”, affirming that good nutrition is a 
cornerstone of good health, and that poor nutrition can cause “reduced immunity, 
increased susceptibility to disease, impaired physical and mental development, and 
reduced productivity” (WHO, 2010).  
20 
 
Malnutrition in the general population  
 
Malnutrition is both a cause and consequence of disease in adults and children 
(Brotherton et al., 2010) and, according to a national report, it is an under-recognized 
and under-treated problem that affects over 3 million people in the UK. The majority 
of these (93%) live in the community, with 5% in care homes and 2% in hospital (Elia 
and Russell, 2009). 
 
One of the first experimental studies exploring the effects of malnutrition in healthy 
adult volunteers was conducted in 1944-1945. This study, known as the “The 
Minnesota Starvation Experiment”, aimed to understand the physical and 
psychological effects of semistarvation and the problem of refeeding civilians who 
had been starved during the World War II. During the experiment, 36 male 
participants were subjected to semistarvation (approximately 1800Kcal/day during 6 
months) in which most lost >25% of their weight, and many experienced anaemia, 
fatigue, apathy, extreme weakness, muscle soreness, hair loss, irritability, neurological 
deficits, lower extremity edema, decreased tolerance to cold temperatures and loss of 
sex drive (Kalm and Semba, 2005). 
 
Weight is an indicator of nutritional status, hence the use of BMI as an indicator of 
chronic protein energy status. In general, a positive energy balance will result in 
weight gain and a negative energy balance will result in weight loss, with depletion of 
both body fat and muscle. Protein-energy deficiency is likely to be associated with 
micronutrient (vitamins, minerals and trace elements) deficiencies, although these can 
also occur in individuals with acceptable protein-energy status (e.g. a normal weight 
or overweight individual can have vitamin D or iron deficiency). Over time, nutrient 
deficiencies (macro and/or micronutrient) have a negative impact in multiple functions 
of the body (Stratton et al., 2003). 
In different groups of population, malnutrition has diverse clinical effects and its 





Table 1.1 - Clinical effects of malnutrition in the general population - reproduced from 




Impaired immune response Impaired ability to fight infection 
 
Reduced muscle strength and fatigue Inactivity and reduced ability to work, shop, cook and self-
care. Poor muscle function may result in falls, and in the 
case of poor respiratory muscle function result in poor cough 
pressure – delaying expectoration and recovery from chest 
infection 
Inactivity In bed-bound patients, this may result in pressure ulcers and 
venous blood clots, which can break loose and embolise 
Loss of temperature regulation Hypothermia with consequent further loss of muscle 
strength 
Impaired wound healing Increased wound-related complications, such as infections 
and un-united fractures 
Impaired ability to regulate salt and 
fluid 
Predisposes to over-hydration, or dehydration 
 
Impaired ability to regulate periods Impaired reproductive function 
 
Impaired fetal and infant programming  
 
Malnutrition during pregnancy predisposes to common 
chronic diseases, such as cardiovascular disease, stroke and 
diabetes (in adulthood) 
Specific nutrient deficiencies Anaemia and other consequences of iron, vitamin and trace 
element deficiency 
 
Impaired psycho-social function Even when uncomplicated by disease, malnutrition causes 
apathy, depression, introversion, self-neglect, 
hypochondriasis, loss of libido and deterioration in social 
interactions (including mother-child bonding) 
Additional effects on children and 
adolescents 
Growth failure and stunting, delayed sexual development, 
reduced muscle mass and strength, impaired neuro-cognitive 
development, rickets and increased lifetime osteoporosis risk 
        
 
 
Although malnutrition affects several different populations/ages, this thesis will only 








Disease-related malnutrition: identification and consequences 
 
The concerns regarding prevalence and adverse effects of disease-related malnutrition 
(malnutrition triggered by illness or disease) and in hospitalised patients were first 
reported more than 30 years ago (McWhirter and Pennington, 1994, Hill et al., 1977, 
Bistrian et al., 1976), justifying the need to correctly and promptly identify this 
unrecognised problem.  The identification of malnutrition has been typically based on 
anthropometric, biochemical and physical parameters, among others. However, 
currently there is no universally accepted gold standard (best method) for the 
assessment of nutritional status (Donini et al., 2007, Foley et al., 2009b). 
 
It was necessary to find a systematic and standardized approach to identify this 
condition, and that is where Nutritional Screening Tools (NST) have an important role 
(Bauer et al., 2010).  
 
A NST helps to identify patients who are currently malnourished or at risk of 
becoming malnourished, so they can be referred for further assessment and nutritional 
intervention, if appropriate (Weekes et al., 2004). Ideally, NSTs should be 
accompanied by an action plan detailing appropriate monitoring procedures for low 
risk patients and clear guidelines for action e.g. food record charts or dietetic referral 
for high risk patients (Elia, 2000). 
Nutrition screening and nutritional assessment are terms that are often used inter-
changeably and it is worth explaining how they differ. 
Both techniques are usually presented as a questionnaire containing variables 
associated with malnutrition, and the responses to the questions are used to determine 
the individual’s nutritional status or risk of malnutrition (Jones, 2006). 
Nutrition screening is the first step in determining nutritional problems. Screening 
should rapidly and accurately identify individuals who should be referred to the 
nutrition specialist (e.g. dietitian, expert clinician) for a further assessment, where it 
would be possible to gather more information and determine if there truly is a 




In general, nutritional assessment continues the data gathering process initiated in the 
screen. The types of data collected in nutritional assessment are often similar to data 
collected in the screening process but in more depth. For example, whereas the screen 
simply determines whether there have been changes in intake, the assessment 
determines the amount of change and the nutrients impacted (Charney, 2008).  
Other examples are presented in the following table, reproduced from “Nutrition 
screening vs. nutrition assessment: how do they differ?” (Charney, 2008). 
 
Table 1.2 - Level of detail of the nutrition screen compared with nutritional 
assessment (Charney, 2008) 
 
Parameters Nutrition Screen 
 
Nutrition Assessment 
Intake Recent changes in intake 
(time period) 
Changes in specific 
nutrient intake 
Changes in energy intake 
Changes in texture 




Change in weight (time 
period) 
Height 
Body mass index 
Body composition 
Medical tests, laboratory 
tests, 
and procedures 
Not usually included Medical diagnosis 
Impact of medical 






Review of systems 
Physical examination 
Patient history Not usually included 
 








According to a review carried out in 2008, the prevalence of hospital malnutrition in 
20 studies conducted in various countries and several groups of diseases after 1990 
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was reported to range between 20% and 50% (Norman et al., 2008). This wide range 
may be partially explained by the different criteria used to diagnose malnutrition. 
Evidence suggests that malnutrition in association with illness is an independent 
predictor of mortality, and these findings apply to heterogeneous populations, 
including young and old hospitalised patients with a wide range of diseases (Landi et 
al., 2000, Gariballa and Forster, 2007). 
Due to impaired immune function, a state of malnutrition has been reported to 
increase the susceptibility to adverse clinical outcomes such as postoperative 
complications (Campos and Meguid, 1992), infections, gastrointestinal haemorrhages 
and pressure sores (Dennis, 2003, Chandra, 1979).   
Cognitive impairment (Correa Leite et al., 2001) and decreased muscle function with 
impaired functional status (Norman et al., 2008) are also associated with poor 
nutritional status. As a result of all these consequences, quality of life can be 
compromised by a state of malnutrition (Vetta et al., 1999).  
Due to an increased morbidity, malnourished patients experience a significantly 
prolonged treatment duration and length of hospital stay (LOS). The average LOS in 9 
studies, conducted in different countries, was increased by 40–70% in malnourished 
patients when compared with the adequately nourished (Norman et al., 2008). 
 
      
 
Economic burden of disease-related malnutrition  
 
Malnutrition poses a greater burden on healthcare resources since malnourished 
patients have more GP visits, more hospital admissions (with 65% and 82% more, 
respectively, for the elderly), longer LOS, and are also more likely to be admitted to 
care homes, when compared with well-nourished individuals (Elia, 2006). 
Amaral et al. suggested that disease-related malnutrition is an important determinant 
of hospitalisation costs, being responsible for an increase in 20% of these costs 
(Amaral et al., 2007). In this study, conducted with 469 hospitalised patients with a 
wide range of diseases, those identified as being nutritionally at risk were more likely 
to be older, thinner, with lower functional capacity, and being transferred from or to 
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other hospitals. Also, the inpatient mortality (11% vs. 2%) and LOS (14.7 vs. 7.6 
days) were significantly higher in this group, which contributes to the increased costs. 
In the United States of America, hospital charges were estimated to be from 35% to 
75% higher for malnourished patients than for well-nourished patients (Gallagher-
Allred et al., 1996). 
Public expenditure on disease-related malnutrition in the UK in 2007 has been 
estimated at in excess of £13 billion per annum, about 80% of which was in England 
(Elia and Russell, 2009). Despite these figures, there is a paucity of Department of 
Health data relating to the burden of malnutrition (Elia and Russell, 2009).  
 
 
The impact of malnutrition may be significantly reduced if it is recognised early and 
treated with relatively simple measures. Effective screening for risk of malnutrition, 
nutritional care planning, delivery of high standards of food service and appropriate 





Potential benefits of nutritional intervention 
 
Given that malnourished patients are more likely to suffer negative outcomes, the aim 
of identifying nutritionally vulnerable patients is to implement nutritional 
interventions that might result in the improvement of these outcomes.  
There are different types of nutritional interventions, such as dietary counseling, food 
fortification, oral nutritional supplements (ONS), enteral tube feeding (nasogastric or 
gastrostomy) and parenteral nutrition. These nutrition support interventions aim to 
meet all patients’ needs regarding energy, protein, fluid and micronutrients (NICE, 
2006a).  
Evidence from systematic reviews and meta-analyses shows that these interventions, 
when used appropriately, result in a number of benefits. Stratton and her colleagues 
concluded that ONS can significantly improve clinical outcome (mortality, 
complication rates and reduced LOS) in certain patient groups at risk of malnutrition 
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(particularly in the hospital setting), which may be due to increase in energy and 
nutrient intake, body weight and muscle mass. Similar conclusions were drawn while 
assessing the effect of enteral tube feeding alone or the combined effect of ONS and 
enteral tube feeding (Stratton et al., 2003, Stratton and Elia, 2007).   These authors had 
the ambitious aim of establishing an evidence base for nutritional interventions in 
different groups of patients and, therefore, reviewed several trials with a wide range of 
interventions, outcomes, conditions and settings, which makes it difficult to present a 
summary of all their analyses and results. For example, one of the aims was to analyse 
the effect of enteral tube feeding (as a sole source of nutrition, as a supplement to food 
intake or in combination with parenteral nutrition) on clinical outcomes of patients in 
hospital (Stratton et al., 2003). Several electronic databases were searched and 74 
trials of enteral tube feeding in the hospital setting were reviewed, which included 
randomised and non randomised trials. Randomised controlled trials (n=33) were 
assessed with the Jadad scoring system, and the majority had low Jadad scores (i.e. 
had poor study designs).  When the outcome was restricted to mortality, 12 trials (n= 
600 patients) had information available on mortality rates in patients with a number of 
conditions: burns, critical illness/injury, gastrointestinal/liver diseases, cancer, 
orthopaedics and surgery. Pooled analysis of the effects of enteral tube feeding (vs. 
routine clinical care or no nutritional support) showed a significantly reduced risk of 
mortality (OR 0.48, 95% CI 0.30-0.78) with no significant heterogeneity between 
studies.  These positive results should, however, be interpreted with caution because 
of the poor quality and small sample sizes of the studies included and their clinical 
heterogeneity (attributable to a variety of underlying conditions). 
While it seems that the beneficial effects of nutritional support are observed when the 
analyses combine studies conducted in patients with a variety of conditions, this may 
not be true for analyses that are condition-specific (e.g. cancer), where the beneficial 
effects are shown to be very limited. For example, a meta-analysis of 13 studies 
demonstrated that oral nutritional interventions (compared with routine care) are 
effective at increasing weight and nutritional intake and improving some aspects of 
quality of life in patients with cancer who are malnourished or are at nutritional risk, 
but failed to show improvement in mortality (Baldwin et al., 2012).  Baldwin and 
colleagues followed the methodology recommended by the Cochrane Collaboration. 
Searches were conducted to find randomised controlled trials or quasi-randomised 
controlled trials undertaken in malnourished or at risk of malnutrition adults with 
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cancer at all sites and all stages; interventions included dietary advice, oral nutritional 
supplements and outcome measures included mortality and quality of life (primary 
outcomes) and weight change and energy intake (secondary outcomes). Subgroup 
analyses were also carried out. The quality of the 13 included studies was clearly 
described and considered to be from low to moderate, and all trials were considered to 
be at risk of bias (e.g. only 1 study reported blinded assessment of some outcomes). 
Risk of mortality between the intervention and control groups was 1.06 (95% CI 0.92-
1.22, with no significant heterogeneity) in 11 studies, with a length that varied from 6 
weeks to 36 months. 
5 studies collected quality of life data from the same cancer-specific questionnaire, but 
they reported results in different components of quality of life. The first analysis 
revealed statistically significant improvements in the majority of the components with 
high heterogeneity; thus, further analyses removed the studies that accounted for 
heterogeneity and showed that interventions resulted in statistically significant 
improvements of 4 components: emotional function, global quality of life, dyspnea 
and loss of appetite. Regarding the effect on nutritional status (data on body weight 
from 8 studies and on energy intake from 4 studies), intervention (vs. routine care) 
was associated with a statistically significant weight gain (mean difference in weight = 
1.86 kg, 95% CI 0.25-3.47, with significant heterogeneity, I
2
=76%) and increase in 
energy intake (mean difference in energy intake = 432 kcal/d, 95% CI 172-693, with 
significant heterogeneity I
2
=97%). However, these results were no longer significant 
after removing the main sources of heterogeneity. 
In addition, a Cochrane review examined trials for improvement in nutritional status 
and clinical outcomes (weight change, dietary intake, mortality, morbidity, functional 
status, among others) when oral protein and energy supplementation was provided to 
elderly people (Milne et al., 2009). Using 6 electronic databases and a hand search, 
authors searched for randomised and quasi-randomised controlled trials of study 
groups with a minimum average age of 65 years, except groups in critical care or 
recovering from cancer treatment. Interventions included commercial sip feeds, milk 
based supplements and fortification of normal food sources, compared with usual 
practice or placebo, for a minimum period of 2 weeks. Further analyses were 
conducted in subgroups of individuals who were undernourished, who were ill, those 
aged 75 years or over, those who received supplements of 400Kcal or more, and those 
who had a longer duration of supplementation (35 days or more). Data extraction and 
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quality assessment of included studies (using a protocol that scores 10 items) was 
carried out by 2 reviewers.   
Heterogeneity was assessed and, when significant (>50%), a random effects model 
was applied. Sensitivity analyses were conducted to assess the influence of study 
quality, of large studies and of studies sponsored by the industry on effect size. 
62 studies with 10187 participants from Europe, USA, Canada, Australia and Hong 
King, were included. 48% of the individuals had no specified disease or condition, but 
other studies included a wide range of diseases or conditions (e.g. stroke, congestive 
heart failure, hip fracture), and 60% of all participants were screened for risk of 
malnutrition, although the method varied between studies (therefore, there was no 
standard methodology to assess nutrition risk). The type and length of intervention 
received also varied between studies, e.g. additional energy varied from 175 to 
1350Kcal/day and protein from 10 to 50g/day, some trials provided extra vitamins and 
minerals, and the intervention period (as well as follow-up period) varied from 10 
days to 18 months.  
Supplementation produced a small but consistent weight gain in older people and 
mortality was reduced by supplementation in older people who were undernourished. 
In other words, the pooled weighted mean difference for percentage weight change 
(which was measured in 42 trials with 3058 participants) in intervention vs. control 
was 2.2% (1.8 – 2.5) with no significant heterogeneity. Risk of mortality by the end of 
the follow-up period for all participants of studies that assessed mortality (n=8031) 
was not significantly reduced for the intervention group vs. control (RR 0.92, 95% CI 
0.81-1.04), but was significantly reduced when analyses were restricted to studies in 
which participants (n=2461) were defined as undernourished (RR 0.79, 95% CI 0.64-
0.97). When analyses were limited to higher quality studies with concealed 
randomisation (n=15 studies, 6604 participants), results were consistent (RR 0.91, 
95% CI 0.79-1.03), and supplementation was beneficial with statistical significance 
(RR 0.78, 95% CI 0.62-0.98) when limited to patients with a variety of geriatric 
conditions (most of them hospitalised, n=2701). 
There may also be a beneficial effect of supplementation on complications (such as 
infective complications and pressure sores) as, in 24 trials, RR of complications was 
0.86 (95% 0.75-0.99) with no statistically significant heterogeneity, but no evidence 
was found of improvement in functional benefit or reduction in LOS with ONS. 
However, the authors noted that most studies had an intervention time that was too 
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short to have a realistic chance of causing differences in morbidity, functional status 
or quality of life. It should be noted that the quality of the majority of the included 
studies was poor, particularly regarding blinding (of outcome assessors, participants 
and treatment providers) and other possible sources of biases include inadequate 
reporting of numbers of participants who were allocated and assessed, and reasons for 
losses to follow-up. Compliance with supplements may be a problem and a limitation 
in studies using supplements and, for those trials that measured it, some of them 
reported problems with acceptance or adverse effects. The symmetrical funnel plot for 
the outcome mortality suggested no evidence of publication bias but the Egger test 
was not conducted. 
 
 




Obesity is a multifactorial chronic disease characterized by an excess of fat in the 
body that has significant health consequences. However, the amount of excess fat, its 
distribution within the body, and the associated health consequences vary considerably 
between individuals with obesity (World Health Organization, 2000).  
Although it affects a wide age range, this thesis will only focus on obesity in adult life. 
 
The prevalence of overweight and obesity is commonly assessed by using body mass 
index (BMI), defined as the weight in kilograms divided by the square of the height in 
metres (kg/m
2
). The WHO defines overweight as a BMI between 25 to 29.9 kg/m
2
 and 
obesity as a BMI over 30 kg /m
2
. Additionally, different classes of obesity are defined: 
class I, BMI 30 - 35 kg /m
2
; class II, BMI 35 - 40 kg /m
2
; class III, BMI greater than 
40 kg /m
2
. The risk of comorbidities associated with obesity is continuous and graded 
and the classification was based on observational and epidemiological studies which 
relate BMI to risk of morbidity and mortality. Normal weight is classified as a BMI 
between 18.5 to 24.9 kg/m
2
 and a BMI less than 18.5 kg/m
2





BMI does not measure body fat mass and may not correspond to the same degree of 
fatness or associated health risk in different individuals and populations; however, it 
allows meaningful comparisons between them and a firm basis for evaluating 
interventions (World Health Organization, 2000).  
 
 
The adipocyte (adipose cell) is not only a store of lipids that can be used to meet 
future needs of the body, it also works as an endocrine cell, being able to 
communicate with the brain in the regulation of various body functions. It is through 
the production of proteins with a prothrombotic action, such as plasminogen activator 
inhibitor-1, and inflammatory cytokines, such as TNF- α, interleukin-6, 
angiotensinogen, adiponectin and others, that the adipose tissue participates in 
mechanisms thatcan lead to hypertension, type 2 diabetes mellitus and cardiovascular 
diseases (Flier, 2004). 
Adipose tissue (composed of adipocytes, inflammatory cells, etc.) is distributed 
throughout the body, being approximately 85% located under the skin (subcutaneous 
adipose tissue) and 15% located within the abdomen (intra-abdominal adipose tissue) 
(Klein et al., 2007). 
Compared with subcutaneous adipose tissue, visceral (intra-abdominal) adipose tissue 
has more cells per unit mass, higher blood flow, more glucocorticoid (cortisol) 
receptors, probably more androgen (testosterone) receptors, and great cathecolamine-
induced lipolysis, which makes this tissue more susceptible to both hormonal 
stimulation and changes in lipid accumulation and metabolism (World Health 
Organization, 2000). 
 
The type of distribution of fat has different associated risks. Abdominal obesity (also 
called android obesity, or central obesity or upper body obesity) is related with an 
increased risk of metabolic complications (such as insulin resistance and raised blood 
pressure), while gynoid obesity - characterised by an more evenly and peripheral 
distribution of fat around the body - is associated with a lower risk (World Health 
Organization, 2000). 
The mechanisms that explain the association between excess intra-abdominal fat 
accumulation (abdominal obesity) and metabolic complications are unknown (Klein et 
al., 2007) but some hypotheses have been proposed. For example, the “lipid overflow-
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ectopic fat model” suggests that excess intra-abdominal fat accumulation may indicate 
that an individual’s subcutaneous adipose tissue is unable to serve as an “energy sink” 
for an energy surplus (due to excess of energy intake and/or reduced energy 
expenditure). This inability of subcutaneous adipose tissue to store the excess energy 
(due to factors such as smoking, genetic susceptibility to abdominal obesity, etc.) 
would result in increased accumulation of fat at undesired locations, such as liver, 
heart, pancreatic β-cells - a phenomenon called ectopic fat distribution. The resulting 
metabolic consequences of this “defect” in energy partitioning include visceral 
obesity, insulin resistance, an atherogenic dyslipidaemia and a pro-thrombotic, 




The amount of abdominal fat can vary dramatically within a narrow range of total 
body fat and BMI, which explains the need of having additional measures to identify 
obesity and its risks (World Health Organization, 2000). 
Waist circumference (WC), measured at the midpoint between the lower border of the 
rib cage and the iliac crest, is a convenient and simple method considered the best 
surrogate of visceral adiposity across a wide age range (Onat et al., 2004). WC 
provides a measure of fat distribution that cannot be obtained by measuring BMI 
(Klein et al., 2007). 
An increased risk of metabolic complications is associated with a WC of 80 cm or 
greater in women and 94 or greater in men; a substantially increased risk is associated 
with a WC of 88 cm or greater in women and 102 or greater in men. However, it 
should be noted that populations differ in the level of risk associated with a particular 











Health consequences and the economic burden of obesity 
 
There are various health problems associated with obesity, with different relative risks 
(RR). Type 2 diabetes mellitus, gallbladder disease, dyslipidemia, insulin resistance 
and sleep apnoea are greatly increased in obese individuals (RR greater than 3). 
Obesity also moderately increases (RR 2-3) the risk for coronary heart disease (CHD), 
hypertension and osteoarthritis, and slightly increases (RR 1-2) the risk for certain 
cancers and reproductive hormone abnormalities. Moreover, abdominal obesity in 
particular is an independent predictor for type 2 diabetes mellitus, CHD, hypertension, 
breast cancer and premature death (World Health Organization, 2000). 
Several benefits of intentional weight loss in these diseases have been described, 
including marked improvements in type 2 diabetes mellitus, dyslipidemia, 
hypertension, cardiovascular risk, ovarian function, breathlessness, sleep apnoea and 
osteoarthritis (World Health Organization, 2000). As an example, a meta-analysis of 
25 randomised controlled trials involving 4874 participants with different ethnicities 
showed a significant reduction in systolic blood pressure of -4.4 mmHg and a 
significant reduction in diastolic blood pressure of -3.6 mmHg for an average weight 
reduction of 5Kg (Neter et al., 2003).  
 
In England, the proportion of men classed as obese increased from 13% in 1993 to 
24% in 2011 and from 16% to 26% for women during the same period. By 2025, it is 
estimated that 47% of men and 36% of women will be obese (NHS, 2013). 
In 2007, estimates of the direct NHS costs of treating overweight and obesity, and 
related morbidity in England were £4.2 billion. The indirect costs estimates ranged 















The WHO defines stroke as “a focal (or at times global) neurological impairment of 
sudden onset, and lasting more than 24 hours (or leading to death), and of presumed 
vascular origin” (World Health Organization, 2006).  
In other words, stroke is a disruption of blood supply to the brain, whether due to 
blood vessel occlusion (ischaemic stroke) or rupture with bleeding (haemorrhagic 
stroke). Cell function and survival is limited by lack of oxygen and nutrients, as the 
blood supply becomes compromised or is interrupted. A zone of cell death is created, 
bordered by a zone of damaged cells (Kidd, 2009). 
The site and extent of this damage within the brain determines whether the stroke is 
fatal or causes permanent or temporary disabilities (Carroll et al., 2001). Although 
some strokes may not totally destroy vital areas of the brain, they can still cause 
ongoing impairment of motor, sensory, or processing pathways and an associated 
degradation of quality of life (Kidd, 2009).  
 
Stroke is just one of a range of disorders affecting the arteries in the brain, collectively 
known as cerebrovascular diseases (Wolfe and Rudd, 2005); and these diseases are 
included on the group of disorders of the heart and blood vessels - the  cardiovascular 
diseases - which are the number one cause of death globally (WHO, 2009).  
 
 
Stroke subtypes and types of stroke events 
 
There are two major stroke subtypes, as mentioned before: the ischaemic and the 
haemorrhagic stroke. 
The ischaemic stroke accounts for approximately 85% of all strokes and is caused by a 
sudden obstruction in an artery supplying blood to the brain (Wolfe and Rudd, 2005). 
Its symptoms last at least 24 hours and may be caused by: 
– a narrowing of the artery (atherosclerotic stroke) 
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– a blood clot forming in the artery (thrombotic stroke) 
– a blood clot or other tissue fragment travelling to the brain from elsewhere in 
the body (embolic stroke). 
The haemorrhagic stroke accounts for the remaining 15% of strokes and leads to a 
bleeding in the brain from a ruptured blood vessel (Wolfe and Rudd, 2005). In the 
same way, its symptoms last at least 24 hours, and the vessel may rupture because it 
is: 
– weakened (e.g. by an aneurysm) 
– abnormally formed (e.g. arteriovenous malformation) 
– subjected to trauma (e.g. a head injury) 
The bleeding may occur in the soft tissues of the brain - intracerebral haemorrhage – 
or in the space between the surface of the brain and the skull (i.e., between the two 
meninges, pia mater and arachnoidea) - subarachnoid haemorrhage (Wolfe and Rudd, 
2005).  
The reference used to provide these figures (Wolfe and Rudd, 2005) is a White Paper 
created by national stroke experts who use mainly worldwide data.  Although there is 
no reference in this white paper related with the proportion of ischaemic and 
haemorrhagic strokes, it seems to be safe to assume that these are worldwide figures. 
Other authors (Markus et al., 2010) state that these are the figures for developed 
countries. 
 
A transient ischaemic attack (TIA) differs from stroke only in degree (Kidd, 2009). 
TIAs are also caused by a blockage in the arteries supplying blood to the brain, or less 
frequently by small haemorrhages, but symptoms are temporary and typically last less 
than 2 hours, although the definition is up to 24 hours (Wolfe and Rudd, 2005). 
 
 
In a WHO manual created for guidance on well-conducted stroke surveillance, (World 
Health Organization, 2006), the following divisions of types of stroke events are 
recommended: 
-  first ever stroke: referring to people who have never had a stroke before, and this 
excludes previous TIAs (as a TIA is not considered a stroke) 
- recurrent stroke: referring to people with history of previous stroke 
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- non-fatal stroke: referring to people who survived at least 28 days after the onset of 
the stroke symptoms. 
- fatal stroke: referring to people who died within 28 days of stroke symptom onset. 
 
 
Symptoms and diagnosis 
 
The brain is a highly complex organ and its different parts control different functions 
of the body. Thus, the consequences of stroke are wide-ranging because they depend 
on the region of the brain affected, as well as the nature and severity of the damage 
(Wolfe and Rudd, 2005).  
The possible symptoms of a stroke are as follows (World Health Organization, 2006). 
 
 
Table 1.3 – List with possible symptoms of a stroke, reproduced from “WHO STEPS 
Stroke Manual” (World Health Organization, 2006) 
 
• Unilateral or bilateral motor impairment (including lack of coordination) 
• Unilateral or bilateral sensory impairment 
• Aphasia/dysphasia (non-fluent speech) 
• Hemianopia (half-sided impairment of visual fields) 
• Forced gaze (conjugate deviation) 
• Apraxia of acute onset 
• Ataxia of acute onset 
• Perception deficit of acute onset  
• Dizziness, vertigo 
• Localized headache 




• Dysarthria (slurred speech) 
• Impaired cognitive function (including confusion) 
• Impaired consciousness 
• Seizures 
• Dysphagia  
 
The clinical impression of focal neurological deﬁcits related to a speciﬁc vascular 
territory is usually followed by a diagnostic workup. This includes the differentiation 
between cerebral infarction and haemorrhage using neuroimaging techniques and a 
search for speciﬁc causes, such as embolism or large artery atherothrombosis (Curioni 
et al., 2009). 
 
The neuroimaging techniques used for the diagnosis of a stroke include a computed 
tomography (CT), which is the most widely available diagnostic method for exclusion 
of alternative diagnoses and to rule out the presence of haemorrhage (that is a 
contraindication to the use of thrombolytic agents) and magnetic resonance imaging 
(MRI), which has excellent capacity to delineate the presence, size, location, and 




The burden of stroke: incidence, mortality and costs 
 
Every year, over 15 million people worldwide suffer a stroke, of which 5 million die 
and another 5 million are left significantly disabled (WHO, 2004). 
Stroke carries a high risk of death, being the third most common cause of death in 
developed countries, exceeded only by coronary heart disease and cancer, as seen in 
figure 1.2, reproduced from “The Atlas of Heart Disease and Stroke” WHO document 
























Fig. 1.1 – Percentages and number of deaths from stroke compared with other causes 
(WHO, 2004)  
 
 
In England and Wales, stroke accounts for 11% of all deaths (RCP, 2012). In England, 
there are at least 110 000 new strokes per annum, nearly 1 million stroke survivors 
and over half are dependent on others for everyday activities (Markus et al., 2010).   
The cumulative risk of stroke recurrence is 26% within 5 years of a first stroke and 
39% by 10 years (Mohan et al., 2011). 
 
The incidence of stroke is declining in many westernized countries, largely as a result 
of reduction of levels of hypertension and smoking (in the stroke population), in 
conjunction with the introduction of statin and antiplatelet therapy for primary 
prevention (in those with vascular risk factors). However, the absolute number of 
strokes continues to increase because of the ageing population (WHO, 2004, Markus 
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et al., 2010).  For instance, in England the proportion of older people is predicted to 
rise from 16% in 2003 to 23% in 2031 (Markus et al., 2010).  Some demographic 
factors, such as sex, age, race or ethnicity have been described to influence the 
incidence of stroke. Almost 1 in 4 men and nearly 1 in 5 women aged 45 years can 
expect to have a stroke if they live to their 85th year. Men have a 25-30% increased 
chance of having a stroke and the incidence doubles with each successive decade over 
the age of 55 years (Wolfe, 2000), having been estimated that 81% of strokes are in 
people more than 64 years old (Carroll et al., 2001). Additionally, African-Caribbean 
and African populations have approximately double the risk of stroke compared to the 
Caucasian population (Wolfe, 2000). 
   
In the first year after a stroke about 30 % of patients will die, most within the first ten 
days (Carroll et al., 2001). The mortality rates are higher for intracerebral and 
subarachnoid haemorrhages than for ischaemic stroke, and higher in Caucasian than in 
African–Caribbean patients (Wolfe, 2000, Andersen et al., 2009). 
 
Stroke is a costly disease because of the large numbers of premature deaths, ongoing 
disability in many survivors, impact on families/carers and impact on health services 
(World Health Organization, 2006). It should be noted that over one-quarter of strokes 
occur in people of working age (Markus et al., 2010). One measure of the burden of 
the disease is called disability-adjusted life years (DALYs), which is the combination 
of years of potential life lost due to premature death with years of productive life lost 
due to disability. The WHO predicts that DALYs lost to stroke will rise from 38 
million in 1990 to 51 million in 2020 (WHO, 2004).  
In 2009, an analysis on the cost of stroke in the United Kingdom from a social 
perspective concluded that the treatment of and productivity loss arising from stroke 
costs £8.9 billion a year, with treatment costs accounting for approximately 5% of 
total UK National Health Service (NHS) costs. Direct care accounted for 
approximately 50%, informal care costs 27% and indirect costs 24% (Saka et al., 
2009). Besides the economic costs, e.g. the cost of healthcare and lost productivity, 
other costs are harder to calculate although  equally important, e.g. the emotional cost 
of losing an important and valuable person through premature incapacity or death 






Stroke is a multifactorial disease where a combination of risk factors influences the 
probability of suffering a stroke. The WHO considers the following major risk factors 
that can be divided into the 3 categories: 
 modifiable:  
hypertension, smoking, physical inactivity, diet (low fruit and vegetable 
consumption), heavy alcohol consumption, overweight, diabetes (and atrial 
fibrillation and other cardiac diseases in developed countries) 
 environmental:  
passive smoking, access to medical treatment. 
 non-modifiable:  
age, sex, ethnicity, family history and genetic predisposition 
The role of hypercholesteraemia as a risk factor for stroke was considered 
controversial, as there is evidence that lower total cholesterol levels might be 
associated with a decreased risk of ischaemic stroke but increased risk of 
haemorrhagic stroke (World Health Organization, 2006). This is supported by a study 
that found that higher total and lower high-density lipoprotein cholesterol levels are
 
associated with increased risk of only ischaemic stroke (Tirschwell et al., 2004). 
Other minor risk factors have been identified, which include drug use, migraine, oral 
contraceptive pill use, infections and thrombophilia (Markus et al., 2010).   
 
Risk factors are reported to be different between ischaemic and haemorrhagic strokes 
(O'Donnell et al., 2010)), between first and recurrent strokes (Carroll et al., 2001), 
between very old (>80 years old) and younger stroke patients (Cristensen et al., 2010) 
and between different ethnic groups (Hajat et al., 2004). 
For instance, in a study that analysed associations between stroke (first ever and 
recurrent) and its potential risk factors using national data, Carroll and his colleagues 
found that the strongest associations with first ever strokes were previous TIA, 
increasing age, atrial fibrillation, diabetes, heart failure, ischaemic heart disease, 
hypertension and smoking. For recurrent stroke, there were statistically significant 
associations with previous stroke, TIA, hypertension, increasing age and diabetes 
(Carroll et al., 2001). 
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It could be argued that stroke risk factors, among other factors (such as stroke subtype 
and severity of stroke), may confound the relationship between nutritional status and 
mortality. Thus, later in this thesis (chapter 3 and 4), the variables presented in the 
following table were considered to be potential confounders and/or effect modifiers 
and treated as such in the multivariable models.  
 
 
Table 1.4. - Potential confounders, effect modifiers and the direction of the association 
between these parameters with the exposure (indicators of nutritional status such as 
BMI and risk of malnutrition) and the outcome (mortality) 
 
Potential confounders 
and effect modifiers  
Direction of association Reference(s)   
Age  
 
- obese stroke patients tend 
to be younger (than non-
obese), and the association 
between BMI and 
mortality may be different 
in different groups of age 









(Yoo et al., 2008) 
Gender - among stroke survivors, 
women are more likely to 
have a higher BMI  
- women have strokes later 
in life; stroke mortality 
rate is higher in men 
among those younger than 
65 years but higher in 
women among patients 
aged 75 years or older 
(Towfighi and Ovbiagele, 
2009) 
 
(Haast et al., 2012) 
Ethnicity - black stroke patients have 
higher rates of obesity and 
white stroke patients have 
a higher risk of mortality 
(Markus et al., 2007) 
 
(Wolfe et al., 2005) 
 
Type of stroke 
 
 
- the type and severity 
stroke are strongly linked 
to mortality, e.g. 
haemorrhagic strokes tend 
to be more severe and 
associated with increased 
mortality 
- nutritional status may be 
associated with type of 







(Choi-Kwon et al., 1998) 
(Ryu et al., 2011) 




stroke and severity of 
stroke e.g. malnutrition 
(including low BMI) is 
more prevalent in 
haemorrhagic strokes and 
is associated with higher 
NIHSS scores 
(Yoo et al., 2008) 
Stroke risk factors * 
- hypertension,  
- diabetes,  
- dyslipidemia,  
- smoking,  
- IHD,  
- heart failure,  
- atrial fibrillation,  
- previous TIA  
- heavy alcohol 
consumption 
- high total and lower HDL 
cholesterol increases  risk 
of ischemic stroke 
- heavy alcohol 
consumption  increases   
risk of total stroke 
(stronger association with 
haemorrhagic stroke) 
- all other risk factors 
increase the risk of total 
stroke 
- the majority of the risk 
factors are positively 
associated with BMI and 
have a similar effect (i.e. 
increased risk) on stroke 
incidence as on stroke 
mortality 
(Tirschwell et al., 2004) 
  
 





 (Carroll et al., 2001, 
Andersen et al., 2009) 
 
(Hart et al., 2000) 
 
*These stroke risk factors were slightly different between chapter 3 (hypertension, CCF, 
angina, myocardial infarction, TIA, migraine, atrial fibrillation, diabetes, depression, 
hypercholesterolaemia) and chapter 4 (hypertension, diabetes, dyslipidemia, smoking, IHD, 
heart failure, atrial fibrillation, previous TIA and heavy alcohol consumption) – selected by 
myself, before collecting the data. In chapter 3, I had to use the risk factors that were available 
in the SLSR database and that were provided to me. In Chapter 4, these risk factors were 
selected by myself, while designing the study, and were based on studies that determined the 















1.3 – Malnutrition and stroke 
 
The prevalence of malnutrition among stroke patients and its consequences has been 
studied by several authors.  
When nutritional status is assessed in the acute stage after stroke, i.e. within a few 
days after hospital admission, prevalence of malnutrition has been reported to be 
between 9 and 62% (Axelsson et al., 1988, Dennis, 2003, Yoo et al., 2008, Westergren 
et al., 2001a, Choi-Kwon et al., 1998, Davalos et al., 1996) . Some studies have 
observed that the nutritional status of a significant proportion of patients deteriorates 
during hospital stay (Axelsson et al., 1988, Yoo et al., 2008, Mosselman et al., 2013, 
Davalos et al., 1996) and others have reported a high prevalence of malnutrition 
(affecting half of participants) at admission to rehabilitation services, with a mean of 
22 days after stroke (Finestone et al., 1995). 
 
Compared with the adequately nourished, malnourished stroke patients are more likely 
to have an increased mortality and morbidity, including poor clinical outcomes 
(development of more infections and pressure sores), functional outcomes (with a 
higher dependency, lower mobility and capacity for self care) and longer length of 




An international multicenter randomized trial “Feed Or Ordinary Diet” trial (FOOD 
trial) was conducted to evaluate various feeding policies on stroke patients (Dennis et 
al., 2006). A total of 5033 participants were enrolled between 1995 and 2003, and an 
observational study was conducted with the first 3012 patients to determine whether 
baseline nutritional status (mainly based on “bedside assessment”) was an independent 
predictor of 6-month outcome after stroke. Of the 275 (9%) undernourished patients, 
37% were dead by final follow-up compared with only 20% of patients with “normal 
nutritional status”. This relationship was maintained after adjustment for age, pre-
stroke functional state, and stroke severity. Undernourished patients had statistically 
significant higher rates of pneumonia, other infections, pressure sores and 
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gastrointestinal haemorrhages during their hospital admission, when compared with 
those classified as “normal” and “overweight” (Dennis, 2003). 
Similar findings were obtained by Davalos et al in 1996, in a study that included 104 
patients admitted to hospital within 24h post stroke. Their nutritional status was 
assessed on admission and after 1 week: 16% were considered to be malnourished on 
admission and 26% at 1 week, as defined by a serum albumin less than 35g/L or a 
triceps skinfold thickness or the mid-arm muscle circumference less than the 10
th
 
percentile of their reference population. When compared to patients with normal 
nutritional parameters, malnourished patients (after the first week of hospitalisation) 
had significantly higher levels of urinary cortisol (increased stress reaction, p=0.025), 
higher frequency of respiratory or urinary infections (50% vs. 24%, p=0.017) and 
bedsores (17% vs. 4%; p=0.054), increased number of deaths at 1 week (5 vs. 1 
patient, p=0.005), poor functional capacity at 1 month (Barthel Index ≤ 50: 70.8% vs. 
35.8%, p=0.012) and a longer duration of hospitalisation (median of 28 days vs. 17 
days, p=0.001) (Davalos et al., 1996). However, when severity of stroke and 
swallowing disability at admission were included in the logistic regression model, 
malnutrition was not selected as an independent predictor of poor prognosis (death or 
Barthel Index ≤ 50 at 1 month). This may be partly explained by the criteria used to 
define malnutrition (as explained below, in the next page, albumin is not a good 
indicator of nutritional status in periods of acute illness), by the relatively small 
sample size or the relatively short follow-up period. Thus, stroke severity and 
swallowing disability seem to be important determinants of poor prognosis and any 
future study will need to take these into account and will need to be large enough to 
test whether there is an effect of malnutrition that is independent of these factors. 
Gariballa et al aimed to measure the effect of nutritional status in 201 hospitalized 
stroke patients on clinical outcome, using a variety of anthropometric and biochemical 
parameters. After adjusting for age, comorbid conditions, sex, medications and stroke 
severity, serum albumin (that was used as an indicator of nutritional status) was 
related to mortality at 3 months after admission. For every 1g/L increase in serum 
albumin the hazard ratio (HR) was 0.91 (95% CI: 0.84, 0.99) (Gariballa et al., 1998a).  
 
Although albumin and pre-albumin are often used in nutritional assessment, the 
hepatic production of these proteins is down-regulated during periods of acute illness 
(Gabay and Kushner, 1999); thus, they are often an indicator of illness rather than 
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nutritional status. Other biochemical markers have been used in the evaluation of 
nutritional assessment, such as serum transferrin, thyroxin binding pre-albumin, 
retinol binding protein and total lymphocyte count, but they are not specific to 
nutritional status and/or have poor sensitivity and specificity. Unfortunately, many are 
affected independently by factors associated with stroke (or any other acute illness), 
which makes it difficult to assess malnutrition and the response to nutritional 
interventions (Foley et al., 2012). 
 
Nutrition assessment tools were also used in stroke patients to assess their nutritional 
status. One study used the “Subjective Global Assessment” tool (Detsky et al., 1987) 
to identify malnourished patients (16%), who had a poor stroke outcome (as defined 
by the modified Rankin Scale) and a higher risk of mortality, although the initially 
significant crude association was no longer statistically significant after adjustment for 
possible confounders (Davis et al., 2004).  
A further development of this tool, the “patient generated subjective global 
assessment”(Ottery, 2000), was used one year later, in 73 patients admitted to an acute 
stroke unit (SU) (Martineau et al., 2005). Fourteen (19.2%) patients were identified as 
being malnourished and, compared to well-nourished patients, they had a significantly 
longer length of stay (13 vs. 8 days), increased complications (50% vs. 14%), 
increased frequency of dysphagia (71% vs. 32%) and were more likely to be on 
modified texture diets (MTD) or enteral feeds (93% vs. 59%). In this study, no 
association was found between serum albumin level and outcomes or nutritional 
status. 
 
There appear to be no studies determining the association between risk of malnutrition 
and outcomes post-stroke. There is one study where patients were screened before 
entering an intervention trial. Ha et al. examined the effect of individualised 
nutritional support on weight loss and functional outcomes in stroke patients aged 65 
years or older (Ha et al., 2010). However, the assessment of nutritional risk status was 
carried out using a modified version (by the authors) of a published NST (the 
“Malnutrition Universal Screening Tool” (Elia et al., 2003)). Furthermore, this 
original NST was previously validated for other  populations, not for stroke (Stratton 





Patients who suffer a stroke can be already malnourished, and a further deterioration 
of nutritional status after stroke can be explained by several factors.  
In a systematic review of 8 studies that examined both swallowing and nutritional 
status of subjects following a stroke, the odds of being malnourished were increased 
given the presence of dysphagia (Foley et al., 2009a).  
Dysphagia is defined as a difficulty with swallowing, characterised by a reduced 
coordination of pharyngeal muscles. After stroke, the incidence of dysphagia has been 
reported to range between 33 to 81%  and, if not well managed, dysphagia can lead to 
aspiration, pneumonia, dehydration, weight loss and malnutrition, among others 
(Vivanti et al., 2009). 
Current guidelines recommend that “people with acute stroke who are unable to take 
adequate nutrition and fluids orally should receive tube feeding with a nasogastric 
tube within 24h of admission or be considered for a nasal bridal tube or gastrostomy if 
they are unable to tolerate a nasogastric tube (…)” (RCP, 2012). As dysphagia 
improves and the risk of aspiration lessens, MTD can be introduced.  
These diets are typically based in distinct consistencies (National Patient Safety 
Agency Dysphagia Expert Reference Group, 2011), from thin custard consistency to 
soft and moist foods, which may help to prevent aspiration pneumonia.  
However, the nutritional adequacy of MTD has been questioned. Wright and her 
colleagues found that older people on MTD had a statistically significant lower intake 
of energy and protein than those consuming a normal hospital diet (Wright et al., 
2005). In stroke patients, it was observed that those receiving enteral tube feeding 
consumed more energy and protein compared with those patients on regular diets or 
MTD (Foley et al., 2006). Moreover, another study demonstrated that individuals with 
dysphagia requiring thickened fluids are unlikely to meet any published estimated 
minimum fluid requirements, unless enteral or parenteral fluids are received (Vivanti 
et al., 2009). 
 
For those who do not have dysphagia, a wide range of ongoing eating problems and 
impairments (as a consequence of the stroke) may affect food choices, preparation and 
consumption. They include upper limb motor/sensory impairment, functionally 
useless arm, visual/perceptual and communication deficits, lip closure difficulties, 
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chewing difficulties (due to facial weakness), postural instability, etc., which may 
contribute to the deterioration of nutritional status (Cairella et al., 2004).  
 
At the gastrointestinal (GI) level, ischaemic stroke may disrupt neuronal modulation 
of oropharyngeal and/or GI motility by interrupting or altering the flow of information 
from the cortex to the lower regulating centers, which may cause not only the already 
mentioned dysphagia, but also GI dysmotility and haemorrhage (Schaller et al., 2006). 
All these factors could also affect nutritional status and stroke recovery. As an 
example, delayed gastric emptying can cause intolerance to enteral nutrition and 




The wide range of estimates of malnutrition after stroke might be due to differences in 
patient characteristics, the definition of malnutrition, as well as the timing and 
methods of assessment, many of which have not been validated previously (Foley et 
al., 2009b). To date, no published studies have validated a NST for use specifically in 
stroke patients (Foley et al., 2012, Cairella et al., 2004, SIGN, 2010). 
This justifies the need of finding validated tools for this particular population to 
identify those patients who are malnourished or at risk of malnutrition and, therefore, 
more likely to benefit from nutritional interventions.  
A small number of studies (Dennis et al., 2006, Gariballa et al., 1998b) tried to 
evaluate the effect of ONS in acute stroke patients (further information is provided in 
section 4.6). This nutritional intervention had no significant effect on important 
outcomes such as death, functional status, LOS and infections, probably because these 
studies failed to systematically identify patients at risk of malnutrition using a 
validated method.  
As mentioned before, within the non-stroke population, timely nutritional 
interventions have been shown to result in improved outcomes of nutritionally 
vulnerable patients (Stratton and Elia, 2007, Kruizenga et al., 2005, Stratton et al., 
2003) but there is a lack of good quality evidence in several areas of nutritional 
support on stroke patients, and the ideal methods and routes of feeding are yet to be 
determined (Gomes et al., 2014).  
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1.4 – Obesity and stroke 
 
In 2010, a meta-analysis of prospective studies with 2 million participants, from both 
Western and Eastern countries analysed the relationship between overweight, obesity, 
and incidence of ischaemic and haemorrhagic stroke (Strazzullo et al., 2010).  
Following a literature search conducted in 3 databases from January 1966 through 
May 2009, the quality of the studies was evaluated and 25 cohorts were included in 
this meta-analysis, which had a minimum follow-up period of 4 years and involved 
participants from 10 countries (from Asia, Europe, United States of America, but not 
from Africa or Latin America). The quality of the included studies was evaluated by 
the Downs and Black score system and the authors were satisfied with the fact that all 
studies had a quality score of at least 15 out of 19. However, the Cochrane Handbook 
for systematic reviews discourages the use of scales with a scoring system, because 
calculating a summary score implies the assignment of “weights” to different items in 
the scale, and it is difficult to justify the weights assigned (Higgins and Altman, 2008) 
In this systematic review, overall scores are presented for each study, but the detail of 
the domains missing in each study is not reported. 
These authors found that, when compared with the normal weight group (BMI < 
25Kg/m
2 
for Western populations and BMI < 23Kg/m
2 
for Eastern populations), the 
unadjusted RR for ischaemic stroke was 1.22 (95% CI 1.05-1.41) for overweight and 
1.64 (95% CI 1.36-1.99) for obesity. For hemorrhagic stroke, unadjusted RR was 1.01 
(95% CI 0.88-1.17) for overweight and 1.24 (95% CI 0.99-1.54) for obesity. 
Another set of analyses was conducted, using the RR or HR adjusted for all the 
confounders included in each study. The number and type of confounders varied 
between studies, e.g. all of them controlled for the effect of age but not for the effect 
of oral contraceptives or intake of specific nutrients. This may contribute to the 
heterogeneity between studies. The significant association between overweight, 
obesity and risk of ischaemic stroke was maintained, although the strength of the 
association was attenuated (adjusted RR was 1.18 (95% CI 1.08-1.28) for overweight 
and 1.50 (95% CI 1.34-1.67) for obesity). The association with hemorrhagic strokes 
was not statistically significant (adjusted RR was 1.14 (95% CI, 0.96-1.37) for 
overweight and 1.34 (95% CI, 1.01-1.79) for obesity). When compared with other 
stroke risk factors, the risk of ischaemic stroke attributed to obesity (OR 1.50, 95% CI 
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1.34-1.67) is smaller than that posed by diabetes (OR 1.60, 95% CI, 1.29-1.99) or 
smoking (OR 2.32, 1.91-2.81) or hypertension (OR 2.37, 2.00-2.79) but greater than 
that associated with heavy alcohol consumption (OR 1.41, 1.09-1.82) (O'Donnell et 
al., 2010). 
Authors also conducted sensitivity analyses and tested these results for evidence of 
publication bias and heterogeneity (table 1.5) and searched for sources of 
heterogeneity. None of these factors were identified as significant sources of 
heterogeneity in the relationship between excess of body weight and ischaemic stroke: 
gender, age, baseline BMI and blood pressure, year of recruitment or publication and 
length of follow-up. Geographical origin was not a statistically significant source of 
heterogeneity (p=0.10) but results suggested that excess of body weight was a better 
predictor of ischaemic stroke in European and American populations (pooled RR 
1.55) than in the Asian individuals (RR 1.08). Moreover, authors used the pooled 
estimates from random effects models because the tests for heterogeneity were 
statistically significant in all analyses. These models allow for differences in the 
treatment effect from study to study and account for unexplained heterogeneity (Riley 
et al., 2011).  
 
 
Table 1.5 – Heterogeneity, publication bias and sensitivity analysis, according to 
groups of total stroke, ischaemic stroke and haemorrhagic stroke (Strazzullo et al., 
2010) 
 Heterogeneity  
 
Publication bias Sensitivity 
analyses 
Overweight vs. normal weight, 
 
 
obesity vs. normal weight,  

















Yes (Egger test, 
p=0.01) but no missing 





“For both analyses, 
the stroke risk did 
not vary 
substantially with 
the exclusion of 
individual studies” 
Overweight vs. normal weight, 
 
 
obesity vs. normal weight,  









No (Egger test, p=0.32) 
 
 
Yes (Egger test, 
p=0.002) but no 
missing study was 
 
“Sensitivity analysis 
showed the pooled 
estimate did not vary 
substantially with 





=88%) identified by the trim-
and-fill method  
one study” 
Overweight vs. normal weight, 
 
 
obesity vs. normal weight,  














No (Egger test, p=0.18) 
 
 




showed the pooled 
estimate did not vary 
substantially with 





Despite the authors recognising the possibility of publication bias, they reinforced the 
claim in favor of strong educational campaigns focusing on prevention of obesity, due 
to the statistically significant graded association between excess body weight and 
incidence of ischaemic stroke (Strazzullo et al., 2010).  Two further important 
limitations of this study were the lack of analysis on the effects of body fat 
distribution, accounting for the effect of visceral and subcutaneous adiposity and the 
lack of information in the category of BMI < 25Kg/m
2
 (where no distinction was 
made between normal weight and underweight categories) and the association with 





The relationship between stroke and obesity might be explained by the fact that some 
modifiable risk factors for stroke are associated with obesity. As mentioned in section 
1.1.3, general and abdominal obesity increases the risk of type 2 diabetes, 
dyslipidemia, hypertension and CHD, which all play an important role in the 
epidemiology of stroke (Markus et al., 2010).  The increased risk
 
of stroke in obesity 
may also be predicted by the prothrombotic/ proinflammatory
 
state that so often 
accompanies excessive adipose tissue accumulation (Poirier et al., 2006). 
 
While analysing the effect of obesity on the risk of stroke, some studies find that this 
was attenuated after adjustment for risk factors such as hypertension, 
hypercholesterolemia, and glucose intolerance. Nevertheless, Lawlor and her 
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colleagues defend that “as these risk factors are likely to be on the causal pathway 
between obesity and stroke, the attenuation of effect with their adjustment should not 
be interpreted as indicating that obesity is not causally related to stroke risk” (Lawlor 
et al., 2006). 
 
 
Given this association between obesity and stroke, drawn from observational studies, 
it would be expected that weight reduction in overweight or obese people should have 
positive health consequences, lowering the risk of strokes. Thus, a systematic review 
was conducted to assess the effects of weight reduction for primary prevention 
(prevention of a first stroke) of stroke in adults with overweight and obesity (Curioni 
et al., 2009). No trials were found in the literature for inclusion in this review, and 
therefore, the authors concluded that recommendations for weight reduction in persons 
with overweight or obesity to prevent a first stroke are still not based on strong 
scientific evidence. The urgent need for well-designed multi-centre randomised 
controlled trials assessing this issue was identified. 
  
The current national clinical guidelines for secondary prevention of stroke state that 
the risk of a recurrent event may vary significantly between individuals according to 
underlying pathology, comorbidities and lifestyle factors (RCP, 2012). 
The same guidelines recommend that patients who are overweight or obese should be 
advised to lose weight, by receiving advice and support for this purpose (RCP, 2012), 
although the authors recognise that the evidence in this area of lifestyle measures 
relates mainly to primary prevention of vascular events. 
Furthermore, guidelines of the American Heart Association/American Stroke 
Association on prevention of stroke in patients with stroke or TIA point out that the 
complex relationship of obesity and weight to stroke has been studied mostly in 
relation to primary prevention and no studies have demonstrated that weight reduction 
reduces risk of stroke recurrence (Furie et al., 2010). 
Thus, there is no strong evidence that supports the recommendations for weight loss in 





It is known that there are several nutrients that may potentially influence the risk of 
stroke (or its risk factors, e.g. hypertension, diabetes, dyslipidemia). Although it was 
not the purpose of this thesis, the associations (drawn from observational studies) for 
some key nutrients have been identified: 
- Salt 
High salt (sodium) intake is associated with an increased risk of stroke (Gardener et 
al., 2012), possibly because salt has an important role in regulating blood pressure and 
this is a major stroke risk factor. 
- Calcium and vitamin D 
Intakes of calcium and vitamin D have been inversely associated with risk of 
hypertension and risk of stroke (Iso et al., 1999, Wang et al., 2008) 
- Fats 
Higher intakes of total fat intake and lower levels of PUFAs in erythrocytes have been 
associated with a higher risk of stroke (Boden-Albala et al., 2009, Park et al., 2009) 
possibly due to the role that dietary fat has in controlling plasma lipid profile, insulin 
resistance, glucose intolerance, among others. 
- Antioxidants, such as vitamins A, C, E and selenium 
Dietary intake of antioxidants has been inversely associated with risk of stroke, 
possibly due to the role of these nutrients in reducing the reactive oxygen species and 
reactive nitrogen species, and thus inhibiting the atherosclerotic process (Rautiainen et 
al., 2012).  
 
  
The aim of this thesis was to determine the association between nutritional status and 
outcomes after a stroke. The next three chapters will describe the three studies (of 
gradually increasing complexity) designed to explore this association, exploring the 


















 Predictive validity of the Nutrition Screening Tool 
currently used in  


















2.1 – Introduction 
 
Elderly and stroke patients are particularly susceptible to nutritional depletion, for 
several reasons. In the elderly population, this might be due to decline in physiological 
and psychological functions, social determinants, medication, chronic illness or 
hospitalisation, among others (Brownie, 2006).  
As discussed, there are several conditions in stroke patients (in its majority, also 
elderly), such as perceptual impairment, swallowing disorders or limb weakness, that 
may reduce the desire and/or the ability to eat (Pennington, 1998). Unless these 
problems are recognized and managed effectively they can lead to nutritional 
depletion. 
 
As mentioned before, one way of identifying patients with nutritional problems that 
might be amenable to nutritional intervention is to use a validated NST.  
 
The differences between nutritional screening (tools) and nutritional assessment 
(tools) were previously described in chapter 1. This study will only focus on the 
purpose of screening, since  NSTs are advocated as tools that healthcare professionals 
(who have received training) should be able to use in all health and other care settings 
including day care, sheltered housing and domiciliary settings (Brotherton et al., 
2010). Furthermore, literature presents more studies on the assessment of nutritional 
status than on the screening of nutritional risk. 
 
The National Institute for Health and Clinical Excellence (NICE) and the British 
Association for Parenteral and Enteral Nutrition (BAPEN) recommends that all 
patients should be screened routinely on admission to hospital, at regular intervals 
throughout their stay and during outpatient and GP appointments (Sizer, 1996, NICE, 
2006a). Thus, a NST should be easy to use by health care professionals with little 
training in nutrition, so all the individuals can be screened, and should be quick to 
perform, particularly in busy hospital wards. It should also be reliable and valid, since 
the performance of an instrument is assessed in terms of reliability and validity (Jones, 




Jones describes that “reliability measures the agreement between the results of the tool 
when administered by different users (inter-rater) or on different occasions (intra-
rater). Good agreement when more than one user applies the tool to the same subject, 
at a similar point in time, implies that use of the tool is not dependent upon the 
particular user.” The inter-rater reliability has the most relevance for NST, since 
demonstration of a high inter-rater reliability is enough to consider that the tool is 
reliable (Jones, 2006). 
Validity indicates whether an instrument measures what it purports to do and there are 
several ways of approaching an assessment of a tool´s validity (Jones, 2006). An 
important type of validity is the predictive validity or the ability to predict clinical 
outcomes, with its economic implications (Stratton et al., 2006).  
 
Anthony defends that “a valid screening tool will be appropriate for the targeted 
population, disorder, diagnosis, or setting and will help demonstrate effectiveness 
related to positive health outcomes”. On the other hand, using a non validated 
screening tool may lead to misclassification of patients, which can result in failing to 
deliver interventions to those who need and/or wasting resources (and possibly cause 
some harm) on those who do not need (Anthony, 2008).  
Thus, a NST should be able to identify patients who are nutritionally at risk, and 





The NST currently in use in Guy’s and St Thomas’ NHS Foundation Trust (GSTT 
NST) (Weekes et al., 2004) was designed based on BAPEN recommendations, which 
are composed of four questions and two measurements and were proposed by a 
BAPEN Working Party in 1995 (Lennard-jones et al., 1995). The tool was designed 
for use within 72 h of admission and weekly throughout a patient’s hospital stay, in 
order to monitor any changes. 
 
Some types of validity of this tool have previously been assessed in different 
populations (Weekes and Elia, 2002, Weekes, 2005), as detailed in the “Discussion” 
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section of this chapter, but not the predictive validity for stroke and elderly care 
patients.  
 
This study was based on a MSc project that was already being carried out in 3 elderly 
care wards and on the SU of St. Thomas’ Hospital (STH). 
 
Details of risk status were obtained from the GSTT NST, during recruitment on the 
wards by the MSc student, Ms. Aoife Feeney. I was responsible for collecting the 
follow-up/outcome data (up to one year) on computerised medical records for each 
recruited patient as well as its statistical analysis.  
In particular, I decided which tests would be used depending on the type of variable 
(e.g. categorical vs. continuous) and on whether data from continuous variables fitted 
the normal distribution (and, when needed, I log-transformed it), which would 
determine the use of parametric or non-parametric tests. Initially, I discussed these 
decisions with both supervisors and one statistician (Mr Peter Milligan) to ensure that 
I was going in the right direction and making the right interpretation of the results, but 
all statistical analyses were carried out by the author.  
The post-hoc analysis to assess the effect of possible confounders on mortality and 
LOS was, unfortunately, limited to the baseline data collected by others (Ms Feeney 




2.2 – Aim and hypothesis  
 
The aim of this study was to assess the predictive validity of the GSTT NST in a 
group of elderly and stroke patients. This includes the collection of outcomes 
regarding mortality (primary outcome) and LOS (secondary outcome) during 1 year 
after recruitment. 
 
The main hypothesis was that the GSTT NST can be used to predict negative 
outcomes in nutritionally-at-risk stroke and elderly care patients. 
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In particular, it was hypothesised that there is a significant difference in rates of 
mortality and LOS (median number of days of all non-elective hospital admissions) 




2.3 - Methods  
 
2.3.1 – Recruitment, inclusion criteria and ethical considerations 
 
Patients are admitted to the elderly care wards of STH is they are 65 years or older and 
have age related significant problems such as the geriatric syndromes of falls, 
incontinence, delirium, dementia or loss of mobility.  
During approximately 6 weeks, between the 22
nd
 February and the 15
th
 April 2010, all 
patients consecutively admitted to the SU and 3 elderly care wards at STH were 
included in this study. In order to increase the sample size and the power of this study, 
data previously collected (between the 4
th
 and the 20
th
 of November 2009, on the same 
wards) by a temporary research dietitian – Ms. Rebecca Prior - were also included in 
this study.  
 
Ethical approval was obtained from Guy’s and St Thomas’ NHS Foundation Trust 
Research Ethics Committee (reference number RJ1 07/0124). 
Consent was not required since the study involved undertaking a routine procedure 
(i.e. nutrition screening) and we were not presenting any patient identifiable data.  
 
All patients consecutively admitted to the wards were included in this study and those 
who were screened by the nurses were allocated to a nutrition risk category, according 
to the GSTT NST score:  
•  low risk (score = 0)  
•  medium risk (score = 2) 




The screening scores and baseline characteristics (e.g. age, gender and pathologies) of 
patients were collected by Ms. Feeney and Ms. Prior from medical records. Ms. 
Feeney also assisted in the screening of some patients who were able to stand. She 
aimed to assess the predictive validity of this NST, considering only 1-month 
outcomes for those patients she had recruited (n=143). Ms. Prior´s aim was to assess 
the accuracy and completion rates (by the nurses) of this tool on patients she had 
recruited (n=65). 
 
The GSTT NST includes questions on recent unintentional weight loss, loss of 
appetite/decrease in dietary intake, inability to eat for more than 5 days and height and 
current weight (body mass index) - appendix 2.1. Each question has an associated 
score. The total score of the sum of the questions is then translated into a level of risk: 
low or medium or high, as explained above. Patients at high risk should be referred to 
a dietitian for assessment. 
Additionally, if a patient has a BMI < 18.5 Kg/m2 or is on tube feeding or parenteral 
nutrition or has grade 3-4 pressures sores, he/she should have the same action plan that 
patients on high risk have, which is the referral to the dietitian, because anyone 
fulfilling any of these 3 conditions is considered to be at high risk. 
This information is collected routinely by nurses for each patient on admission to 
hospital, including height (that can be measured or recalled) and weight, using Seca 
clinical chair scales or, when not possible, hoist weighing scales available on the ward 
and calibrated regularly. 
 
When available in the medical notes, the National Institutes of Health Stroke Scale 
(NIHSS) score for each stroke patient was recorded. 
This scale is a systematic assessment tool that provides a quantitative measure of 
stroke-related neurologic deficit. It is valid for predicting lesion size and can serve as 
an international measure of stroke severity (NIH, 1999-2010). A maximal score of 42 







2.3.2 – Follow-up procedure 
 
I conducted the retrospective review of the Trust computerised medical records on the 
20
th
 April 2011, to establish each patient’s cumulative LOS for all non-elective 
hospital admissions to STH and mortality (when applicable) at 1 month, 3 months, 6 
months and 1 year after admission.  
 
The cumulative LOS is the number resulting from the sum of the days in each non-
elective hospital admission, including the initial admission after recruitment, during 
the follow-up period (up to 1 year), for those patients who survived.  
 
In order to know how the record of deaths is obtained at STH, it was necessary to 
contact the person responsible for these records. According to the information 
provided by the Head of Information Analysis at Guy´s and St Thomas´ NHS 
Foundation Trust (GSTT), he is notified electronically of deaths that occur after 
discharge, for patients that the Trust has previously treated. A report is run weekly to 
list deaths of these patients via a NHS number, the “Summary Care Records”, using 
the NHS number of each patient. Thus, collecting mortality data using computerized 




2.3.3 - Statistical analysis 
 
1. Patients were classified into 3 categories of nutritional risk according to GSTT NST 
score: low, medium and high.  
2. The demographic characteristics of patients’ in each risk category were compared 
using the Chi-square test for categorical variables and the one-way analysis of 
variance (ANOVA) for continuous variables. 
3. The Chi-square test was conducted to compare mortality rates between NST risk 
categories. LOS data were tested for normality using the Kolmogorov-Smirnov test; 
data that were not normally distributed were log-transformed and tested again for 
normality. In order to compare LOS (of those patients who survived) between 
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categories, non parametric tests (e.g.  Kruskal-Wallis test) were used for the non-
normally distributed data and parametric testes (e.g. ANOVA) were used on data that 
fitted the normal distribution.  
4. A post-hoc analysis to assess the effect of possible confounders (e.g. age and sex) 
on mortality and LOS (ranked or log-transformed) included a binary logistic 
regression and univariate analysis of variance. 
5. The data were also analysed by combining the 3 GSTT nutrition risk categories into 
2 categories (low and medium vs. high; low vs. medium and high). 
 
Data were analysed using SPSS software version 19.0 for Windows (Chicago, Illinois, 
USA). Any differences were considered statistically significant when p < 0.05. 
 
 
2.4 – Results 
 
From a total of 208 patients admitted to the wards, 65 were recruited in November 
2009 and 143 were recruited in March and April 2010. From the total of 208 patients 
included in this study, only 182 (87.5%) had the GSTT applied on admission. Reasons 
for not screening may include the patient being discharge before screening and 
severity of illness, i.e., when the patient was not supposed to receive any active 
treatment due to entry on the Liverpool Care Pathway. 
 
Differences between patients who had and had not the GSTT NST applied on 
admission are shown in table 2.1. There were no statistically significant differences 
regarding gender and age between the groups (p=0.140 and p=0.265, respectively), 
which suggests that the sample used to assess the predictive validity of the NST did 








Table 2.1 – Characteristics of patients who were and were not screened for the risk of 
malnutrition 
Patients screened 









































      (100%) 
75.8  
(16.6) 






 - ANOVA, p=0.265 
b




Table 2.2 shows the categorisation of patients in each nutritional risk category, and 
their characteristics with regards to age, gender and BMI. The mean age was 75 years, 
in a group that included patients from 25 to 106 years, with 54% being women. 
 




















































































13.0 – 41.9 
a
 - ANOVA, p=0.024 
b




Fifty eight (32%) patients were categorised as being at high risk of malnutrition, and 
this was the group that presented the highest mean age and the lowest mean BMI. The 
greater the NST risk, the higher was the mean age, with a statistically significant 
difference between the mean age of each group (p=0.024). 
The distribution of patients according to gender in each NST risk category was similar 
(p=0.925).  
 
With regards to the diagnoses of the individuals, there was a wide range of 
pathologies, with many patients presenting multiple diseases, which prevented the 
analysis of diseases prevalence. Some examples of the pathologies mentioned in the 
medical records included vitamin B12 deficiency, constipation, hypertension, type 2 
diabetes mellitus, shortness of breath due to stage 4 metastatic lung cancer, 
exacerbation of chronic obstructive pulmonary disease, renal failure, unexplained 
falls, anaemia, acute confusional state secondary to urinary tract infection, community 
acquired pneumonia, viral illness, etc. 
 
 
Some of the individuals in this study were recruited from the SU but not all of those 
admitted at the SU received a diagnosis of stroke. 
The number of patients who were diagnosed as having a stroke in this admission was 
too small (n=25, 14%) for a valid statistical analysis of the predictive validity of the 
GSTT in stroke alone. However, the baseline characteristics of this group of patients, 













Table 2.3 – Baseline characteristics of patients who had a stroke in this admission, 





















































































17.7 – 34.6 
a
 - ANOVA, p=0.394 
b
 - Chi-square test, p=0.575 
 
 
The distribution of patients according to age and gender in each NST risk category 
was not significantly different (p=0.394 and p=0.575, respectively), although those 
classified at high risk of malnutrition tended to be older. 
 
The proportion of patients at high risk of malnutrition was lower in comparison with 
the entire group of 182 individuals. This may be due to the different characteristics of 
the population (stroke vs. mainly elderly) but these results should be interpreted with 
















When the analyses for the first outcome measure were performed, there was a 
significant difference in mortality rates between patients in the three malnutrition risk 
categories at all time points (p=0.011 at 1 month, p=0.002 at 3 months, p=0.001 at 6 
months and p<0.001 at 1 year) - table 2.4 and fig 2.1. 
 
Mortality rates increased progressively with malnutrition risk category (fig. 2.1). One 
month after admission, those identified as at high risk of malnutrition had, at least, a 
four-fold increased rate of mortality compared with those at low and medium risk. At 
3 months, 6 months and 1 year, rates of mortality of patients at high risk of 
malnutrition were, at least, 2 times higher than the rates of mortality of patients at low 





Fig. 2.1 – Rates of mortality in each GSTT NST risk category, at all periods of follow-









Mortality at 1 
month 
Mortality at 3 
months 
Mortality at 6 
months 




























Mortality at 1             
month a Total 
Mortality at 3 
months b Total 
Mortality at 6 
months c Total 
Mortality at 1 
year d Total 
Alive Dead Alive Dead Alive Dead Alive Dead 
low               
risk 
n            
(%) 
89 2 91 86 5 91 83 8 91 79 12 91 
97.8% 2.2% 100% 94.5% 5.5% 100% 91.2% 8.8% 100% 86.8% 13.2% 100% 
medium 
risk 
n             
(%) 
32 1 33 29 4 33 29 4 33 27 6 33 
97.0% 3.0% 100% 87.9% 12.1% 100% 87.9% 12.1% 100% 81.8% 18.2% 100% 
high               
risk 
n           
(%) 
50 8 58 43 15 58 39 19 58 32 26 58 
86.2% 13.8% 100% 74.1% 25.9% 100% 67.2% 32.8% 100% 55.2% 44.8% 100% 
Total 
n             
(%) 
171 11 182 158 24 182 151 31 182 138 44 182 
94.0% 6.0% 100% 86.8% 13.2% 100% 83.0% 17.0% 100% 75.8% 24.2% 100% 
a - Chi-square test, p=0.011   
b - Chi-square test, p=0.002   
c - Chi-square test, p=0.001   
d - Chi-square test, p<0.001 
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Binary logistic regression was used to determine the risk of mortality for each GSTT 
NST risk category (using low risk as the reference group) in the unadjusted models, 
and to investigate the effects of age and gender in the association between these 2 
variables in the adjusted models, at each time point - table 2.5. In the adjusted model, 
the low risk of malnutrition is the reference group, men are compared with women 
(reference group) and age is treated as a continuous variable. 
 
In the adjusted models, at 1 and 3 months, neither of these possible confounders was 
found to be significant in the final model, i.e., the variables age and sex were not 
significant predictors of mortality. At 6 months and 1 year, age had a significant effect 
on mortality (p=0.018 and p<0.001) but it did not affect the significant association 
between risk of malnutrition and mortality. At 3 months, 6 months and 1 year, this 
association between nutrition risk status and mortality remained significant (and was 
nearly significant at 1 month) after taking into consideration the effect of age and 
gender (p=0.057 at 1 month, p=0.013 at 3 months, p=0.006 at 6 moths and p=0.001 
at 1 year) (see table 2.5). At 1 month, the trend for a statistically significant 
association between risk of malnutrition and mortality (and the wide confidence 
intervals observed in each group) may be explained by the relatively low number of 
















Table 2.5 – Logistic regression of the association between risk of malnutrition and 







model          
 (OR, 95% CI) 
p value 
Adjusted  
model          







0.028  0.057 
Low Reference group Reference group 
Medium 1.39 (0.12-15.86) 0.791 1.39 (0.12-15.94)  
High 7.12 (1.46-34.84) 0.015 5.98 (1.21-29.70)  
Gender (male) _ _ 1.16 (0.31-4.35) 0.827 
Age (per 1-year 






0.004  0.013 
Low Reference group Reference group 
Medium 2.37 (0.60-9.44) 0.220 2.43 (0.60-9.80)  
High 6.00 (2.05-17.60) 0.001 5.14 (1.72-15.36)  
Gender (male) _ _ 0.72 (0.28-1.84) 0.488 
Age (per 1-year 






0.001  0.006 
Low Reference group Reference group 
Medium 1.43 (0.40-5.11) 0.581 1.46 (0.40-5.31)  
High 5.05 (2.04-12.55) <0.001 4.27 (1.68-10.86)  
Gender (male) _ _ 0.77 (0.33-1.81) 0.547 
Age (per 1-year 
increase) _ _ 1.05 (1.01-1.09) 0.018 
Mortality 
at 1 year 
Risk of 
malnutrition  
<0.001  0.001 
Low Reference group Reference group 
Medium 1.46 (0.50-4.28) 0.487 1.52 (0.49-4.67)  
High 5.35 (2.41-11.88) <0.001 4.62 (1.99-10.73)  
Gender (male) _ _ 1.04 (0.48-2.26) 0.926 
Age (per 1-year 
increase) _ _ 1.08 (1.03-1.12) 
<0.001 
OR = Odds ratio 
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2. Length of hospital stay 
 
Distribution of LOS (secondary outcome) at 1 month, 3 months, 6 months and 1 year 
were analysed with histograms and Q-Q plots. Data were tested for normality and, as 
anticipated from the literature, they were not normally distributed (Kolmogorov-
Smirnov test, p<0.001, at all time points). 
LOS data at 4 time points were log-transformed (which could help mitigate the 
skewness) and tests for normality were repeated. This revealed that the log-
transformed LOS at 1 month continued to be not normally distributed (Kolmogorov-
Smirnov test, p=0.001) but the log-transformed LOS at 3 months, 6 months and 1 year 
follows a normal distribution (Kolmogorov-Smirnov test, p=0.200). 
Non-parametric tests were used therefore, to explore differences on LOS at 1M 
between categories and parametric tests were used for the other follow-up periods. 
As ANOVA assumes that the data come from populations that have equal variances, 




As shown in table 2.6, the distribution of LOS at 1 month was significantly different 
across categories of risk of malnutrition (Kruskal-Wallis test, p=0.034). LOS (of 
patients who did not die within the first month) increased progressively with 
malnutrition risk category, from a median of 12 to 16 days.  
At 3 months, 6 months and 1 year, there were no statistically significant differences in 
the LOS between the risk categories (ANOVA, p=0.062, p=0.057 and p=0.270, 
respectively). However, the trend for a longer LOS in the high risk group was 









Table 2.6 – Length of hospital stay in each GSTT NST risk category, for those 
patients who survived at 1 month, 3 months, 6 months and 1 year 
Length of hospital stay 
(LOS) 
LOS at 1 
month 
a
            
n=171 
LOS at 3 
months 
b
                      
n=158 
LOS at 6 
months 
c
                      
n=151 
LOS at 1 
year
d 




Mean (SD)  
(range) 
Mean (SD)  
(range) 
































Mean (SD) values are presented as the anti-logged mean (SD) of the log-transformed data 
   
a
 - Kruskal-Wallis test, p=0.033 
   
b
 - ANOVA, p=0.062  
   
c
 - ANOVA, p=0.057 
   
d
 - ANOVA, p=0.270 
 
 
The visual representation of the LOS data distribution can be found in the following 
box plots (fig. 2.2, 2.3, 2.4 and 2.5).  




 percentile (the lower 
and upper quartiles, respectively), and the band near the middle of the box is the 50
th
 
percentile (the median). The ends of the vertical lines or "whiskers" indicate the 
minimum and maximum data values, excluding outliers. The circles and asterisks 
above the upper “whisker” represent the outliers, which can be defined as any data 

























Fig. 2.3 - Distribution of data regarding the LOS in each GSTT NST risk category, at 







































The effects of age and gender on the relationship between the GSTT NST risk 
categories and the ranked LOS at 1 month or the log-transformed LOS at 3 months, 6 
months and 1 year, were investigated using univariate analysis of variance (table 2.7).  
 
The initial significant association between the GSTT NST risk categories and LOS at 
1 month was attenuated (p=0.156) after taking into consideration the effects of age 
and gender, where age was a significant predictor of LOS (p<0.001). 
The association between risk categories and the log-transformed LOS at 3, 6 and 12 
months remained non-significant (p=0.246, p=0.259 and p=0.405, respectively), but 
age was shown to have a significant effect on this outcome (p<0.001, at all time 
periods).  
 
Table 2.7 – Association between risk of malnutrition and ranked or log-transformed 
LOS, adjusted for the effect of age and gender (univariate analysis of variance), at 




F p value 
Ranked 
LOS 




Gender 0.86 0.356 
Age 25.89 <0.001 
Log-
transformed 





Gender 0.53 0.467 
Age 26.87 <0.001 
Log-
transformed 




Gender 0.83 0.365 
Age 28.06 <0.001 
Log-
transformed 




Gender 0.21 0.652 




The data were also analysed by combining the 3 GSTT NST nutrition risk categories 
into 2 categories (low and medium vs. high; low vs. medium and high). The results 
were similar to the findings described so far, i.e., there was a statistically significant 
difference in rates of mortality at all time points between the risk categories (table 
2.8), even after the adjustment for the effect of age and gender (p<0.05 in all periods 
of time, using logistic regression – data not shown). 
 
Differences in LOS (median or mean number of days) were significant at 1, 3 and 6 
months between malnutrition risk categories (table 2.9), but were no longer significant 
after the adjustment for the effect of age and gender (p>0.05 in all periods of time, 




























Table 2.8 – Mortality rates for each GSTT NST risk category (divided in 2 groups) at 1month, 3 months, 6 months and 1 year after admission. 
 
 



























Low/medium               
risk (n=124) 










































Medium/high               
risk (n=91) 














Table 2.9 – Length of hospital stay in each GSTT NST risk category (divided in 2 groups), for those patients who survived at 1 month,  
3 months, 6 months and 1 year. 
Risk of 
malnutrition 
LOS at 1 month            
n=171 
LOS at 3 months                      
n=158 
LOS at 6 months                         
n=151 





























(1-30) (1-90) (1-132) (1-196) 
High  
16 19.5 (2.2) 23.3 (2.3) 23.7 (2.2) 










(1-30) (1-90) (1-132) (1-196) 
Medium/high  
15.5 17.6 (2.3) 20.6 (2.5) 22.5 (2.4) 
(2-30) (2-90) (2-132) (2-132) 
     Mean (SD) values are presented as the anti-logged mean (SD) of the log-transformed data
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2.5 – Discussion  
 
This is the first study to evaluate the predictive validity of the GSTT NST in a group 
of hospitalised elderly and stroke patients, over a period of up to 1 year. 
Independently of the method chosen to group risks of malnutrition, i.e., 3 categories or 
2 categories (low and medium vs. high; low vs. medium and high), the results take the 
same direction: patients in the medium and high risk categories had more negative 
clinical outcomes, i.e. a significantly higher rate of mortality and a trend for an 
increased LOS. 
 
As discussed in chapter 1, the literature shows that malnourished patients have 
increased LOS and increased mortality when compared with well-nourished patients. 
These parameters may, therefore, be used to test the predictive validity of a NST, and 
they are frequently used in studies with this purpose (Jones, 2002, Stratton et al., 
2006). The ability to predict mortality and a longer LOS would suggest that a nutrition 
score has real prognostic value and is correctly identifying those patients who are 
more likely to suffer adverse outcomes.  
Mortality and LOS are important factors, not only for the patient but also for the NHS, 
since mortality and a longer LOS poses a great economic burden on the NHS. 
Furthermore, these variables were also chosen as relevant outcomes to study the 
predictive validity of this tool because they are easily and reliably collected by the 
computerised medical records, for all patients. 
 
 
In this study, the proportion of patients categorised as being at high risk of 
malnutrition was 32%, which is similar to the 35% found in older hospitalised patients 
using the MUST (Henderson et al., 2008).  In hospitalised stroke patients, a similar 
prevalence of malnutrition was found - 32% (Westergren et al., 2001b) and 26.3% 
(Crary et al., 2006), although the authors used nutrition assessment rather than NSTs. 
 
It should be noted that the medium and high risk categories included patients who had 
a normal weight and also those who were overweight and obese, as the maximum 
BMI values in these groups were 34.9 Kg/m
2
 and 40.8 Kg/m
2
, respectively. This 
76 
 
contradicts the idea that only underweight individuals are malnourished or at high risk 
of malnutrition and, consequently, it does not support the use of a subjective 
evaluation of patients’ nutritional status (based purely on simple observation), which 
has been reported in previous studies (Dennis et al., 2006). 
 
 
No statistically significant difference in LOS was found between the risk categories at 
3 months, 6 months and 1 year, and the statistically significant difference on LOS at 1 
month initially observed disappeared after the adjustment for the effect of age. There 
are several reasons that can explain these results. 
First, it is possible that LOS might be influenced by different circumstances unrelated 
to nutritional status, such as, the waiting time for transfer to a rehabilitation facility or 
a nursing home. This may be the case of, for example, the individuals who stayed in 
the hospital for a very long continuous period of time, i.e. more than 4 months (132 
days) within only one admission, when the censoring point was 6 months. 
Second, age might be a more important factor than NST risk category to predict LOS, 
although it can be argued that these factors are interlinked. There are several 
physiological functions that tend to decline with age and can have a negative impact 
on nutritional status. This includes a reduction of lean body mass and metabolic rate, 
decreased gastrointestinal motility and secretion of digestive juices, changes in the 
oral cavity (such as loss of teeth and reduced salivary secretion), sensory function 
deficits (e.g. diminished sense of taste), changes in fluid and electrolyte regulation 
(e.g. reduced glomerular filtration rate), multiple chronic diseases and polypharmacy 
(Brownie, 2006). Consequently, a poor nutritional status may delay the recovery 
during hospitalisation and favor the occurrence of new infectious diseases (since the 
immune system is compromised by inadequate nutrition), which increases even more 
the LOS.  
Third, it is also possible that there is no causal relationship between nutritional status 
and LOS, since LOS may be predominantly a reflection of the severity of the 
underlying disease, instead.  
It should be noted that LOS was measured only in people who escaped from the first 
and worse outcome, i.e., death. Those who survived and were at medium and high risk 
of malnutrition still presented a trend for a longer LOS than those who were classified 
as being at low risk of malnutrition. 
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Additionally, this study had a relatively small sample size and a heterogeneous 
population. 
 
Several aspects of validity and reliability of this NST were already studied, as 
summarized in the next table. 
 
Table 2.8 – Type of assessments previously conducted on the GSTT 





- general medical inpatients 




- general medical and elderly 
inpatients 




- respiratory outpatients 




The inter-rater reliability was studied in general medical inpatients and respiratory 
outpatients to see whether different examiners (nurse vs. nurse and nurse vs. doctor) 
reliably identify the same nutritionally at risk patients, using this tool. A good inter-
rater reliability (κ = 0.67) was observed between pairs of nurses on general medical 
inpatients and a very good inter-rater reliability (κ = 0.94) between the nurse and 
doctor´s assessment on respiratory outpatients (Weekes, 2005). 
 
The concurrent validity, which is one way of establishing validity by comparing 
different methods of screening, was assessed in general medical and elderly inpatients. 
The results suggested good/very good concurrent validity between this tool and the 
Malnutrition Advisory Group Tool (Elia, 2000) and very good concurrent validity 





The predictive validity of this tool was tested in general medical inpatients and 
respiratory outpatients, using mortality and LOS as relevant negative outcomes and a 
follow-up period of twelve months (Weekes, 2005).  
On medical inpatients, a higher proportion of patients died within one year in the 
higher risk categories, similar to the findings observed in the current study, for the 
elderly and stroke patients. However, the present study showed a graded association 
between risk of malnutrition and mortality, while the mortality of medical inpatients 
was surprisingly higher on the medium risk group (32% of deaths at 1 year on the 
medium risk groups vs. 17% on the high risk group). 
Weekes found statistically significant differences in the mean LOS between the risk 
categories, even after controlling for the effect of age. The current study found the 
same tendency (but not a significant difference) for a longer LOS in higher risk 
categories of malnutrition. The potential reasons for the lack of statistical significance 
have already been discussed.  
 
In respiratory outpatients, the findings of Weekes 2005 are similar to those described 
for the medical inpatients. The differences for both outcomes were statistically 
significant between the risk categories and, for both patient groups, LOS was at least 
two-fold higher in medium or high risk patients compared with low risk patients. 
Mortality rates in respiratory outpatients also presented a graded increase in nutrition 
risk categories, where those identified as being at high risk had at least a three-fold 
increase in mortality compared with those at low risk (Weekes, 2005), similar to what 
happened in the elderly and stroke population (at all time points). 
 
Therefore, this NST seems to have a similar performance to predict mortality in 
different populations (respiratory outpatients, medical inpatients and elderly and 
stroke inpatients). 
 
Nonetheless, validity is a continuous process and the predictive validity of this NST 







This study had several limitations, which are as follows: 
- data collection procedures were not standardised and, therefore, the level of 
detail and possibly the quality of the data were not the same between the 2 
investigators (Ms. Feeney and Ms. Prior)  
-  the nutritional interventions that patients received while in hospital were not 
taken into consideration. These interventions, if appropriate, could have the 
potential to modify the outcomes. However, this would be difficult to measure and 
it has not been taken into consideration in previous studies on the association 
between nutritional status or risk and outcomes 
-     the study did not capture (LOS of) admissions that may have occurred in other 
hospitals 
-  only 183 patients (88%) were screened on admission, and there is no 
information available regarding the reason why 12% of the recruited patients were 
not screened. This study was conducted on elderly care and stroke wards, which 
manage severely frail, disabled individuals who are bed-bound. It is possible that 
the non-screened patients had these characteristics and this study was lacking the 
associated clinical outcome of this potentially vulnerable patient group. However, 
both groups presented a similar mean age and proportion of genders, suggesting 
that they had similar characteristics.  
-  this was a pilot-study and may, therefore, have been underpowered.  The 
number of stroke patients was too small to allow for a separate analysis of the 
GSTT NST predictive validity in this particular population and results were not 
adjusted for an important possible confounder, i.e., the severity of stroke (as this 
information was obtained for only 5 out of 25 patients who had a stroke) 
 
 
Contributions and lessons learnt from this study 
 
Despite its limitations, this study was very useful to obtain information about the 
practicalities of data collection, to refine the techniques and to inform the design of 
future studies. It also had the advantages of showing the evolution of the outcomes at 
several time-points, from one month up to one year, and it captured mortality and LOS 
(of other admissions) that may have occurred after discharge, while previous studies 
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contained information on outcomes concerning only the first hospitalisation (from 
screening to discharge or death (Raslan et al., 2010, Raslan et al., 2011)).   
 
In particular, this study enabled me to: 
-  have the first contact with the UK research fieldwork (e.g. become familiar with 
abbreviations used in medical notes and tools available for data collection), on busy 
wards that care for frail and severely ill patients. This was also the first time I was 
exposed to a new national health service and its nutrition screening practices 
- realise that NST are widely used and advocated as fundamental tools that should be 
applied to all patients on admission to hospital, but not all patients actually have the 
NST applied by the nursing staff, and when it is applied, it is usually incomplete (e.g. 
weight on admission may be recorded but patient’s usual weight is not) 
- understand how outcome data can be accurately and systematically collected. With 
respect to mortality, I realised that the computerised medical records at GSTT are a 
simple and reliable method to obtain mortality data (after consulting the Head of 
Information Analysis of this Trust). With regard to cumulative LOS, I realised that 
collecting information on every admission to GSTT that 182 patients had over several 
time periods (1 month, 3 months, 6 months and 1 year) is a very time consuming task 
and susceptible to human error, especially when this is done manually, not through an 
automated process.  
- realise that computerised medical records provide mortality information held 
nationally but hospital (re)admissions data is only related to admissions that occurred 
at GSTT. Thus, if a patient is readmitted to another hospital in England while on 
holiday or if the patient is transferred to another hospital post-discharge from GSTT, I 
am not able to capture that information 
- recognise that the quantity and quality of potential confounders collected in this 
study is not enough. For example, ethnicity and smoking data could have been 
collected, and not all stroke patients had the NIHSS applied. This is a limitation of 
working with (baseline) data collected by someone else. 
 - become familiar with statistical analyses, data handling and transformation (e.g. 
choose adequate tests for normally and not normally distributed data), which will be 
later used in chapter 4 
- become aware of the time required to recruit stroke patients from the Stroke Unit of 
St. Thomas´s Hospital (and the number that I can potentially achieve within my PhD) 
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- although many other studies that have assessed the predictive validity of NST or 
nutrition assessment tools are usually conducted in heterogeneous populations (e.g. 
patients recruited from multiple medical specialities (Raslan et al., 2010, Correia and 
Waitzberg, 2003) or elderly care wards (Stratton et al., 2006, Henderson et al., 2008)), 
this study enabled me to understand that it becomes difficult to take into account the 
effect of the disease on outcomes in a sample that includes individuals with very 
different type and severity of diseases. 
 
Thus, I learnt that in a future, prospectively designed, study (chapter 4), I will need to: 
- apply the NST myself to all patients on ward (this may include weigh the patient 
myself and collect information from multiple sources) 
- increase the sample size of stroke patients and do a power calculation to determine 
the size of the sample needed  
- allow for enough time to recruit a large sample size of patients with a diagnosed 
acute stroke and consider expanding my research sites to achieve that target 
- find a way of capturing data regarding hospital admissions that occur nationally and, 
ideally, in an automated process (such as the Hospital Episode Statistics)  
- have a thorough selection of potential confounders and make an effort to collect 





2.6 – Conclusion 
 
In studies that explore the association between (risk of) malnutrition and outcomes in 
heterogeneous populations (e.g. those that include a comprehensive range of several 
medical specialties (Middleton et al., 2001, Correia and Waitzberg, 2003, Raslan et 
al., 2010)), it is difficult to distinguish the effect of disease from the effect of 
malnutrition on outcomes. In fact, malnutrition and disease are interrelated and both 
may contribute to worse clinical outcomes.  
Although the present findings suggest that the GSTT NST can be used to predict 
negative outcomes in the elderly and stroke hospitalised population, more research is 
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needed to make definitive conclusions. Therefore, an adequately powered study was 
designed to investigate the predictive validity of NSTs in patients who have had a 
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3.1 - Introduction 
 
As mentioned in chapter 1, obesity has been established as a stroke risk factor 
(Strazzullo et al., 2010, Wang et al., 2013) and the current guidelines for secondary 
prevention of stroke recommend patients who are overweight or obese should be 
advised to lose weight (RCP, 2012, AHA, 2009). Recent studies however, suggest a 
protective effect of a high BMI in terms of mortality in particular populations, 
including the stroke population - a phenomenon that has been called “the obesity 
paradox”. 
 
Landi et al studied the effect of age on the relationship between BMI and mortality in 
a large cohort of hospitalized patients with a wide range of diseases (Landi et al., 
2000). The authors found that the graphed relationship between BMI and mortality in 
younger patients (aged under 65 years) was typically hyperbolic (U-shaped), with 
increased risk of mortality at the lowest and highest BMIs. However, the older patients 
(aged 65 years and over) showed an increased risk of mortality at the lowest BMIs 
with only a slight elevation for the heaviest group (BMI > 35 kg/m
2
), supporting the 
hypothesis that the optimal weight for longevity may be higher in older patients. 
Nevertheless, this relationship between BMI and mortality seems to be, not only age-
dependent, but also ethnicity-dependent.  
A large pooled analysis with more than 1 million Asians (likely to include healthy and 
diseased individuals) (Zheng et al., 2011) revealed a U-shaped association between 
BMI and mortality in East Asians (including Chinese, Japanese and Koreans), 
similarly to the pattern observed in white adults (Berrington de Gonzalez et al., 2010). 
On the other side, in the cohorts of Indians and Bangladeshis there was no excess risk 
of mortality associated with a high BMI, suggesting a J-shaped curve (Zheng et al., 
2011). 
 
Furthermore, this “reverse epidemiology” of the association between BMI and 
mortality (where obesity may, counterintuitively, be protective) has also been 
described in several diseases, such as rheumatoid arthritis (Kremers et al., 2004), 
chronic obstructive pulmonary disease (Landbo et al., 1999), chronic kidney disease 
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(stages 3 and 4 (Kovesdy et al., 2007)), hypertension and coronary artery disease 
(Uretsky et al., 2007) and, more recently, diabetes (Carnethon et al., 2012). 
According to Kalantar-Zadeh and his colleagues, these paradoxical associations 
between better survival in more obese persons have been observed in chronic disease 
states and advanced age, which are populations with a shorter life expectancy than the 
general population and with greater likelihood of wasting and cachexia (Kalantar-
Zadeh et al., 2007). 
The stroke population does not seem to be an exception. After a literature review, a 
summary of studies that have analysed the association between BMI and mortality on 
patients who had a stroke is presented below.  
The systematic approach used to conduct this literature review included the following 
inclusion criteria: 
- type of studies and participants: observational prospective studies of human adults 
who had a stroke at baseline and a record of BMI obtained (as soon as possible) after 
the event 
- outcome: mortality, assessed in different categories of BMI 
This review excluded studies that looked at the incidence of stroke and mortality in a 
cohort of initially healthy individuals and studies that included participants who had a 
TIA. 
In order to identify relevant studies, “Ovid Medline” and “Embase” electronic 
databases were searched (up to August 2013) and several search terms were used to 




- cerebrovascular accident 
- cerebral infarction 
- cerebral haemorrhage 
- subarachnoid haemorrhage 
- body mass index 
- obese/ obesity / obesity paradox 
- mortality/ survival 
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The full search strategy can be found in appendix 3.1. After removing the duplicates, 
3774 references were found and only 8 studies were identified as being relevant for 





Number of subjects, 
type of stroke, age 
Follow-up period 
Results: mortality hazard ratio 
comparing to the normal weight 
category 
Results corrected 
for the possible 
confounders 






3012 patients with 
undefined strokes 
6 months 
Underweight: 1.82 (1.34-2.47)       





Only 20% of patients were weighed or 
had their BMI calculated and there was a 
lack of standardization of assessment of 
nutritional status, with a large proportion 
of patients having their nutritional status 
assessed informally (i.e. based on simple 
observation, as a bedside assessment). 
2008, Olsen et 
al (Denmark)  
21884 ischaemic and 
haemorrhagic strokes 
(excluding subarachnoid 
haemorrhages and TIAs) 
Up to 5 years 
(median: 1.5 
years)  
Underweight: 1.63 (1.41-1.90)                    
Overweight: 0.73 (0.66-0.81)       
Obesity: 0.84 (0.74-0.96)                 
Severe obesity: 0.84 (0.64-1.10) 
Age, sex, civil 
status, SSS 
(severity of stroke 
scale) and risk 
factors. Obtained 
same result without 
risk factors. 
Only patients over 40 years; BMI was 
measured in only 21884 patients (55%) 
and, from these, complete data set 






644 ("majority of 
strokes in this study 
were likely ischaemic") 
It varies (mean 
time: 14.1 years) 
BMI increases were associated 
with:                                                          
- lower mortality in the elderly                                               
- higher mortality in the younger 
individuals  
Several risk factors 
for stroke 
Sample size is inadequate; relies on self-
reported history of stroke (data were 
obtained from a national survey); BMI 
was not assessed when patients had a 
stroke; all patients with BMI <25 kg/m
2
 
in a single category, with no separate 
analysis of underweight patients   
2011, 
Vemmos et al 
(Greece) 




haemorrhages and TIAs) 
Mean follow-up 
of 47 +/- 37 
months (range, 
1day-10years)  
Overweight: 0.82 (0.71-0.94)                                                 
Obesity: 0.71 (0.59-0.86)     
Gender, stroke 
subtype, severity of 
stroke scale, age 
and risk factors  
All patients with BMI <25 kg/m
2
 in a 
single category, with no separate analysis 
of underweight patients; from the entire 
cohort of 2820 patients, 35 (1.2%) were 
excluded because of lack of data 
regarding body weight or height or both. 




BMI = body mass index
2011, Ryu et 
al (Republic of 
Korea) 
1592 patients with 
ischaemic strokes 
Median follow-up 
of 4 years (range, 
1 – 2,693 days) 
Underweight: 2.79 (1.92–4.05) 
Overweight: 0.95 (0.73–1.25)                            
Obesity: 0.76 (0.57–1.01) 








into 0–1, 2–3, 4–6, 
and ≥7. 
Patients whose height could not be 
obtained due to a severe neurological 
status during admission (n=36) were 
excluded. Included only ischaemic 
strokes. 
Cut-offs of BMI groups used in this 
study were based on WHO criteria for 
the Asian Pacific population  
2011, Kim et 








of 33.6 +/- 15.5 
months                  
(no significant 
results were found 
at 30 days) 
<18.5 Kg/m
2






: 0.69 (0.49–0.96)                     
>25 Kg/m
2
: 0.61 (0.43–0.88)                          







This study is a sub-analysis of an 
original study. From 1604 patients with 
an intracerebral haemorrhage, 248 
(15.5%) were excluded due to lack of 
data or misclassification. Cut-offs of 
BMI groups used in this study were 
based on WHO criteria for the Asian 
Pacific population 
2012, Kim et 








of 32.6 +/- 23.1 
months (no 
significant results 
were found at 30 
and 90 days) 
<18.5 Kg/m
2
: 1.36 (1.25–1.48) 
18.5–20 Kg/m2: 1.14 (1.03–1.26) 
20–23 Kg/m2: Reference  
23–25 Kg/m2: 0.89 (0.84–0.95) 
25–27.5 Kg/m2: 0.82 (0.77–0.88) 
27.5–30 Kg/m2: 0.83 (0.74–0.92) 
30–32.5 Kg/m2: 0.77 (0.63–0.93) 
>32.5 Kg/m
2
: 0.85 (0.64–1.12) 
Data not available. 
However, in order 
to investigate the 
potential effect of 
age on risk of 
mortality, authors 
performed stratified 
analyses by age 
group. 
This study is a sub-analysis of an 
original study. From 43723 registered 
acute stroke patients, 9591 (21.9%) were 
excluded by the pre-established selection 
criteria and, from the remaining 34132 
patients, 5250 (15.4%) were excluded 
due to lack of BMI data. Cut-offs of BMI 
groups used in this study were based on 
WHO criteria for the Asian Pacific 
population  
2013, Hassan 





81579 patients with  
ischaemic strokes 





Obese: 0.6 (0.5-0.8) 
Age, sex, diabetes, 
hypertension, renal 
failure, hospital 
location and disease 
severity 
These results were only related to in-
hospital mortality, and the study was 
conducted in a subset of ischaemic 
strokes (only thrombolysed patients). 
The definition of “obese” and “non 
obese” is not provided. 
 
These results suggest a trend for an increased risk of mortality in the underweight patients 
and a decreased risk in overweight and/or obese patients.  
 
 
When Towfighi and Ovbiagele (Towfighi and Ovbiagele, 2009) tried to assess the 
association between BMI and mortality among stroke survivors in continuous series of age, 
they found that in younger individuals an increase in BMI was marginally associated with 
a higher risk of mortality; but in the elderly, an increase in BMI was associated with a 
modest decrease in mortality (Towfighi and Ovbiagele, 2009). For example, an 80-year-old 
obese stroke survivor had a significant 42% lower risk of death than a normal-weight 
individual of the same age (HR 0.58, 95% CI 0.36 to 0.93) and an 80-year-old overweight 
individual had a non-significant reduced risk of death (by 20%)  when compared with a 
normal-weight stroke survivor of the same age (HR 0.80, 95% CI 0.59 to 1.10). However, 
this study has major methodological limitations such as: the selection of the study 
participants was based on self-reported baseline history of stroke in non-institutionalized 
individuals from a national survey conducted between 1988 and 1994 (consequently, it was 
not possible to adjust for severity of stroke, there was no information regarding type of 
stroke and BMI was not assessed at the time that the individuals had a stroke); when BMI 
was analysed as categorical variable, normal and underweight people were grouped 
together into a “nonoverweight” group (BMI < 25Kg/m2), which does not allow to 
determine the association between these 2 different BMI categories (normal and 
underweight, separately) and mortality.   
In a prospective study of 2785 patients with ischaemic and haemorrhagic first-ever strokes 
conducted in Greece (Vemmos et al., 2011), BMI was assessed on admission to hospital in 
the acute phase post stroke, all data were entered into a stroke database, and the mean 
follow-up period was 47 months (up to 10 years). Only 1.2% of patients were excluded 
because of lack of BMI data but unfortunately, this study also grouped underweight and 
normal weight individuals into the same category “normal weight”. It was observed that 
obese and overweight stroke patients had significantly better short (1 week and 1 month) 
and long-term survival (10 years) compared to those with normal BMI. In the multivariable 
analysis, after taking into consideration several potential confounders including stroke 
severity, HR of 10-mortality was 0.82 (95% CI 0.71 – 0.94) for the overweight group and 
0.71 (95% CI 0.59 – 0.86) for the obese group, when compared with the “normal weight” 




Similar results were obtained in a Danish cohort with 21884 patients (Olsen et al., 2008), 
as well as in two studies conducted in the Republic of Korea – one with ischaemic strokes 
(Ryu et al., 2011), the other with haemorrhagic strokes (Kim et al., 2011) – and in a 
multicenter observational study that included the first 3012 patients randomized in the 
FOOD trial (Dennis, 2003). All these four studies have also determined the risk of 
mortality of the underweight group of patients, which was significantly higher when 
compared with the “normal weight” group.  
However, each of these studies had other limitations, as follows. 
The Danish study is based on data collected for a registry started in 2001, which aims to 
capture all hospitalized ischemic and hemorrhagic stroke patients, aged 40 years or older, 
in Denmark. From all patients included in this registry, only 55% had their BMI assessed 
on admission to hospital, and from these, complete dataset was available for only 60%. 
Thus, multivariable analyses included 13242 first and recurrent strokes, with a follow-up 
period up to 5 years post stroke (mean of 1.5 years). After controlling for the effect of age, 
gender, civil status, severity of stroke and risk factors, risk of mortality was higher for 
underweight patients (HR 1.63, 95% CI 1.41–1.90) and lower for overweight, obese and 
severely obese individuals (HR 0.73, 95% CI 0.66–0.81; HR 0.84, 95% CI 0.73–0.98; HR 
0.84, 95% CI 0.64–1.10, respectively), when compared with the normal weight group. 
Authors reported to have repeated the analyses without risk factors, and the effect of BMI 
on mortality remained the same (Olsen et al., 2008).  
Similar results were found when the study population was limited to haemorrhagic strokes. 
In 2011, Kim and his colleagues analysed the association between BMI and mortality in 
1365 haemorrhagic stroke patients recruited from 33 stroke centers across Republic of 
Korea. Over a mean follow-up period of 33.6 months, and after controlling for the effect of 
age, diabetes, severity of stroke, glucose, volume of haematoma and extension of 
haemorrhage into ventricles, there was an increased risk of death for underweight 
individuals (HR 1.64, 95% CI 1.11–2.40) and a lower risk for overweight (HR 0.69, 95% 
CI 0.49–0.96) and obese patients (HR 0.61, 95% CI 0.43–0.88), when compared with the 
normal weight group. It should be noted that this study is a sub-analysis of an original 
study; and from 1604 patients with an intracerebral haemorrhage, 248 (15.5%) were 
excluded due to lack of data (it is not specified if this included BMI data) or 
misclassification. Cut-offs of BMI groups used in this study were based on WHO criteria 
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for the Asian Pacific population, therefore BMI ranges for normal weight is 18.5–23 
Kg/m
2
, for overweight is 23.0–24.9 Kg/m2 and for obesity is >25 Kg/m2. 
The same author published another study in 2012, with a larger population of first and 
recurrent ischaemic strokes (Kim et al., 2012). Data were extracted from the Korean Stroke 
Register, which is a nationwide prospective multicentre hospital based register of acute 
ischaemic strokes, established in 1999. From 43723 registered acute stroke patients, 9591 
(21.9%) were excluded by the pre-established selection criteria and, from the remaining 
34132 patients, 5250 (15.4%) were excluded due to lack of BMI data. Thus, 28882 patients 
were divided into 8 categories of BMI (reference category is BMI between 20 and 23) and 
the adjusted HR over a mean follow-up period of 32.6 months were: 1.36 (CI 1.25-1.48) 
for BMI <18.5 Kg/m
2
, 1.14 (CI 1.03-1.26) for BMI 18.5-20 Kg/m
2
, 0.89 (CI 0.84-0.95) for 
BMI 23-25 Kg/m
2
, 0.82 (CI 0.77-0.88) for BMI 25-27.5 Kg/m
2
, 0.83 (CI 0.74-0.92) for 
BMI 27.5-30 Kg/m
2
, 0.77 (CI 0.63-0.93) for BMI 30-32.5 Kg/m
2
, 0.85 (CI 0.64-1.12) for 
BMI > 32.5 Kg/m
2
. The paradoxical association between BMI and mortality remained 
preserved when authors performed stratified analysis by groups of age (<55, 55-65, 65-75, 
75-85, >85 years) and by causes of death (cancer, vascular and other). However, it should 
be noted that this study is also limited by the fact that it is a sub-analysis of an original 
study. 
Another cohort of ischemic strokes was identified in the same country (Ryu et al., 2011). 
This is a study that included 1592 patients consecutively admitted to a South Korean 
Hospital within 48h post stroke. Survival analyses over a mean follow-up period of 4 years 
were conducted using the normal weight category of BMI between 18.5 and 23 Kg/m
2 
as 
the reference group (as defined by the WHO criteria for the Asian Pacific population) and 
several models were presented. In the model that adjusted for the effect for age, sex, 
previous stroke, hypertension, diabetes, current smoking, and heart disease, HR for the 
underweight group (BMI < 18.5 Kg/m
2
) was 2.54 (95% CI 1.77–3.63), for the overweight 
group (BMI between 23.0 and 24.9 Kg/m
2
) was 0.77 (95% CI 0.60–1.00) and for the obese 
group (BMI ≥25.0 Kg/m2) was 0.59 (95% CI 0.45–0.78). In another model, the results 
were adjusted for the variables of the previous model plus admission NIHSS score 
categorized into 0–1, 2–3, 4–6, and ≥7: HR for the underweight group was 2.79 (95% CI 
1.92–4.05), for the overweight group  was 0.95 (95% CI 0.73–1.25) and for the obese 
group was 0.76 (95% CI 0.57–1.01). It should be noted that 36 patients were excluded 
because height could not be obtained due to a severe neurological status. 
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The FOOD trial was already described in the “Introduction” (chapter 1) as being an 
international multicenter randomized trial that aimed to evaluate various feeding policies 
on stroke patients (Dennis et al., 2006). A total of 5033 participants were enrolled between 
1995 and 2003, and an observational study was conducted with the first 3012 patients to 
determine whether baseline nutritional status (mainly based on “bedside assessment”) was 
an independent predictor of 6-month outcome after stroke (Dennis, 2003). Researchers 
(randomising clinicians) categorized patients with a recent first ever or recurrent stroke 
into undernourished (9.3%), normal (74.3%) or overweight (16.4%), based on a bedside 
assessment or, when practical, a full assessment. After adjustment for age, pre-stroke 
function, living conditions and stroke severity, risk of mortality was 1.82 (95% CI 1.34-
2.47) for the underweight group and 0.87 (95% CI 0.65-1.15) for the overweight. The main 
limitations of this study include being a sub-analysis of an original study (with specific 
inclusion criteria) and the methodology/quality of the data collection, given that only 20% 
of patients were weighed or had their BMI calculated and there was a lack of 
standardization of assessment of nutritional status, with a large proportion of patients 
(60%) having their nutritional status assessed informally (i.e. based on simple observation, 
as a bedside assessment).  
Another study looking at a subset of patients with ischaemic strokes, i.e., those treated with 
intravenous thrombolysis, also found that obese patients had significantly lower in-hospital 
mortality, when compared with non-obese patients (Hassan et al., 2013). 81579 patients 
with ischaemic strokes and treated with intravenous thrombolysis, admitted to 1050 USA 
hospitals between 2002 and 2009, were included in this study and the follow-up period was 
until discharge from hospital. The definition of BMI groups used by the authors is not very 
clear in this paper, as they claim to have “identified obese patients using comorbidity files 
with secondary conﬁrmation by the ICD-9-CM diagnosis codes of 278.0, 278.00, or 278.01 
in the discharge record”. Thus, patients were classified into non-obese (reference category) 
and obese (accounting for only 6.3% of all patients). After adjusting for the effect of age, 
sex, diabetes, hypertension, renal failure, hospital location and a surrogate marker of 
disease severity, the risk of in-hospital mortality was 0.6 (95% CI 0.5-0.8) for obese 
individuals, possibly due to their decreased rates of intracerebral haemorrhage (4.5% in 
obese patients vs. 6.3% in non-obese patients, p=0.01). However, limitations of this study 
include the fact that these results were only related to in-hospital mortality, it was 
conducted in a subset of ischaemic strokes (only thrombolysed patients), and the definition 
of “obese” and “non obese” used in this study hinders the comparison with other studies 
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that have used the traditional assessment of BMI to define obese (and non-obese) patients. 
It should be noted that only 6% of this study population was classified as obese, when 
compared with 24% of the other USA study discussed previously (Towfighi and 
Ovbiagele, 2009). 
 
An additional small study also conducted in thrombolysed patients did not find significant 
differences between obese and lean patients in mortality at 90 days after stroke, but the 
authors of this conference abstract recognize the study was underpowered (Schlick et al., 
2012). 
 
However, all these studies present some limitations, which were partially identified above 
and will be further discussed at the end of this chapter.  
 
After this literature review, it was possible to affirm that the available data regarding the 
associations between BMI and mortality after stroke over a long period of time were still 
limited, justifying the need for further investigations, especially in multi-ethnic 
populations, such as the population of London. None of the studies identified above have 
adjusted the results for the effect of ethnicity, possibly because the study populations were 
ethnically homogeneous. However, it should be noted that other authors have shown that 
ethnicity plays an important role in the prognosis of those who have suffered a stroke 
(Wolfe et al., 2005). 
 
An ongoing population-based register, recording strokes that occurred in south London, 
was used as the source of data for this study, which was designed to explore the 
associations between BMI and mortality in patients who have had a first stroke. 
 
 
3.2 - Aim and hypothesis   
 





The main hypothesis was that there is a significant difference in the risk of mortality 
between patients in different BMI categories who had a first stroke, up to 8-years after the 
event, independent of several potential confounders such as age and ethnicity. 
 
 
3.3 - Methods  
 
3.3.1 - Study population 
 
The South London Stroke Register (SLSR) is an ongoing population based stroke register 
recording first stroke in patients of all age groups, within a defined area of south London, 
and was set up in January 1995. Data are collected prospectively by the registry team, 
which is made up of doctors, nurses and research assistants/associates. Cases of stroke are 
identified, by using 12 referral sources, in the defined area that corresponds to 22 wards of 
Lambeth, Southwark, and Lewisham Health Commission (Stewart et al., 1999). At the 
2001 Census, this multi-ethnic source population was composed of 271,817 individuals, 
with 63% white, 28% black and 9% of other ethnic groups (Crichton et al., 2012). 
The referral sources are accident and emergency records; hospital wards; brain imaging 
requests; death certificates; coroner's records; general practitioners; hospital medical staff; 
community therapists; bereavement officers; hospital based stroke registries; general 
practice computer records; and "miscellaneous," including notification by patients or 
relatives of patients. Several methods are used to ensure complete ascertainment of cases 
(Stewart et al., 1999). Hence, for example, many patients who were not admitted to 
hospital when they had a stroke will attend a neurovascular clinic at the hospital and are 
registered there. 
Hospital surveillance of admissions for stroke includes two teaching hospitals within and 
three outside the study area. Community surveillance of stroke includes patients under the 
care of all general practitioners within and on the borders of the study area (n=147).  
 
Patients are examined and initial data are collected within 48 hours of notification to the 
register, when possible.  
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The complete initial form is filled in during the course of the hospital stay. The current 
version is divided into three sections. The first is completed as soon as possible after stroke 
and contains patient socio-demographic characteristics (e.g. age, ethnicity and living 
conditions prior to stroke), clinical assessment, risk factor history, stroke severity, etc. The 
next section is retained by the initialling team until the patient is discharged from hospital 
and bed/ward movements and other variables relating to inpatient care are collected along 
with discharge details and medications on discharge. The final part looks at stroke 
classification. Stroke is defined using WHO criteria and classified as cerebral infarction 
(ischaemic stroke), primary intracerebral haemorrhage and subarachnoid haemorrhage 
based on brain imaging (CT or MRI) within 30 days of stroke onset, necropsy examination, 
or cerebrospinal examination (for patients with subarachnoid haemorrhage). Where there is 
no known pathological confirmation of stroke subtype patients are classified as undefined 
(Crichton et al., 2012, Stewart et al., 1999). 
This initial form is completed during the hospital stay and reviewed by clinicians. In 
summary, patients are assessed within 48hrs when possible but the process of completing 
the initial form takes place over the hospital stay. 
Follow-up data are collected by a study nurse or specially trained field worker at 3 months, 
12 months and then, annually after stroke, by postal questionnaire (Crichton et al., 2012).  
 
The notification of death comes from the “Medical Research Information Service” 
(previously from the Office for National Statistics), based on NHS number of each patient 
or other characteristics, such as name, date of birth, place of last residence, etc. 
It should be noted that information collected at initial assessment has been amended as 
practice has developed in response of results generated so far, such as BMI, which was 
included from 2004. Weight and height are clinical data obtained routinely and researchers 
(fieldworkers) collect this information if it is available in medical records. If these 
measurements are not recorded in medical notes, the researchers may register these data as 





3.3.2 - Ethical considerations 
 
Ethical approval (06/Q0702/147) for the SLSR and all research projects using register data 
was given by the Research Ethics Committees at Guy’s and St Thomas’ Hospitals and at 
King’s College Hospital when the register commenced in 1995 and has regularly been 
renewed since. 
Written informed consent needs to be obtained from all living patients before participation 
in the register. The patient must be allowed time to read the patient information booklet, 
before giving consent. 
 
If a patient is not able to give consent, for example due to cognitive impairment, decreased 
consciousness, or expressive / receptive dysphasia, assent from the patient’s carer or next 
of kin is taken instead.  
 
3.3.3 - Study design and inclusion criteria 
This is an analysis of a cohort of patients within the SLSR (observational prospective 
study). 
Only patients who had a confirmed first stroke since 1st January 1995, and who were 
living in the study area at time of stroke were eligible to be included in the register. 
 
Eligible patients must have been permanent residents in the area before the stroke 
happened. For people who just moved here, the expressly stated plan to make a permanent 
home in the study area is crucial. 
It is aimed to register all patients prospectively within the first two weeks of their stroke 
and within 6 months at the latest. However, people with stroke will occasionally be 
registered retrospectively. 
From this register, only data from patients who fulfilled the two key inclusion criteria were 
selected for the study of the association between BMI and mortality: 
- registered on the SLSR with a record of BMI, and 
- had a follow-up period of at least 1 year. 
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BMI has been included in the SLSR since 2004 and the official death records may take up 
to 6 months to arrive. In order to allow a minimum follow-up period of 1 year, this study 
included all patients admitted on the SLSR between 1
st
 January 2004 and 31
st
 of December 
2010.  
Data extraction was requested in July 2012, allowing for the minimum follow-up period of 
1-year (i.e., mortality data were available up to December 2011) and for the maximum 
possible period of reception of mortality data (6 months). 
 
 
3.3.4 - Data selection 
a) baseline data 
The following baseline data were extracted from the SLSR initial form: 
- Patient identification number 
- Date of stroke 
- Date of admission 
- Stroke subtype 
- Age at time of stroke 
- Ethnicity 
- Living conditions prior to stroke 
- Swallow test results (on admission to hospital) 
- How weight was obtained 
- Weight 
- Height (this register does not include method used to obtain height) 
- The NIHSS score (this score started to be collected only in the second half of 2004) 
- Glasgow Coma Scale (GCS) score, a neurological scale that gives a reliable objective 
way of recording the conscious state of a person 
- Risk factors diagnosed prior to stroke: hypertension, congestive cardiac failure (CCF), 
angina, myocardial infarction, TIA, migraine, atrial fibrillation, diabetes, depression, 
hypercholesterolaemia. 
b)  Mortality data 
Mortality was the primary outcome and date of mortality (day/month/year), when 




3.3.5 - Statistical analysis 
 
1. Patients were classified into 3 groups of BMI: less than 18.5 kg/m
2
 (underweight), 18.5 
to 24.9 kg/m
2 
(normal weight) and 25.0 kg/m
2
 or more (overweight). Further analyses were 
conducted with 4 groups, where the overweight group was divided into 25.0 to 29.9 kg/m
2
 
(overweight) and 30.0 kg/m
2
 or more (obese).  
2. Baseline characteristics of patient groups were compared using the Chi-square test for 
categorical variables and the ANOVA or the t-test for continuous variables. 
3. To examine the effects of BMI on mortality during follow-up, Cox proportional hazards 
models were used to calculate crude and adjusted hazard ratios (HR) with 95% confidence 
intervals (CIs). The “normal weight” category was used as a reference. Multiple analyses 
were performed, e.g. with different types of stroke, and were adjusted for the several 
covariates, such as, age at time of stroke, gender, ethnicity, NIHSS score at admission, type 
of stroke. Further analyses were conducted with BMI as a continuous variable. 
 
Data were analysed using SPSS software version 19.0 for Windows (Chicago, Illinois, 
USA). Any differences were considered statistically significant when p <0.05. 
 
 
3.4 - Results  
 
All patients registered on the SLSR, from the 1
st
 of January 2004 to the 31
st
 of December 
2010 were included in the analysis (n=1619 patients). Of these, 856 (53%) had records of 
weight and height, and therefore, BMI is available. For the remaining 763 (47%) 
individuals, no complete records (of weight, height or both parameters) existed. 
 
As shown in figure 3.1, of those patients who had a record of BMI, the majority  had 
ischaemic strokes, which is in line with national statistics, where the incidence of 








Fig. 3.1 - Number of patients included in the study, according to the availability of records 




When comparing the group of patients with records of BMI with the group of patients with 
no records of BMI, there were no significant differences in type of stroke, gender and 
ethnicity. Rates of mortality at 1 month and at 8 years, mean age, mean NIHSS score and 
mean GCS score were significantly different between the groups. The group of patients 
with no records of BMI had a higher rate of mortality (3 times higher), was older, had a 
higher score of NIHSS and a lower score of GCS.  
Higher scores of the NIHSS reflect more severe strokes and the lower the GCS score, the 











Table 3.2 - Baseline characteristics of patients with and without records of BMI. 
 
Numbers in parentheses indicate percentages for categorical data, which were tested with the Chi-squared 
test, and SD (standard deviation) for continuous data, which were tested with the Student’s t-test.BMI = body 
mass index; NIHSS = National Institutes of Health Stroke Scale; GCS = Glasgow Coma Scale 
 
 
The higher rate of mortality of the patients with no BMI recorded, in conjunction with the 
significantly higher mean NIHSS score, suggests that patients in this group were more 
likely to have severe strokes and die more quickly from that cause, i.e., patients did not 
have their BMI recorded probably due to their poor prognosis, and it could have been 
unsafe or unethical to weigh the patient. 
For those patients with a record of BMI, the method used to obtain the weight was: 
measured for 416 (49%), recalled by patient or a relative for 293 (34%) and obtained from 
medical records for 147 (17%). The method used to obtain height was not described 










Type of stroke 
    Ischaemic, n (%)  
    Haemorrhagic, n (%) 
      Subarachnoid haemorrhage, n (%) 











      0.108 
 
Age, mean in years (SD)                            68.5 (15.2) 70.2 (16.1) 0.031 
Gender,  
   Male, n (%) 










   White, n (%) 
   Black Caribbean, n (%) 
   Black African, n (%) 
   Black other, n (%) 















NIHSS score, mean (SD) 8.6 (7.5) 11.6 (10) < 0.001 
GCS score, mean (SD) 13.5 (2.9) 12.1 (4.1) < 0.001 
Rates of mortality at  
1 month, n (%) 
60 (7)           197 (26) < 0.001 
Rates of mortality at  
8 years, n (%) 
317 (37) 
 
410 (54) < 0.001 
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Analyses were conducted in two different groups: a group with all types of strokes and a 
group with ischaemic strokes only. The last option removes the effect of heterogeneity 
relating to stroke subtype and enables comparison with previous studies conducted 





All types of strokes 
 
Patients were followed-up for a mean (survival) period of 1.3 +/-1.7 years.  
The maximum possible period of follow-up (8 years) started on 1
st
 of January 2004 and 
finished on 31
st
 of December 2011. 
Patients who had a stroke early in 2004 had a follow-up period of 8 years; those who had a 
stroke at the end of 2010 had a follow-up of 1 year. The following histogram shows the 
number of patients who had a stroke in each year, from 2004 to 2010. 
 
 





















Year of stroke  
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For these 856 patients, mean age was 68.5 +/- 15 years (including individuals from 18 to 
100 years old), 49 (6%) were underweight, 331 (39%) were normal weight and 476 (55%) 













































Group of Body Mass Index 
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Table 3.3 - Baseline characteristics of patients with all types of stroke, according to BMI 
groups. 
 
Numbers in parentheses indicate percentages for categorical data, which were tested with the Chi-squared 
test, and SD (standard deviation) for continuous data, which were tested with the ANOVA test. 
BMI = body mass index; NIHSS = National Institutes of Health Stroke Scale; GCS = Glasgow Coma Scale; 
CCF = congestive cardiac failure; TIA = transient ischaemic attack. 
 
There was a statistically significant difference between BMI categories regarding the type 













Type of stroke 
   Ischaemic, n (%)  
   Haemorrhagic, n (%) 
      Subarachnoid haemorrhage, n (%) 

















    0.002 
Age, mean in years (SD)          









    Male, n (%) 













   White, n (%) 
   Black Caribbean, n (%) 
   Black African, n (%) 
   Black other, n (%) 





















NIHSS score, mean (SD) 8.1 (5.9) 9.0 (8.1) 8.4 (7.1) 0.483 
GCS score, mean (SD) 14.1 (1.8) 13.2 (3.3) 13.6 (2.7) 0.084 
Living conditions prior to stroke 
     Home, n (%) 
     Institutionalized, n (%) 














Risk factors  
hypertension, n (%) 
      CCF, n (%) 
angina, n (%) 
myocardial infarction, n (%) 
TIA, n (%) 
migraine, n (%) 
atrial fibrillation, n (%) 
diabetes, n (%) 
depression, n (%) 
















































in the overweight group), age (underweight patients tended to be older) and living 
conditions (with more overweight patients coming from home and more underweight 
patients coming from an institution).  
 
With regards to the risk factors, there was a statistically significant difference between 
BMI categories in the prevalence of hypertension, diabetes mellitus and 
hypercholesterolemia, all of which were higher in the overweight group. 
Gender and severity of stroke were not significantly different between groups. 
 
Kaplan Meier methods were used to estimate early (6 months) and long term (up to 8 
years) survival across BMI categories and survival functions were compared using log rank 
tests (table 3.4 and figure 3.4). 
 
Table 3.4 - Early and long term survival rates of patients who had a stroke, in each BMI 
category  
 Survival rates at 6 months (%) 
(log rank test, p=0.008) 
Survival rates up to 8 years (%) 
(log rank test, p<0.001) 
Underweight 71.4 32.7 
Normal weight 83.1 60.1 
Overweight 87.2 68.1 
 
Survival functions of three BMI groups were significantly different at both periods of time. 
Underweight patients had the lowest rates of survival, while overweight patients presented 
















Fig. 3.4 - Long term survival (up to 8 years) of patients after stroke according to BMI 







Cox proportional hazards models were used to calculate crude and adjusted HR (hazard 
ratios), i.e. risk of mortality, with and without adjustment for possible confounders, over a 
period of 8 years.  
Baseline characteristics presented in table 3.5 were included as covariates in the 
multivariable model, as all of them may have an influence on outcome (mortality).  
“Normal weight” category was used as a reference and the results are summarized in the 





Table 3.5 - Risk of 8-year mortality according to BMI category, using univariate and 










































 - results adjusted for the effect of type of stroke, ethnicity, age, gender, severity of stroke, living conditions 
prior to stroke, hypertension, CCF, angina, myocardial infarction, TIA, migraine, atrial fibrillation, diabetes, 
depression, hypercholesterolaemia. 
BMI = body mass index; HR = hazard ratio 
 
 
There was a statistically significant difference in the risk of mortality between BMI 
categories, before (p<0.001) and after (p=0.009) adjusting for possible confounders. 
Having the normal weight category as a reference group, it was observed that the risk of 
mortality was higher for the underweight individuals (2.1 times and 82% more, in the 
crude and adjusted analyses, respectively) and lower for those who were obese (24% and 
11% less, in the crude and adjusted analyses, respectively).  
 
The multivariable analysis attenuated the relationship between BMI and post-stroke 
mortality in both underweight and overweight groups, which appeared to be largely due to 
the significant confounding effects of age (p<0.001), NIHSS score (p<0.001), atrial 
fibrillation (p=0.007) and diabetes mellitus (p=0.043). 
Type of stroke (p=0.964), gender (p=0.099), living conditions (p=0.677), ethnicity 
(p=0.099) and the remaining risk factors for stroke did not have a significant effect on this 




Table 3.6 - Multivariable Cox Proportional Hazards Model showing the effect of different 
variables on 8-year mortality  
 HR 95% CI p value 
BMI  groups 
     Underweight 
     Normal weight (reference) 











Type of stroke 
   Ischaemic 
   Haemorrhagic 
      Subarachnoid haemorrhage 














Age (per 1-year increase) 1.06 1.05-1.08 <0.001 
Ethnicity 
   White 
   Black Caribbean 
   Black African 
   Black other    
















Gender (female) 0.79 0.59-1.05 0.099 
NIHSS score (per 1-unit increase) 1.07 1.05-1.09 <0.001 
Living conditions prior to stroke 
     Home 
     Institutionalized 

























































BMI = body mass index; NIHSS = National Institutes of Health Stroke Scale; CCF = congestive cardiac 
failure; TIA = transient ischaemic attack; HR = hazard ratio. 
 
 
This model included ethnicity divided into 5 groups and accounted for the importance of 
distinguishing black Caribbean from black African populations (while studying the impact 
of ethnicity on stroke risk factors (Hajat et al., 2004)). In view of the small numbers of 
patients within some groups of ethnicity, another model was run with ethnicity divided into 
3 groups: white, black and other. The association between BMI and mortality remained the 
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same (p=0.009) but ethnicity had a significant effect in this model (p=0.027) - see 
appendix 3.2. 
 
Further analyses included the effect of smoking as a risk factor (see appendix 3.3), 
demonstrating that smoking has a significant effect on mortality (p=0.026) but does not 

























Fig. 3.5 - Cumulative survival after stroke according to BMI group (univariate analysis) 
 
 
Not all patients had complete data for all covariates and, therefore, the number of patients 
included in this multivariable analysis (n=632) is lower than the number of patients 


























While Kaplan-Meier survival curves show the proportion of patients alive at any point 
during the study with a series of horizontal steps of declining magnitude, Cox regression 
hazard functions produce continuous survival curves (assuming that the effect of the 
predictor variable(s) is constant over time). Although the Cox regression analysis allows 
taking into consideration the effect of other confounders, the log-rank test makes fewer 
assumptions and may be less prone to bias; hence both methods were used. 
 
 
In order to know whether stroke risk factors influence the association between BMI and 
mortality, a multivariable Cox regression model was conducted, where results were 
adjusted for age, ethnicity, gender, living conditions, severity and type of stroke, but not 
for risk factors (hypertension, CCF, angina, myocardial infarction, TIA, migraine, atrial 
fibrillation, diabetes, depression, hypercholesterolaemia). Similar results were observed, 
i.e., there was a statistically significant difference in the risk of mortality across BMI 
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categories (p=0.003); when comparing to the normal BMI group, underweight patients had 
a significantly higher risk of mortality (HR, 1.82; 95% CI, 1.19-2.76) and overweight 
patients had a lower risk (HR, 0.87; 95% CI, 0.67-1.14).  
It is noteworthy that this analysis without risk factors includes more individuals (n=721) 
than the analysis with risk factors (n=632), due to lack of information on risk factors for 
some patients (which may not be randomly distributed).  
Hence, for this reason and because it was shown that risk factors do not affect the 
association between BMI and mortality, further multivariable analysis presented in this 
chapter (i.e. 4 categories of BMI, 2 groups of age, BMI as a continuous variable) did not 







The same statistical analyses were conducted for the subgroup of ischaemic strokes 
(n=691).  
The follow-up period mentioned before was the same for this group of patients. 
 
From the 691 patients included in this analysis, the mean age was 69.8 +/- 14 years 
(including individuals from 18 to 100 years old), 40 (6%) were underweight, 264 (38%) 
were normal weight and 387 (56%) were overweight. Of this overweight group, 166 (24%) 
were obese. 
Similar to the analysis conducted on patients with all types of stroke, the following table 
(table 3.7) summarizes the baseline characteristics of the 3 groups of BMI of those 










Table 3.7 - Baseline characteristics of patients with ischaemic strokes, according to BMI 
groups. 
 
Numbers in parentheses indicate percentages for categorical data, which were tested with the Chi-squared 
test, and SD (standard deviation) for continuous data, which were tested with the ANOVA test. 
BMI = body mass index; NIHSS = National Institutes of Health Stroke Scale; GCS = Glasgow Coma Scale; 
CCF = congestive cardiac failure; TIA = transient ischaemic attack 
 
 
Similar to the observations described for the group with all types of strokes, there was a 
statistically significant difference between BMI categories regarding age (being the 
underweight individuals those with a higher mean age) and living conditions (with a higher 










Age, mean in years (SD)       









    Male, n (%) 













   White, n (%) 
   Black Caribbean, n (%) 
   Black African, n (%) 
   Black other, n (%) 





















NIHSS score, mean (SD) 7.8 (5.9) 6.7 (7.4) 7.8 (6.6) 0.295 
GCS score, mean (SD) 14.3 (1.4) 13.6 (2.9) 13.9 (2.4) 0.109 
Living conditions prior to stroke 
     Home, n (%) 
     Institutionalized, n (%) 














Risk factors  
hypertension, n (%) 
CCF, n (%) 
angina, n (%) 
myocardial infarction, n (%) 
TIA, n (%) 
migraine, n (%) 
atrial fibrillation, n (%) 
diabetes, n (%) 
depression, n (%) 
















































underweight patients coming from an institution). With regards to the risk factors, there 
was also a statistically significant difference between BMI groups in the prevalence of 
hypertension, diabetes mellitus and hypercholesterolemia, which was higher in the 
overweight group and lower in underweight individuals.  
The remaining risk factors, gender and severity of stroke were not significantly different 
between groups, as well as ethnicity (as opposed to what was observed in the group with 
all types of stroke). 
 
Kaplan Meier methods were used to estimate early (6 months) and long term (up to 8 
years) survival across BMI categories and survival functions were compared using log rank 
tests (table 3.8 and figure 3.7). 
 
 
Table 3.8 - Early and long term survival rates of patients who had an ischaemic stroke, in 
each category of BMI 
 Survival rates at 6 months (%) 
(log rank test, p=0.002) 
Survival rates up to 8 years (%) 
(log rank test, p<0.001) 
Underweight 70.0 32.5 
Normal weight 83.0 57.2 
Overweight 88.6 66.7 
 
In this group of ischaemic strokes, survival functions of three BMI groups were also 
significantly different at both periods of time. Underweight patients had the lowest rates of 








Fig. 3.7 - Long term survival (up to 8 years) of patients who had an ischaemic stroke, 




Cox proportional hazards models were used to calculate crude and adjusted HR, i.e. risk of 
mortality, with and without adjustment for possible confounders, over a period of 8 years.  
Baseline characteristics presented in table 3.9 were included as covariates in the 
multivariable model, as all of them may have an influence on outcome (mortality).  
“Normal weight” category was used as a reference and the results are summarized on the 








Table 3.9 - Risk of 8-year mortality according to BMI category, using univariate and 










































 - results adjusted for the effect of  age, gender, ethnicity, severity of stroke, living conditions prior to stroke, 
hypertension, CCF, angina, myocardial infarction, TIA, migraine, atrial fibrillation, diabetes, depression, 
hypercholesterolaemia. 
BMI = body mass index; HR = hazard ratio 
 
There was a statistically significant difference in the risk of mortality across BMI 
categories, before (p<0.001) and after (p=0.011) adjusting for all possible confounders. 
Having the normal weight category as a reference group, it was observed that the risk of 
mortality was higher for the underweight individuals (2 times and 81% more, on the crude 
and adjusted analyses, respectively) and lower for those who were overweight (28% and 
16% less (not significant), in the crude and adjusted analyses, respectively).  
 
The multivariable analysis attenuated the relationship between BMI and post-stroke 
mortality in the overweight group, which appeared to be largely due to the significant 
confounding effects of age (p<0.001), NIHSS score (p<0.001), CCF (p=0.042), atrial 
fibrillation (p=0.005), diabetes mellitus (p=0.019) and hypercholesterolaemia (p=0.023). 
Gender (p=0.380), ethnicity (p=0.174), living conditions (p=0.853) and the remaining risk 





Table 3.10 - Multivariable Cox Proportional Hazards Model showing the effect of different 
variables on 8-year mortality  
 
 HR 95% CI p value 
BMI  groups 
     Underweight 
     Normal weight (reference) 













Age (per 1-year increase) 1.06 1.05-1.08 <0.001 
Ethnicity 
   White 
   Black Caribbean 
   Black African 
   Black other    
















Gender (female) 0.87 0.64-1.19 0.380 
NIHSS score (per 1-unit increase) 1.06 1.04-1.08 <0.001 
Living conditions prior to stroke 
     Home 
     Institutionalized 












Risk factors  
Hypertension 











































BMI = body mass index; HR = hazard ratio; NIHSS = National Institutes of Health Stroke Scale; CCF = 















































Not all patients had complete data for all covariates and, therefore, the number of patients 
included in this multivariable analysis (n=512) is lower than the number of patients 


































All types of strokes, 4 categories of BMI 
 
Similar results were obtained when further analyses were conducted with the group of all 
types of strokes, dividing individuals into 4 categories of BMI. Thus, the previous 
overweight group (BMI>25Kg/m
2
) was divided into 2 groups: overweight (BMI 25-29.9 
kg/m
2
) and obesity (BMI>30 kg/m
2
). 




Table 3.11 - Survival rates and risk of 8-year mortality according to BMI category, using 
univariate and multivariable Cox Proportional Hazards Models 
a
 - results adjusted for the effect of type of stroke, ethnicity, age, gender, ethnicity, severity of stroke and 
living conditions prior to stroke. 
BMI = body mass index; HR = hazard ratio 
 
 
Rates of survival increased as BMI increased and the difference was statistically significant 
across BMI groups (log rank test, p<0.001). Obese patients had the highest rate of survival 
over a period of 8 years (72%). 
 
There was a statistically significant difference in the risk of mortality across BMI 
categories, before (p<0.001) and after (p=0.006) adjusting for possible confounders. 
Having the normal weight category as a reference group, it was observed that the risk of 
mortality was higher for the underweight individuals and lower for those who were 
overweight and obese.  
However, the multivariable analysis attenuated the relationship between BMI and post-










































0.65 0.48-0.89 0.96 0.68-1.37 
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Not all patients had complete data for all covariates and, therefore, the number of patients 
included in this multivariable analysis (n=721) was lower than the number of patients 
included in the univariate analysis (n=856). 
 
For the purpose of this thesis and given the relatively small sample size of this study, 






All types of strokes, 2 groups of age: over and under 65 years 
 
It has been suggested that the association between BMI and mortality is age-dependent 
(Towfighi and Ovbiagele, 2009). Therefore, the group with all types of strokes (n=856) 
was divided in 2 groups of age (over and under 65 years); log rank tests, as well as 
univariate and multivariable survival analyses were conducted in each group. This cut-
point is based on the definition of “elderly” or older person that is used in most developed 
world countries, including the UK (Age UK, 2013).  
The younger group was composed of 309 individuals (36%) and the older of 547 (64%). 













Table 3.12 - Survival rates and risk of 8-year mortality of patients aged under 65 years who 
had a stroke, according to BMI category, using univariate and multivariable Cox 
Proportional Hazards Models 
a
 - results adjusted for the effect of type of stroke, ethnicity, age, gender, ethnicity, severity of stroke and 
living conditions prior to stroke. BMI = body mass index; HR = hazard ratio 
 
 
Table 3.13 - Survival rates and risk of 8-year mortality of patients aged 65 and over who 
had a stroke, according to BMI category, using univariate and multivariable Cox 
Proportional Hazards Models 
a
 - results adjusted for the effect of type of stroke, ethnicity, age, gender, ethnicity, severity of stroke and 



































































53.6% 0.79 0.62-1.01 0.89 0.68-1.19 
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There was a statistically significant difference in survival rates between the 3 BMI 
categories, for both the over and under 65 years groups (log rank test, p=0.006 and 
p=0.005, respectively) with lowest survival rates observed in the underweight categories 
and greater survival rates on the overweight categories.  
 
Based on Cox regression models, the difference in risk of mortality across BMI categories 
was also statistically significant in both younger and older patients, before (p=0.017 and 
0.004, respectively) and after (p=0.008 and 0.029, respectively) adjusting for possible 
confounders.  
 
In both univariate and multivariable analyses and having the normal weight category as a 
reference group, the risk of mortality was higher for the underweight individuals and there 
was a non-significant trend for a lower risk of death in those who were overweight. 
 
However, these results should be interpreted with caution due to the relatively small 
sample size of each group.  
The group of patients under the age of 65 years old was composed of 309 individuals in the 
univariate analysis, and only 260 in the multivariable analysis (not all patients had 
complete data for all covariates, as explained before). 
The group of patients aged 65 years and older had 547 subjects in the univariate analysis, 
and 461 in the multivariable analysis. 
 
Mortality curves for both age groups, adjusted for the effect of type of stroke, ethnicity, 
age, gender, ethnicity, severity of stroke and living conditions prior to stroke, are shown on 































Fig. 3.10 - Cumulative survival of patients aged under 65, after a stroke, according to BMI 

















Fig. 3.11 - Cumulative survival of patients aged 65 and over, after a stroke, according to 
BMI group (multivariable analysis)  
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Analyses in different groups of ethnicity 
 
It was demonstrated in the “Introduction” of this thesis that ethnicity plays an important 
role in the epidemiology of stroke, and on table 3.3, the distribution of patients according 
to ethnicity in each category of BMI was statistically significant (p=0.018). There was a 
higher proportion of white patients in the underweight group and a higher proportion of 
black (Caribbean and African) patients in the overweight group. 
Analyses were not conducted separately in the black and white populations because the 
size of the black population is too small: the total number of black (Caribbean, African and 
other) patients is 230 or 194 and there are only 9 or 8 black patients in the underweight 
category in the univariate and multivariable analyses, respectively).  
However, it should be noted that all the multivariable analyses presented in this section 




Survival analysis using BMI as a continuous variable 
 
The analysis of BMI as a continuous variable allows the study of association between the 
entire distribution of the BMI and mortality, without losing the information imposed when 
BMI is grouped into categories. It also permits the identification of the level associated 
with a minimum risk of death. Hence, it was investigated whether the relationship between 
BMI and mortality is linear, quadratic or of a higher power.  
Multivariable Cox regression models were performed using BMI as a continuous variable 
and taking in consideration the effect of age, ethnicity, severity of stroke, gender and type 









Table 3.14 - Multivariable Cox regression model output for 8-year mortality, using BMI as 
a continuous variable (linear and quadratic terms)  
 Beta coefficient SE HR (95% CI) p value 
BMI -0.165 0.043 0.85 (0.78-0.92) <0.001 
BMI squared 0.002 0.001 1.002 (1.001-1.004) <0.001 
Type of stroke -0.083 0.092 0.92 (0.78-1.10) 0.364 
Gender -0.214 0.193 0.81 (0.63-1.04) 0.100 
NIHSS score 0.068 0.008 1.07 (1.05-1.09) <0.001 
Age 0.065 0.006 1.07 (1.05-1.08) <0.001 
Ethnicity -0.158 0.073 0.85 (0.74-0.98) 0.030 
 
 
After the adjustment for possible confounders, the quadratic term (BMI squared) was 
shown to be significant (p<0.001) on the model, which suggests that there is a U shaped 
relationship between BMI and mortality after stroke.  
BMI was also fitted to the model as a cubic term, but the result was not significant 
(p=0.522).  
The linear term is negative (Beta coefficient = -0.165) and the quadratic term (Beta 
coefficient = 0.002) is positive. 
The graphed relationship was obtained by using the equation  
Y = exp (Beta BMIsquared x BMI
2
 + Beta BMI x BMI) 






Fig. 3.12 - Adjusted 8-year mortality hazards ratio by BMI, showing the shape of the BMI-
mortality association after a stroke 
 
 
This curve shows an increased risk of death in the lowest BMI range and a modest 
elevation in risk of death in the highest range of BMI (>50 Kg/m
2
). The lowest risk of 




Knowing that a small proportion of outliers may affect the shape of the previous curve, a 
dot plot was created to identify data values that did not fit the trend of the data. This was 
the case for the 4 individuals with the highest values of BMI (BMI>50Kg/m
2
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Fig. 3.13- Dot plot showing distribution of patients according to BMI  
 
 
A model fit to the data when the 4 outliers were removed was conducted and results are 
shown on table 3.15. 
 
 
Table 3.15 - Multivariable Cox regression model output for 8-year mortality, using BMI as 
a continuous variable (linear and quadratic terms), after removing outliers 
 Beta coefficient SE HR (95% CI) p value 
BMI -0.198 0.074 0.82 (0.71-0.95) <0.007 
BMI squared 0.003 0.001 1.002 (1.000-1.006) 0.020 
Type of stroke -0.091 0.092 0.913 (0.76-1.10) 0.327 
Gender -0.226 0.132 0.79 (0.62-1.03) 0.087 
NIHSS score 0.068 0.008 1.07 (1.05-1.09) <0.001 
Age 0.065 0.006 1.07 (1.06-1.08) <0.001 




After the adjustment for possible confounders, the quadratic term (BMI squared) was also 
shown to be significant (p=0.02) in the model, but not the cubic term (p=0.104). This 
equally suggests that there is a U shaped relationship between BMI and mortality after 
stroke.  
The graphed relationship was obtained by using the equation Y = exp (0.003 x BMI
2
 – 





Fig. 3.14 - Adjusted 8-year mortality hazards ratio by BMI, showing the shape of the BMI-
mortality association after a stroke. Extreme values of BMI (>50Kg/m
2
) were excluded. 
 
The laterally inverted J shaped curve did not change significantly after the removal of the 4 
cases with extreme BMI values. The lowest risk of death continued to be located in the 
overweight group, when BMI = 33 Kg/m
2
, as opposed to the findings of studies conducted 
in healthy populations, where all-cause mortality is generally lowest with a BMI of 20 to 
25 Kg/m
2
 (Berrington de Gonzalez et al., 2010) (see figure 3.15). 
Barrington de Gonzalez and her colleagues pooled the data from 19 prospective studies 
that included 1.46 million non-Hispanic white adults, from 19-84 years old (median 58), 
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prospective studies in the National Cancer Institute Cohort Consortium (involving more 
than 15 countries), where information on self-reported BMI at baseline, smoking status and 
pre-existing conditions (like cancer and heart disease) were available (Berrington de 
Gonzalez et al., 2010).  
Fig. 3.15 was divided into men and women, and within each gender, there are 2 curves: 
-  “all subjects”: includes all subjects, encompassing current of former smokers, and those 
who reported having cancer or heart disease at baseline  
- “healthy subjects who never smoked”: this group includes only individuals who reported 
no history of cancer or heart disease at baseline and who had never smoked. Thus, in this 
subgroup, results should not be affected by the confounding effect of smoking or prevalent 
illness. Also, the HR of both curves took into consideration the effect of age, alcohol 
intake, educational level, marital status and overall physical activity.   
The authors of this study showed that all-cause mortality was generally lowest with a BMI 
between 20 and 25, and from 25 to 45 the higher the BMI, the higher the risk of death 
(particularly in healthy subjects who never smoked).  
In summary, when figures 3.14 and 3.15 are compared, it is possible to see that the BMI-
mortality curves are different between the healthy population (fig. 3.15, specially the 
healthy subjects who never smoked) and the stroke population (fig. 3.14). This reinforces 
the idea that the ideal BMI for the healthy population may be different from the ideal BMI 






Fig 3.15 - Estimated hazard ratios for death from any cause according to BMI of healthy 








3.5 - Discussion 
 
The aim of this study was to determine the association between BMI and mortality in a 
multiethnic population that had a first stroke. 
 
In order to compare the prevalence of BMI categories between this study population and 
the healthy UK population, data from the National Diet and Nutrition Survey were used 
(table 3.16). The most recent report of this survey presents combined results from 3 years 
of the rolling programme (2008/09 – 2010/11) for a sample of the UK population designed 
to be nationally representative (NDNS, 2012).  
 
Table 3.16 – Comparison of nutritional status (determined by BMI) between the SLSR 







underweight 6% 1% 2% 










Although excess weight has been recognised as a risk factor for stroke, the prevalence of 
overweight (including obese) individuals was slightly lower in the stroke population. 
However, when compared with the prevalence of overweight and obesity (41.0% and 
18.1%, respectively) in a Greek study with first-ever strokes (Vemmos et al., 2011), the 
prevalence of these BMI categories in the SLSR is greater. 
 
It should be noted that all survival analyses conducted in different subgroups of this 
population demonstrated that BMI (both as a categorical and as a continuous variable) was 
a statistically significant independent risk factor for mortality after a first ever stroke.  
Underweight patients had a significantly lower and overweight patients had a significantly 
higher survival, in both early (6 months) and late (up to 8 years) stages of follow-up 
period. When the analysis was conducted using 4 categories of BMI, the overweight group 
presented the lowest risk of mortality. 
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As mentioned in chapter 1, malnutrition has been shown to be a predictor of poor outcome 
in patients who have had a stroke and the association between underweight and a 
significantly higher risk of mortality was a consistent finding in all 8 studies of the review 
conducted in the introduction of this chapter (table 3.1), as well as in the present study. A 
very low BMI had an important prognostic implication for patients who had a stroke, 
independently of type of stroke, age, gender, ethnicity, severity of stroke and several risk 
factors. 
 
In the current study, the difference in risk of mortality of the overweight group in 
comparison with the reference group was not significant after the adjustment for possible 
confounders, which may have possible explanations.  
First, this may be due to the demographic characteristics of the study population. To our 
knowledge, this is the first study exploring the association between BMI and long-term 
mortality after stroke in a multiethnic population and, as discussed before, this association 
is ethnicity-dependent in healthy persons (Zheng et al., 2011). None of the 8 papers 
presented on table 3.1 (Olsen et al., 2008, Towfighi and Ovbiagele, 2009, Vemmos et al., 
2011, Kim et al., 2011, Kim et al., 2012, Ryu et al., 2011, Dennis, 2003, Hassan et al., 
2013) adjusted their results for the effect of ethnicity, probably because the studies were 
conducted in ethnically homogenous populations. Nonetheless, a study that examined 
survival differences in the SLSR underlined the importance of taking into consideration the 
effect of ethnic differences in survival after stroke (Wolfe et al., 2005); i.e., black patients 
were more likely to survive than white patients, even after controlling for several factors. 
Second, the other possible reason for the lack of significant results is the relatively small 
sample size of this study. Studies that included thousands of patients were able to 
demonstrate significant differences in mortality risk (in each BMI group, when compared 
with the reference range), in ischaemic (Kim et al., 2012), haemorrhagic (Kim et al., 2011) 
or both types of stroke (Olsen et al., 2008, Vemmos et al., 2011).  
Finally, the possibility of a selection bias cannot be excluded. Only 53% of the individuals 
included in the SLSR had a record of BMI, and when both groups with and without BMI 
were compared, it was observed that the second group had more deaths and more severe 
strokes. It is possible that patients did not have their BMI recorded due to practical reasons, 
i.e. in the case of a poor prognosis it might have been considered by the staff as unsafe or 
unethical to weigh the patient (although I will demonstrate in the next chapter that, with 
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effort, it is possible to obtain information regarding weight current and height in all - or 
almost all - patients). 
The same problem was also raised in other studies exploring the association between BMI 
and mortality in stroke patients. A study conducted in South Korea had to exclude 15.4% 
of their patients due to lack of BMI data (Kim et al., 2012) and, in the Danish cohort, BMI 
was measured in only 55% of the registered stroke patients and, from these, complete data 
was available for only 60% (Olsen et al., 2008). Nevertheless, this limitation is unlikely to 
affect results. In the Greek study, from the entire cohort of 2820 consecutive admissions to 
hospital with a first stroke (and registered in a stroke databank), only 1% were excluded 
because of lack of data regarding body weight or height or both, and their finding were 
similar, showing that overweight and obese individuals had significantly better survival 




When analyses were conducted on groups of patients aged under and over 65, similar 
results were obtained in both groups: the risk of mortality was higher for the underweight 
individuals and there was a trend for a lower risk of death in those who were overweight, 
before and after the adjustment for possible confounders. 
The lack of significant results in the overweight category (when comparing to the reference 
range) may be explained by the relatively small sample size of both groups.  
While Towfighi and Ovbiagele suggested that the association between BMI and mortality 
is age-dependent in their analysis of 644 individuals with a self-reported stroke (Towfighi 
and Ovbiagele, 2009), the most recent study with 34132 acute ischaemic strokes conducted 
stratified analyses by age groups and results remained significant in all age strata (Kim et 
al., 2012). This South Korean study supported the idea that the obesity paradox after stroke 
is independent of age, as well as cause of death. 
 
In the current study, using multivariable Cox regression model with all types of strokes, the 
effect of BMI on mortality was not affected by the removal of stroke risk factors (as 
confounders) from the model. This is in line with similar findings from a previous study 
(Olsen et al., 2008), which is not surprising as it could be argued that diabetes, 
hypertension and dyslipidemia are mediators between obesity and mortality and, therefore, 
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should not be treated as confounders. However, the majority of the studies identified in the 
review have included risk factors as confounders in their models. 
 
When analyses were conducted with BMI as a continuous variable, the risk of mortality 
was higher in the lowest range of BMI and decreased gradually until the overweight group. 
In the analysis without the 4 outliers, the lowest risk point was reached when BMI was 
33.0 Kg/m
2






These findings suggest that weight management strategies targeting the optimal BMI range 
used for the healthy population may require further evaluation and individualization in 
secondary prevention of strokes. This also reinforces the need to identify and treat 
underweight patients (not only in hospital but also in the community) and the need to adopt 




Limitations and strengths 
 
Beside the limitation regarding the availability of BMI records, the method used to obtain 
the weight for those patients with a record of BMI included not only measured weight 
(49%) but also weight recalled by patient or a relative (34%) and weight obtained from 
medical records (17%).  
It has been reported that underweight individuals tend to overestimate their weight and that 
overweight individuals tend to underestimate it but the validity of the reported weight is 
acceptable and there is small error (1-2%) in the classification of these individuals into 
BMI categories (calculated by measured versus reported weights) (Schmidt et al., 1993). 
Other studies have reported the need to use alternative sources of information to obtain 
patients’ weight (Vemmos et al., 2011), and this is preferred over the option of excluding 
patients from the analysis, which could induce a selection bias.  
The problem regarding quality of the data collection is also a limitation of the FOOD trial 
(Dennis, 2003), where only 20% of patients were weighed or had their BMI calculated and 
there was a lack of standardization of assessment of nutritional status, with a large 
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proportion of patients having their nutritional status assessed informally (i.e. based on 
simple observation, as a bedside assessment).  
 
The present study has a relatively small sample size but it has advantages over other 
studies that have explored the association between BMI and mortality after stroke.  
The SLSR is a register designed to prospectively collect data on individuals who had a 
diagnosed stroke for the first time, constituting a good source of information for 
epidemiological studies. On the contrary, other studies are sub-analyses of an original 
study with specific inclusion and exclusion criteria, which may have biased the results 
(Kim et al., 2012, Kim et al., 2011), and another study selected their study participants 
based on self-reported history of stroke in a national survey of non-institutionalized 
individuals (Towfighi and Ovbiagele, 2009). Additionally, there was no information 
regarding the type of stroke and BMI was not assessed at the time that the individuals had 
the stroke.  
 
Lack of analysis of specific subgroups (e.g. age or BMI categories) of the population is 
also a limitation of some studies. 
The SLSR includes individuals of all ages. Contrary to the present study that includes 
young stroke patients aged over 18 years, Olsen et al decided to exclude patients under 40 
years (Olsen et al., 2008).   
Given the poor prognosis of underweight patients, it is important to analyse this group 
separately. Unfortunately, both studies conducted by Vemmos and Hassan (and their 
colleagues) merged the underweight with the normal weight group (and the overweight 
group in Hassan’s study), which was used as a reference group (Vemmos et al., 2011, 
Hassan et al., 2013). 
It should be noted that the majority of all these studies, including the present study, points 
out two important limitations, which are: BMI is the only measure of obesity (or indicator 
of nutritional status) and lack of assessment of weight or nutritional status change over 
time. 
 
Future research could include the analysis of other data available on the SLSR, such as the 
follow-up information obtained at 1 year after stroke that may suggest changes in patients’ 
weight since admission. This includes questions regarding the need for help with feeding, 
swallowing problems and any attempt at losing weight. 
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Contributions and lessons learnt from this study 
In particular, this study enabled me to: 
- learn to manage a large database from an ongoing population based stroke register, which 
records strokes occurring in a specific area of South London.  
- learn to develop advanced statistical models, such as Cox Regression Hazards Models 
using BMI as a categorical and as a continuous variable, and the graphed relationship 
between BMI and long term mortality 
- realise that BMI data were poorly collected and this may lead to a selection bias. For 47% 
of individuals, there were no complete records of weight, height or both parameters, and 
for the remaining 53% where BMI was available, different methods were used to obtain 
weight. 
- realise that other variables that can be entered in the model as potential confounders (e.g. 
NIHSS score) were not available or were not collected for all patients and this excludes 
several patients (not necessarily randomly) between univariate and multivariable analyses 
-  understand that stratified analyses are limited in such a relatively small sample size. For 
example, in this sample of 856 patients, when I decided to conduct separate survival 
analyses in 2 groups of age (over and under 65 years, n= 547 and n=309 respectively), in 
the group of patients under 65 years, there were only 6 individuals who were in the 
underweight category. Therefore, results need to be interpreted with caution  
- recognise that potentially important confounders (e.g. smoking) were not included in the 
multivariable analyses. I have not adjusted the results for the effect of smoking as this 
information was not available in the SLSR dataset that was provided to me. 
- appreciate that BMI was the only indicator of nutritional status and mortality was the 
only outcome assessed in this study 
 
Thus, I learnt that in a future, prospectively designed, study (chapter 4), I will need to: 
- make an effort to collect BMI data for every recruited patient 
- make an effort to collect data on potential confounders for every recruited patient. For 
example, if I see that the NIHSS was not applied to the patients that I recruited, I will need 
to request the consultants to retrospectively assess the severity of the stroke according to 
reported symptoms and neurological evaluation conducted on admission to hospital 
- consider adjusting results for confounders such as ethnicity, age and type of stroke, 
instead of performing stratified analyses in subgroups of patients 
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- have a thorough selection of potentially important confounders not captured in this study 
(e.g. smoking) and collect these data for every recruited patient in the prospectively 
designed study 
- include other indicators of nutritional status such as waist circumference and risk of 






3.6 - Conclusions 
 
This study showed that BMI is a significant risk factor for mortality in a multiethnic 
population of individuals who had a stroke for the first time. The association between BMI 
and mortality over a period of 8 years is represented by a J shaped curve, where the lowest 
risk is attributed to the overweight group. 
 However, further research is needed. In particular, it is important to evaluate other 
outcomes, such as the risk of having a recurrent stroke as well as other indicators of 
nutritional status and distribution of body fat, such as WC. A prospective study was 



























Nutritional status after stroke: a cohort study about the 
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4.1 – Introduction 
 
The purpose of this prospective observational study was to explore the relationship 
between nutritional status (both undernutrition and overnutrition) and post-stroke 
outcomes. The study was divided into 3 sub-studies, described below (A, B and C). 
 
A. Risk of malnutrition and post-stroke outcomes 
Malnutrition has been clearly identified as a problem that affects the outcomes of patients 
who have had a stroke and, as it was mentioned before (in “Chapter 1 - Introduction”), one 
way of identifying patients with nutritional problems that might be amenable to nutritional 
intervention is to use a validated NST.  
To date, no published studies have validated a NST for use specifically in stroke patients 
(Foley et al., 2012, Cairella et al., 2004, SIGN, 2010) and this was identified as an area that 
lacks a strong evidence base in the most recent Scottish guidelines on the management of 
patients with stroke (SIGN, 2010). 
Malnutrition Universal Screening Tool (MUST) is a NST, launched in 2003, which 
involves assessment of BMI, % weight loss and the effect of acute illness on dietary intake 
(Elia, 2003) and it has been suggested as an appropriate tool for patients who have had a 
stroke (RCP, 2012). 
 
As mentioned in chapter 2, mortality and LOS data can be collected to establish the 
predictive validity of a NST, i.e., the ability of the tool to predict clinical outcomes. MUST 
has been suggested to predict clinical outcomes in elderly patients (Stratton et al., 2006) 
but the predictive validity of MUST in stroke patients is not yet known. 
This study was designed to determine the ability of MUST to independently predict 
negative outcomes in acute stroke patients, more specifically mortality, LOS and 
readmissions at 6 months post stroke. If patients who are at risk of malnutrition are 
correctly and promptly identified, they should be more likely to benefit from nutritional 
support.  
 
Moreover, malnutrition poses a significant burden on healthcare resources (Elia, 2006) and 
it has been suggested that disease-related malnutrition is an important determinant of 
hospitalisation costs (Amaral et al., 2007) but, to date, this association has not been tested 
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in patients who have had a stroke. Thus, this study will also analyse the association 
between malnutrition and hospitalisation costs, at 6 months post stroke.  
 
B. Comparison of two NST with regards to their performance to predict post-stroke 
outcomes 
Different NSTs use different criteria to identify patients at risk of malnutrition and 
therefore may perform differently in the same patient group. For example, in a study 
conducted in a geriatric population, the proportion of patients with malnutrition varied 
between 6.5 and 85%, after using 7 different sets of diagnostic criteria (Joosten, 1999). 
Several different tools have been developed to screen for malnutrition and they include 
various important features. Hence, it is useful to compare their performance to predict 
relevant outcomes in a specific population. 
 
The GSTT NST (described in chapter 2) is similar to MUST, however it includes a 
question on recent dietary intake that MUST does not and it does not require the 
quantification of weight loss. Given that both NST were being used in the hospitals where 
the data were collected, it was decided to apply both tools to each recruited patient. The 
aim of this study was to determine which NST best predicts mortality, LOS and 
hospitalisation costs at 6 months post stroke. 
 
 
C. BMI, central obesity and post-stroke outcomes 
As explained in chapter 1 (“1.1.3 – Obesity”), BMI may not be an accurate measure of 
adiposity in some adults, e.g. those who are highly muscular (and may be classified as 
“false obese”), which explains the need of having additional measures to identify obesity 
and its risks.  
Thus, it is recommended that the assessment of health risks associated with overweight and 
obesity in adults should be based on BMI and WC (NICE, 2006b).  
 
A few studies have explored the impact of body fat distribution on the risk of stroke. 
In a study with 576 stroke patients and 1142 controls, Suk et al identified abdominal 
obesity - measured by waist-to-hip ratio - as an independent, potent risk factor (and 
stronger than BMI) for first ischaemic stroke, with a greater effect among younger people 
(Suk et al., 2003).  
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Another case-control study (379 cases with stroke and 758 controls) that used a number of 
markers of abdominal obesity, such as WC, waist-to-hip ratio and waist-to-height ratio, 
reported a similar strong and graded association of abdominal fat markers with the risk of 
ischaemic and haemorrhagic stroke or TIA (Winter et al., 2008). In this paper, authors 
concluded that WC and related ratios can better predict cerebrovascular events than BMI 
and the same findings are supported by a longitudinal study with more than 50000 healthy 
individuals who were followed-up for 11 years (Bodenant et al., 2011). 
 
Other studies with large American (Jacobs et al., 2010) and European (Pischon et al., 2008) 
cohorts have examined the impact of body fat distribution on the risk of death in the 
general population and found that WC and waist-to-hip ratio were positively and strongly 
associated with all cause mortality. 
 
The studies previously mentioned in chapter 2 that explored the impact of BMI on 
mortality after stroke (Olsen et al., 2008, Towfighi and Ovbiagele, 2009, Vemmos et al., 
2011, Kim et al., 2012, Kim et al., 2011, Ryu et al., 2011, Dennis, 2003, Hassan et al., 
2013) did not measure any indicator of body fat distribution and, to date, no published 
studies have reported an association between abdominal obesity and mortality (or other 
outcomes) post stroke. 
The association between central obesity and mortality after stroke therefore remains 
unknown.  
 
According to estimates of stroke incidence in England and Wales, every year 133,700 
people have a stroke, of which 87,700 are first strokes and 53,700 are recurrent strokes 
(Carroll et al., 2001). This significant proportion of recurrent strokes (40%) justifies the 
importance of including recurrent events as an outcome in the current study. 
Although recurrent strokes are not as easily recorded and traceable as mortality, a complete 
approach investigating the impact of BMI and abdominal obesity on clinical outcomes 
after a stroke should include stroke recurrence as one of the outcome measures.  
A few studies have evaluated the impact of BMI on stroke recurrence but they have 
limitations, such as: 
- the inclusion of only first strokes and combination of underweight and normal weight 
patients in one BMI group (the “lean” group) (Vemmos et al., 2011) 
-  the inclusion of TIAs (Doehner et al., 2013),  
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- being a sub-analysis of an intervention study with specific inclusion and exclusion 
criteria, which may have biased the results (Doehner et al., 2013, Ovbiagele et al., 2011),  
- having a significant proportion of patients (36%) who were included in the study, but had 
no record of BMI (Andersen and Olsen, 2013). 
 
 
4.2 – Aims and hypotheses 
 
The following aims and hypotheses were established:  
 
A. Aim: to determine the ability of MUST to independently predict negative outcomes in 
acute stroke patients, specifically mortality, LOS, readmissions and hospitalisation costs at 
6 months post stroke. 
The main hypothesis was that MUST can be used to predict risk of negative outcomes in 
stroke patients. 
In particular, it was hypothesised that there is a significant difference in rates of mortality, 
LOS, number of readmissions and hospitalisation costs between patients in different 
malnutrition risk categories, at 6 months post stroke. 
 
B. Aim: to determine whether MUST or GSTT NST is the most effective NST in 
predicting negative outcomes in patients at 6 months post stroke. 
The main hypothesis was that MUST and GSTT NST have different performance in 
predicting negative outcomes and, therefore, have a different predictive validity for 
mortality, LOS, readmissions and hospitalisation costs, at 6 months post stroke. 
 
C. Aim: to determine the association between BMI, central obesity and outcomes (i.e. 
mortality and recurrent stroke) at 6 months post-stroke. 
The main hypothesis was that there is a significant difference in the risk of mortality and 
risk of stroke recurrence between patients in different BMI and WC categories, at 6 months 
post-stroke. 
 











4.3 - Methods  
 
4.3.1 – Recruitment, inclusion criteria, ethical considerations and 
baseline data collection 
This was an observational prospective (cohort) study, which was hypotheses-generating. It 
generated data to facilitate the design of adequately-powered randomised, controlled 
clinical trials, e.g. to study whether nutritional support given to patients identified as being 






Recruitment started on 13
th
 June 2011 at St. Thomas’ Hospital (located in Lambeth) and on 
22
nd
 November 2011 at Princess Royal University Hospital (located in Bromley), and 
finished on 18
th
 May 2012. During this period, all patients consecutively admitted to the 
hyper-acute stroke units (HASU) or SU of both hospitals were screened for eligibility for 
this study.  
HASUs provide the immediate response to a stroke, where the patient is stabilised and 
receives primary intervention. The patient´s LOS is typically no longer than 72h, and after 
this time (or when they are medically stable), they are moved to SUs closer to their place 
of residence that will provide a multi-therapy rehabilitation (NHS, 2008). 
 
 
Inclusion criteria  
The principal inclusion criterion was having a diagnosis of stroke (ischaemic or 
haemorrhagic), confirmed by a CT scan, a magnetic resonance imaging scan or the 
consultant’s clinical judgment, as well as having an NHS number (a requirement to track 
the patient 6 months subsequent to recruitment). 
All patients admitted to the SU and HASU of STH and Princess Royal University Hospital 
following an acute stroke were considered eligible for inclusion, and they were considered 
ineligible if they fulfilled any of the following criteria: 
 Non-adults (less than 18 years old) or pregnant women 
 Diagnosis of TIA (as explained before, a TIA gives a clinical picture similar 
to a stroke except that it is transient (less than 24h) and reversible)  
 "Stroke mimics", which is the term employed for manifestations of 
nonvascular disease processes when a stroke like clinical picture is produced 
 Patients without an NHS number, which is usually recorded on the hospital 







Ethical approval was obtained from the “National Research Ethics Service for Yorkshire 
and the Humber – Leeds West”, in May 2011 (reference number 11/YH/0054) - appendix 
4.1. This committee covers research involving adults who may lack capacity. Local 
approvals from both R&D departments at GSTT and at South London Healthcare NHS 
Trust were obtained during the following month. 
 
Once the diagnosis of stroke was confirmed, a member of the clinical care team evaluated 
whether the patient was able (not incapacitated) to give permission to speak with the 
researcher and able to consent to participate in the study. 
After obtaining permission, the study was briefly introduced to the patient by the 
researcher (regarding aims, objectives and conduct of the study) followed by the delivery 
of the patient information booklet (appendix 4.2). Patients and carers were given the 
opportunity to ask questions and were allowed up to 24 hours to decide whether or not they 
wish to take part in the study. 
 
If the patient was incapacitated or confused, a discussion with his/her consultant took place 
to identify the most appropriate consultee from whom to seek advice (e.g. next of kin or 
close relative). 
Once the patient (or his/her consultee, for patients who were incapacitated or confused) 
decided they wished to take part in the study, written consent/advice was obtained on a 
standard pro forma (appendices 4.3 and 4.4). All signed consent forms were kept in a 
lockable cabinet in the Departments of Nutrition & Dietetics at St Thomas’ Hospital, 1 
copy was filed in the patient’s medical notes and another copy was given to the patient or 
his/her consultee.  
All patients who consented to be part of the study were also handed a “next of kin 
information letter” (Appendix 4.5) confirming their agreement to be in the study and 
summarizing the research process. The study participant was advised to hand this letter to a 
close relative or friend. This procedure complies with the requirements of the Mental 





Baseline data collection 
All subjects admitted at the SU and HASU of both hospitals were recorded on a 
“Recruitment Log” sheet. Those who fulfilled the inclusion criteria and gave 
consent/assent were allocated a unique identifier (study ID number), which was recorded 
on all data collection sheets. Details that could make the subject identifiable e.g. name, 
date of birth, hospital number and NHS number were recorded in a “Master list” that was 
kept in a lockable cabinet in the Dietetic Department at STH. 
Recruitment and baseline data collection were aimed to be completed within 3 days of 
admission, at both hospitals (to maximize recruitment and allow for a greater heterogeneity 
of patients). Data collection sheets (appendix 4.6) were used to collect information:  
 from the medical notes:  
- date of admission,  
- date of stroke 
- gender 
- ethnic group 
- type of stroke 
- living conditions prior to stroke (support includes formal support e.g. from social 
services, and informal support e.g. from family or friend). 
- medical history as identified by the medical team, potentially relevant as stroke risk 
factors and chronic conditions likely to affect nutritional status prior to admission. 
For “cognitive dysfunction” and “impaired mobility”, these conditions were only recorded 
if they were present prior to current admission, as they may be affected by stroke. For all 
other conditions, they were recorded if the disease was present prior to current admission 
or if it was newly diagnosed during hospitalisation. 
The first 9 items are well known risk factors for stroke and the last 3 items are chronic 
conditions that are likely to affect nutritional status prior to admission. Gastrointestinal 
diseases include Crohn’s disease, pancreatic insufficiency, irritable bowel syndrome, etc. 
- record of previous stroke 
- NIHSS score, i.e., the result of a routinely applied scale that measures the severity of 
stroke (appendix 4.7)  
- Swallow test result, i.e., the result of the routinely applied swallow test, aimed to detect 




 from the nutritional screening tools that are routinely used in both hospitals 
(appendix 2.1 and 4.9, and table 4.1 a) ): 
- Patient’s height. This was measured using a portable stadiometer (Seca, Leicester, UK), 
according to standard methodology, in patients who could mobilise safely and were able to 
stand. In patients who were unable to stand, recalled height (if judged to be reliable and 
realistic) or a surrogate measure, i.e. height estimated using ulna length, was used to 
calculate height. Ulna length was measured between the olecranon process and the styloid 
process, as described by the MUST explanatory booklet (Elia et al., 2003).  
- Patient’s current weight.  This was measured using Seca clinical scales, either chair or 
hoist scales, regularly calibrated, with patients wearing light clothing and without shoes. 
When weight could not be measured (e.g. in case of a recent hip fracture), recalled weight 
(if reliable and realistic) was used. The presence of oedema and any record of a previous 
amputation were documented and weight was corrected accordingly.  
- Patient’s usual weight. This was obtained from the patient, the relative or carer and 
medical notes, some of which had weight records from previous hospital admissions, 
outpatient appointments and visits to General Practitioners. 
- Unintentional weight loss in the last 6 months (affirmative or negative) for the GSTT 
NST, or unintentional weight loss in the past 3 to 6 months (<5%, 5-10% or > 10%) for the 
MUST. Usual (previous) and current weights were used to calculate percentage of weight 
change according to the following equation: 
% weight change = usual weight (Kg) – current weight (Kg) x 100 
    usual weight (Kg) 
- Loss of appetite/decrease in dietary intake in the last 6 months (for the GSTT NST), as 
reported by patient, relative or carer, and medical notes. 
- Inability to eat or “nil by mouth” for more than 5 days, as described in medical notes. 
 As a new parameter (not collected routinely): WC.  
The measurement was standardised at the midpoint between the lowest rib and the iliac 
crest and, when possible, was taken on patients with their waist uncovered. Participants 
were asked to breathe normally and the reading was taken at the end of a normal 
exhalation.  
In subjects who were safe to stand WC was measured while they were standing and, for 
those with a good mobility, the same measurement was also taken in the supine position 
(with patients lying down on the bed), in as many patients as possible. For patients who 
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were confined to bed, WC was only measured in the supine position (if possible, without 
causing physical or psychological distress).  
A direct comparison will be made between the WC measurements obtained from patients 
standing and in the supine position, enabling inferences to be made about the validity of 
measurements obtained from patients who are bed-bound. 
 
Table 4.1 a) - Factors included in assessment of nutritional risk according to MUST and 
GSTT NST 
 MUST GSTT NST 
Unintentional weight loss 
in the last 6 months 
Yes, quantified into: 
 < 5%, 5-10%, >10%. 
Yes, not quantified: 
 “yes” or “no” 
Unintentional reduced 
intake/appetite in the last 6 
months 
No Yes 
Body Mass Index (Kg/m
2
) Yes, with 3 levels of score:  
< 18.5, 18.5-20, >20. 
 
Yes, with 2 levels of score 
< 18.5,  ≥18.5 
Nil by mouth or inability 
to eat for more than 5 days 
Yes, in the presence of acute 
disease 
Yes 
Patient on tube feeding or 
parenteral nutrition 
No Yes. These parameters are 
considered to be at high risk 
of malnutrition (equivalent 
to score ≥ 4) because of 
local policies, i.e., at GSTT 
patients on tube feeding or 
parenteral nutrition or with 
grade 3-4 pressure sores 
should be automatically 
referred to a dietitian 
 





All the equipment was cleaned and disinfected after use, and disposable tape measures 
were used for patients who were isolated (as in some cases, isolation was needed to prevent 
the transmission of infectious diseases). 
 
With regards to the baseline data collection, and in particular the data from the NSTs, it 
must be noted that both tools were applied by the same person (the author), allowing for a 
standardized methodology of data collection.  
This also prevents missing data that is frequently observed in clinical settings. For 
example, patients must be weighed on admission to hospital and, unless they are severely 
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ill, this is done and recorded on the NST and on the “weight chart”. However, in the vast 
majority of the cases, the NST was not fully completed by the staff (e.g. "usual weight" 
and "actual height" fields were frequently left uncompleted).  
Old case notes were available for the majority of the patients and were thoroughly 
reviewed to obtain potentially useful information. In several cases, patients’ General 
Practitioners were contacted (by fax) to obtain information on previous medical history and 
medication, which would also contain additional information on previous weights and 
heights measured during routine appointments. All these data were used to inform about 
previous and validate current measurements concerning nutritional status. In summary, a 
variety of information sources was utilized to gather the baseline data, which was 
consistently collected by the author. 
 
The number of patients who could not be weighed or measured due to severity of their 
clinical condition was recorded, and when there was no alternative method to obtain these 
data. When alternative methods were used, their validity was analysed and discussed. All 
efforts were made to recruit all eligible patients and to collect all the baseline data for 
every recruited patient. The follow-up procedure (described in the following section) was 
chosen to minimise loss of data from recruited patients. All these factors are crucial to 
minimise potential sources of bias. 
 
4.3.2 – Follow-up procedure 
This study was designed to have a minimal impact on patients, and to recruit as many 
individuals as possible. Thus, after recruitment and collection of the baseline data, patients 
were not contacted again. The data regarding outcomes of each patient for a follow-up 
period of 6 months after the stroke were obtained from the Summary Care Records and the 
Hospital Episode Statistics (HES) databases. The NHS number was used to track each 
patient in both systems. 
The primary outcome - 6 month mortality - was obtained through the Summary Care 
Records, an electronic patient record that stores a defined set of key patient data for every 
patient in England. These data make a summary record created from information held on 
GP clinical systems, from basic demographic data to date of death (when applicable). 
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Mortality data is quickly updated, through notifications from GPs, hospitals and register of 
deaths.  
Access to data is available to NHS personnel anywhere in England, but only if they have 
the correct access rights on their smartcard approved by senior management.  After 
receiving the training and authorization to use a smartcard, mortality data were collected 
for each patient on 18
th
 December, 2012 (one month after the 6-month follow-up period of 
the last recruited patient, as recommended by the Summary Care Records system to 
guarantee that all death notifications were received and recorded). 
 
HES is a data warehouse containing details of all admissions, outpatient appointments and 
A&E attendances at NHS hospitals in England. Through a tailor-made report requested 
from HES, and after gaining the adequate approval in March 2013, a database was received 
in April 2013. HES is not a live system; there is a time lag of around 6 months (which 
justifies the reception of the data in April 2013) between the hospitals submitting the data 
to HES and the time point when the data can be accessed. This is because various data 
quality checks and validations are applied to the data, which is then cleansed prior to 
release.  
We requested information from the inpatient data set, which is the most commonly used 
and holds data from 1998 onwards. It is patient based, and is made up of records for each 
period of care under one consultant (episodes). Each episode is made up of information 
relating to the patient such as age, sex, ethnicity and home postcode; the treatment journey 
such as admission and discharge dates, diagnoses, operations, and information relating 
professionals associated with the patient’s care. Data (fields) requested to HES can be 
found in appendix 4.10. 
Once the database was received, the information was organized by patient, in such a way 
that could allow for the calculation of each patient’s cumulative LOS, number of re-
admissions, recurrent strokes and hospitalisation costs. It was also cleaned and validated 
against the information collected on baseline/recruitment. Any issue or disagreement was 
discussed directly with the HES data linkage team, via e-mail or telephone. 
This follow-up method helps to identify any NHS hospital related event that may occur 
anywhere in England. For example, a patient who lives in Manchester and has a first stroke 
in London while visiting this city, is recruited at the London-based hospital where he/she 
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was admitted. After returning to Manchester, if the patient has another hospital admission 
and/or a stroke in a period of 6 months, this follow-up procedure (i.e. using HES data) will 
identify these potential events. In contrast, hospital computerised medical records are not 
able to capture admissions that occur in another hospital.  
 
Analyses on cumulative LOS, hospitalisation costs, hospital readmissions and stroke 
recurrence were conducted on patients who survived at 6 months post stroke. Patient 
centred outcomes such as functional disability and quality of life were also considered, but 
it was decided not to include them for the reasons explained in section “4.5 – Discussion”, 
under “Limitations”. 
 
The cumulative LOS is the total number of days spent in hospital during the follow-up 
period. In other words, it is the sum of days in each hospital admission (including the 
initial admission after recruitment), during 6 months post stroke, for those patients who 
survived.  
 
Analyses of hospitalisation costs comprised the cost estimation of all hospital admissions 
that each surviving individual had over a period of 6 months post stroke. 
Diagnoses codes for inpatients are grouped into Healthcare Resource Groups (HRG), 
which are standard groupings of clinically similar treatments that use common levels of 
healthcare resource. HRGs were supplied by HES for every hospital admission of patients 
included in the present study.  
The cost analyses were based on the “Payment by Results” system. This is the hospital 
payment system in England in which commissioners pay providers (NHS trusts, etc.) a 
national tariff for admitted patient care, outpatients and A&E. 
The “2012-13 tariff information spreadsheet” (Department of Health, 2012) was used to 
transform the HRG (from the database provided by HES) into the tariffs paid by the 
commissioners, for each patient. These cost analyses included relevant adjustments to the 
tariffs for length of admission (long or short stays) and for type of admission (elective or 
non-elective), but excluded the adjustment for the market forces factor and the specialised 
services increment, as this is not applicable for the purposes of this study aim, i.e. we 
aimed to know whether being nutritionally vulnerable increases hospitalisation costs, 









NHS = National Health Service 
























Baseline data collection: 
- From medical notes 
- Nutrition Screening Tools + 
anthropometric measurements 
(weight, height, waist 
circumference) 
 
6 months  
(follow-up period) 
Follow-up data collection: 
- Mortality 
- Length of hospital stay 
- Readmissions  
- Hospitalization costs 
- Recurrence of stroke 
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4.3.3 – Statistical analysis and sample size calculation 
 
1. Patients were classified into: 
- 3 nutrition risk categories, according to MUST and GSTT NST scores: low, medium and 
high.  
- 4 BMI categories: less than 18.5 kg/m
2
 (underweight), 18.5 to 24.9 kg/m
2 
(normal 
weight), 25.0 to 29.9 kg/m
2
 (overweight) and 30.0 kg/m
2
 or more (obese).  
- Quartiles of WC  
 
2. Baseline characteristics of NST, BMI and WC categories were compared using the Chi-
square test for categorical variables and the ANOVA or the t-test for continuous variables. 
Outcome data were tested for normality using the Kolmogorov-Smirnov test and, when 
needed, were log-transformed. 
 
3. The Chi-square test was conducted to compare categorical outcomes (e.g. mortality 
rates) between BMI, WC and nutrition risk category.  
In order to compare continuous variables (e.g. LOS) between categories, non parametric 
tests (e.g.  Kruskal-Wallis or Mann-Whitney tests) were used for the non-normally 
distributed data and parametric testes (e.g. ANOVA) were used if data fitted the normal 
distribution.  
A post-hoc analysis to assess the effect of possible confounders (e.g. ethnicity, age, gender, 
type and severity of stroke, stroke risk factors) on outcomes included a binary logistic 
regression and univariate analysis of variance. 
 
4. Cox Proportional Hazards Models were used to compare risk of mortality (crude and 
adjusted HR, with 95% confidence intervals (CIs)) between categories of BMI, WC and 
risk of malnutrition. Multivariable models allowed for the adjustment of several covariates, 
such as age at time of stroke, gender, ethnicity, type and severity of stroke, and stroke risk 
factors.  
The “normal weight” group, the first quartile of WC group and the “low risk of 
malnutrition” group were used as the “reference category”, for models containing BMI, 
WC and risk of malnutrition, respectively. 
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Further analyses were conducted with subgroups of stroke subtype and age, and also with 
BMI as a continuous variable. 
 
5. Both NST were compared for their ability to predict negative outcomes by using the area 
under the receiver operating characteristic (ROC) curves. 
 
6. Sensitivity analyses were conducted as needed, e.g. to handle missing data: 2% of the 
HRG codes provided by HES were not valid or there are no published tariffs for these 
codes and, therefore, admissions or episodes linked to these codes were excluded. The 35 
patients who had one admission with an invalid code or a code with no published tariff 
were identified, to allow for a sensitivity analysis (i.e. to conduct the cost analyses with 
and without those 35 patients). Also, the definition of recurrent stroke was analysed in 
different ways (i.e., including and excluding patients who died at 6 months) and the same 
applies to the definition of BMI (i.e., analyses were conducted using BMI as a categorical 
and as a continuous variable). 
 
Statistical analyses were carried out using SPSS software version 19.0 for Windows 
(Chicago, Illinois, USA). Any differences were considered significant when p < 0.05. 
 
 
Sample size calculation 
 
Assuming 20% patients are malnourished on admission to the Stroke Unit (Davalos et al., 
1996), and that 21% of patients die during the first 6 months after a stroke, being 35% 
deaths on malnourished patients and 20% in the adequately nourished (data from the 
FOOD Trial Collaboration, (Dennis, 2003)), a total sample size of 539 subjects was 
required to achieve a power of 95%, to detect a difference in mortality between 
malnourished and adequately nourished patients, with a significance level of 0.05 in a two-
tailed Chi-squared test. 






4.4 - Results  
 
From screening to recruitment 
 
During the 11-month recruitment period, 925 patients were admitted and screened at both 
hospitals: 361 at St. Thomas’ Hospital and 564 at the Princess Royal University Hospital. 
550 patients were recruited for this study and the remaining were not recruited for the 
following reasons: 
1) Did not have a stroke: n = 289  
Patients were admitted to the HASU but they did not have a stroke and received other 
diagnoses, such as: TIA, epileptic attack, seizure activity, migraine, alcohol intoxication, 
Bell's palsy, multifocal motor neuropathy, systemic lupus erythematosus; old stroke, 
subdural haemorrhage, small vessels ischaemic changes. 
2) It was not possible to follow-up because: 
- patients had a stroke but did not have a NHS number. It should be noted that London has 
several “visitors” and recent immigrants who are not registered with a GP; this was more 
common at St. Thomas’ Hospital (n = 16) than at Princess Royal University Hospital 
(n=4), due to the central location of the first: n = 20  
- had a stroke and a NHS number but moved to his home country after discharge, which 
makes it impossible to obtain the follow-up data: n = 1 
3) Had a stroke and a NHS number and recruitment was discussed, but patients or their 
relatives/carers did not provide (i.e., refused to) consent: n = 5 
4) Had a stroke and a NHS number but were discharged before being seen or approached 
for the present study, due to a quick transfer to a step-down rehabilitation unit (usually 
close to their residence), immediately after receiving the diagnosis (less than 2 days): n = 
11 
5) Had a stroke and a NHS number, and there was an attempt to approach these patients 
with regards to the study but they were unable to consent (e.g. due to presence of aphasia 
or not being alert) and there were no visits from relatives, friends or carers who could 
provide consent on their behalf: n = 16 
6) Had a stroke and a NHS number, but patients were not weighed within the first 3 days 
after stroke due to the severity of illness. The majority of them were put on the Liverpool 
Care Pathway, which is a care pathway that a patient can expect in the final days and hours 
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of life. In other words, they were not for active treatment, and weighing the patient was not 
considered an option: n = 21  
7) Had a stroke and a NHS number but were recruited before, i.e., these were recurrent 
strokes of patients previously recruited to this study: n = 12 
In total, 925 screened patients – 289 – 20 – 1 – 5 – 11 – 16 – 21 – 12 = 550 recruited 
patients. 
The percentage of eligible stroke patients (which also excludes those on LCP) who could 
not be recruited was only 5%. 
 
Furthermore, 7 out of the 550 patients were recruited and, later, withdrawn from the study. 
For 6 patients their final diagnosis (after being submitted to further exams and 
assessments) was not a stroke; for the other patient, his family decided to take him back to 
his home country, making it impossible to obtain information about his outcomes. 
Thus, the number of patients included in this study is 543 (n = 550 – 7 = 543).  
The following figure summarizes the consort-type diagram of the study, from screening to 




















































Fig. 4.2 – Consort-type diagram of the study 
 
 
550 patients recruited 
- 209 patients from STH 
- 341 patients from PRUH 
925 patients admitted and screened at 
the HASU and SU of both hospitals 
543 patients included in the study  
7 withdrawn  
289 with no stroke  
21 not possible to follow-up: 20 with 
no NHS number + 1 returned to home 
country  
5 refused to consent  
11 discharged before being seen or 
approached  
16 unable to consent and no visits from 
relatives/friends/carers 
21 not weighed due to the severity of 
illness (LCP)  
12 were recruited before  
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Baseline characteristics  
 
a) Missing data 
 
There were no missing data from variables collected at baseline and follow-up, except for: 
- WC in 1 patient who refused to be measured, and 
- MUST score in 6 patients where it was impossible to quantify weight loss, because this 
information could not be obtained from any source.  
Therefore, the analysis for BMI and GSTT NST score related to 543 patients, while 
analysis related with WC related to 542 patients, and analysis related with MUST score 
contained 537 patients. 
 
b) Characterisation of the study population 
 
The 543 patients included in the study had a mean age of 74.7 years, 51 % were men, 87% 
had an ischaemic stroke, 80% were white, 22% had a previous stroke and 34% failed the 
swallow screening test on admission to hospital.  


















Table 4.1 – Baseline characteristics of patients included in the study (n=543) 
 
 
Numbers in parentheses indicate percentages for categorical data and SD (standard deviation) for 
continuous data; NIHSS = National Institutes of Health Stroke Scale 
 
Age, mean in years (SD)  74.7 (13.9) 
          Range (minimum-maximum)                           22 - 99 
Gender, n   
   Male, n (%) 278 (51) 
   Female, n (%) 265 (49) 
Ethnicity,  n   
   White, n (%) 437 (80) 
   Black, n (%) 79 (15) 
   East Asian, n (%) 10 (2) 
   South Asian, n (%) 14 (3) 
   Mixed ethnic background, n (%) 3 (1) 
   Any other background, n (%) 0 
Type of stroke, n   
    Ischaemic, n (%)  472 (87) 
    Haemorrhagic, n (%) 68 (12) 
    Subarachnoid haemorrhage, n (%) 3 (1 ) 
   Unclassified, n (%)   
NIHSS score, mean (SD) 7.6 (5.7) 
    Range (minimum-maximum)                           (0-27) 
Living conditions prior to stroke   
     Home (unsupported), n (%) 124 (23) 
     Home (with support), n (%) 382 (70) 
     Institutionalized, n (%) 7 (1) 
     Other, n (%) 30 (6) 
Medical History   
    Hypertension, n (%)         375 (69) 
    Diabetes, n (%)                    116 (21) 
    Dyslipidemia, n (%)        161 (30) 
    Smoking, n (%)     65 (12) 
    Ischaemic heart disease, n (%) 75 (14) 
    Heart failure, n (%)          16 (3) 
    Atrial fibrillation, n (%)                128 (24) 
    Previous TIA, n (%)                       61 (11) 
    Heavy alcohol consumption, n (%)   24 (4) 
    GI diseases, n (%)                         52 (10) 
    Cognitive dysfunction, n (%)       37 (7) 
    Impaired mobility, n (%)               62 (11) 
Had a previous stroke 119 (22) 
Failed swallow screening test 185 (34) 
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c) Anthropometric data 
 
Weight was measured on admission to hospital in 542 patients. It was not possible to 
weigh one patient who was bed-bound following a recent fracture in the neck of femur.  
However, the patient had been weighed 2 weeks before admission to a hospital setting 
(before a surgery) and this was used as the current weight. 
 
Height was preferentially measured, as described in section 4.1 “Methods - Baseline data 
collection”. Due to safety issues and limited mobility in the acute stage post-stroke, 
recalled height had to be used for several patients (n=342), and this was compared against 
recent documented height (when available). It has been suggested that self-reported height 
is valid for identifying relationships in epidemiological studies (Spencer et al., 2002). 
39 patients were not able to stand safely to have their height measured and were not able to 
recall their height; therefore, ulna length was measured to estimate their height, as 
recommend by the MUST explanatory booklet (Elia et al., 2003).   
 
 
WC was preferentially measured with patients standing (n=338), as described in section 
4.1 “Methods - Baseline data collection”. For patients who were confined to bed (n=204), 
WC was only measured in the supine position. In a proportion of patients (n=77), WC was 
measured while they were standing and also in the supine position, and both methods were 
compared to make inferences about the validity of measurements obtained from patients 
who were bed-bound. 
A Pearson product-moment correlation coefficient was computed and showed that there is 
a strong positive correlation between both methods of measuring WC (r=0.997, p<0.001). 
A paired t-test revealed a very small consistent bias (mean difference 0.29 cm, p=0.03), 
which is of little practical significance. 
The differences between both methods are represented on the Bland-Altman plot (fig. 4.3) 
showing that in 95% of the cases the difference was not more than 2cm, and the variation 
was slightly higher at the upper end of the plot, i.e., in patients with larger WC (greater 
than 100cm), as expected. 
Thus, WC of patients in the supine position was considered to be an acceptable and valid 




Fig. 4.3 - Bland-Altman plot representing the differences (in cm) in waist circumference 
measurements and average values of patients standing and in the supine position. The 
middle horizontal line represents the mean of the differences between both measurements 





d) BMI, WC and risk of malnutrition 
 
Table 4.2 shows the distribution of patients into groups of BMI, WC and risk of 
malnutrition. 55% of patients were overweight or obese (n=299), and approximately 30% 
of patients were at high risk of malnutrition, according to MUST (n=156) and GSTT NST 
(n=171). It is noteworthy that patients at high risk of malnutrition also included overweight 
and obese individuals: 29 (19%) overweight and 21 (14%) obese patients using MUST; 39 
(18%) overweight and 19 (11%) obese patients using GSTT NST. 
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Table 4.2 – Distribution of patients into groups of BMI, WC and risk of malnutrition (as 
assessed by MUST and GSTT NST) 
 
  Groups Criteria n % 
Body mass index 
(kg/m2) 
underweight <18.4 38 7.0 
normal weight 18.5 to 24.9 206 37.9 
overweight 25.0 to 29.9 177 32.6 
obese >30.0 122 22.5 
Waist circumference, 
gender specific                
(men / women, in cm) 
1st quartile <91.5 / <84 143 26.4 
2nd quartile 91.6-100 / 85-94 139 25.6 
3rd quartile 101-109 / 95-107 132 24.4 
4th quartile >110 / >108 128 23.6 
Malnutrition Universal 
Screening Tool 
Low risk Score = 0 342 63.7 
Medium risk Score = 1 39 7.3 
High risk Score ≥ 2 156 29.1 
Guy´s and St Thomas´ 
NHS Foundation Trust 
Nutrition Screening 
Tool  
Low risk Score = 0 320 58.9 
Medium risk Score = 2 52 9.6 





Results are presented by outcome, which were determined for each patient at 6 months 





The Chi-square test was used to compare rates of mortality and Cox Proportional Hazards 
Models were used to compare risk of mortality (crude and adjusted HR) between 
categories of BMI, WC and risk of malnutrition. Baseline characteristics (such as age, 
gender, ethnicity, type and severity of stroke) and stroke risk factors were included as 
covariates in the multivariable model, as they may have an influence on outcome 
(mortality).  
Results are summarized in the following tables and figures. 
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Table 4.3 - Rates of mortality and risk of mortality according to groups of BMI and 




 - results were adjusted for the effect of age, gender, ethnicity, type of stroke, severity of 
stroke and stroke risk factors (hypertension, diabetes, dyslipidemia, smoking, IHD, heart 
failure, atrial fibrillation, previous TIA and heavy alcohol consumption) 
 
There was a significant difference in mortality rates between patients in the 4 groups of 
BMI and WC (p<0.001 and p=0.046, respectively). In the current study, the higher the 
BMI and the WC quartile, the lower the mortality rates.  
Similarly, risk of mortality was significantly different between categories of BMI and WC 
(p<0.001 and p=0.044, respectively). The underweight group and the 1
st
 quartile of WC 
presented the highest risk of mortality; the obese group and the 4
th






rates    
Univariate Cox 
Proportional 





Model    
(Chi-
square 
test)   
Hazard 
ratio  
95% CI    
Hazard 
ratio   
95% CI    
Body Mass 
Index categories   
543 p=0.001   p=0.001   p=0.057 
Underweight   
  
38 28.9% 1.18 0.62-2.28  0.82 0.41-1.65  
Normal weight   
  
206 23.8% Reference group  Reference group  
Overweight   
  
177 12.4% 0.48 0.29-0.79  0.57 0.33-0.97  
Obesity   
  




542 p=0.046   p=0.044   p=0.107 
1st quartile    143 25.2% Reference group  Reference group  
2nd quartile   139 15.8% 0.60 0.35-1.02  0.64 0.37-1.09  
3rd quartile   132 14.4% 0.54 0.31-0.94  0.59 0.33-1.06 
4th quartile   128 14.1% 0.51 0.29-0.91  0.52 0.29-0.94 
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the lowest risk. The survival curves for both parameters are displayed on figure 4.4 and 
4.5. 
After taking into consideration all the potential confounders in the multivariable analyses, 
there was a trend for a statistically significant association between BMI and mortality 
(p=0.057), but the association between WC and mortality was no longer significant 
(p=0.107). Details regarding the effect of different variables on 6-month mortality can be 
found in appendix 4.11 a) and b).  
 
The small number of underweight patients explains the wide confidence intervals of the 
underweight group, and the non-significant decreased risk has to be interpreted with 
caution. It can be concluded that, having the normal weight category as a reference group, 
being overweight was associated with a 43% decreased risk of death and with a 54% 
decreased risk for obese patients.  
 
 
Fig. 4.4 - Survival curves after stroke according to groups of BMI (univariate analysis). 
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A similar analysis was conducted to study the association between risk of malnutrition and 
6-month mortality, which proved to be statistically significant and graded: the greater the 
risk of malnutrition, the higher the rate of mortality (p<0.001 for both NST), and the 
higher the unadjusted (p<0.001 for both NST) and adjusted risk of mortality (p<0.001 for 
both NST) – see table 4.4 and figures 4.6 and 4.7.  Further information regarding the effect 





Table 4.4 - Rates of mortality and risk of mortality according to nutrition risk category, 




rates    
Univariate Cox 
Proportional 





Model    
(Chi-
square 
test)   
Hazard 
Ratio 
95% CI    
Hazard 
Ratio   
95% CI    
Guy's and St. 
Thomas' 
Nutrition 
Screening Tool  
543 p<0.001   p<0.001   p<0.001   
Low risk 320 5.3% Reference group Reference group 
Medium risk 52 13.5% 2.7 1.10-6.40 2.1 0.87-5.09 
High risk 171 41.5% 10.2 6.01-17.34 5.99 3.42-10.50 
Malnutrition 
Universal 
Screening Tool  
537 p<0.001   p<0.001   p<0.001   
Low risk 342 5.8% Reference group Reference group 
Medium risk 39 25.6% 4.89 2.29-10.45 3.77 1.71-8.31 
High risk 156 41.7% 9.27 5.61-15.30 5.58 3.24-9.64 
a
 - results adjusted for the effect of age, gender, ethnicity, type of stroke, severity of stroke and 
stroke risk factors (hypertension, diabetes, dyslipidemia, smoking, IHD, heart failure, atrial 




When compared to the reference group (low risk of malnutrition), patients at high risk of 
malnutrition had an approximately 6-fold increased risk of death, using both NST. At 6 
months after stroke, less than 6% of patients at low risk of malnutrition were dead while 











































Further analyses with subgroups and using BMI as a continuous variable 
 
In order to remove the heterogeneity related to stroke subtype and age, the same statistical 
analyses were conducted for the subgroup of ischaemic strokes (n=472) and for the 
subgroup of patients aged 65 and older (n=434) 
Similar results were observed: the higher the BMI, the lower the risk of mortality, and 
there was a non significant trend for a lower risk of death in patients with greater WC. Risk 
of malnutrition continued to have an important prognostic value, where the higher the risk 
of malnutrition, the higher the risk of mortality. Details regarding these data can be found 
in appendices 4.12, 4.13, 4.14 and 4.15. 
However, these results should be interpreted with caution due to the relatively small 
sample size of each group.  
 
It was also investigated whether the relationship between BMI and mortality is linear or 
quadratic. Multivariable Cox regression models were performed using BMI as a 
continuous variable and taking into consideration the effect of age, ethnicity, severity of 
stroke, gender, type of stroke and stroke risk factors, suggesting that there is no linear (p= 



















b) Length of hospital stay 
 
Distribution of LOS was analysed with histograms and Q-Q plots. Data were tested for 
normality and, as anticipated from the literature, they were not normally distributed 
(Kolmogorov-Smirnov test, p<0.001). 
LOS data were log-transformed and tests for normality were repeated, showing that the 
log-transformed LOS was also not normally distributed (Kolmogorov-Smirnov test, 
p=0.001). Therefore, non-parametric tests were used to explore differences on LOS 
between patients in the 3 malnutrition risk categories. 
 
 
As shown in table 4.5, the distribution of LOS was significantly different across nutrition 
risk categories (Kruskal-Wallis test, p<0.001, for both NST), and this association remained 
significant after taking into account the effects of age, gender, ethnicity, type and severity 
of stroke, using univariate analysis of variance on ranked data (p<0.001, for both NST). 
Furthermore, adding stroke risk factors to the model did not alter the signiﬁcant association 
between nutrition risk category and LOS (p<0.001) – appendix 4.16 a) and b). 
LOS increased progressively with malnutrition risk category, from a median of 14 to 48 
days.  
 
Figure 4.8 illustrate a clear graded association between nutrition risk category and LOS 
(data taken from table 4.5). For those who survived, the median number of days spent in 
hospital in a period of 6 months was at least 2 times higher for patients who were at high 











Table 4.5 – Length of hospital stay in patients who survived a 6 months, according to risk 
of malnutrition (unadjusted and adjusted results) 



















Low risk 303 (68% 14 2-173 
<0.001 <0.001 Medium risk 45 (10%) 27 2-161 
High risk 100 (22%) 48 2-194 
MUST  
(n=442) 
Low risk 322 (73%) 14 2-173 
<0.001 <0.001 Medium risk 29 (7%) 19 3-165 
High risk 91(20%) 48 2-194 
a
 - analysis of ranked LOS and adjusted for the effect of age, gender, ethnicity, type and severity of 
stroke 
GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool 
MUST = Malnutrition Universal Screening Tool 
 
 
    
Fig. 4.8 – Median number of days in each category of risk of malnutrition  
GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool 







































Similar analyses were conducted for groups of BMI and WC, showing that there were no 
statistically significant differences in LOS between patients in the 4 categories of BMI 




c) Costs of hospitalisation 
 
2% of the HRG codes provided by HES were not valid or there are no published tariffs for 
these codes and, therefore, admissions or episodes linked to these codes were excluded. 
The 35 patients who had one admission with an invalid code or a code with no published 
tariff were identified, to allow for a sensitivity analysis, which was later conducted. From 
these, 2 patients had costs equal to zero because the excluded admission was the only 
admission that they had. As a result, these 2 patients were excluded from the cost analyses 
otherwise their null cost would be incorrectly taken into account.  
 
Distribution of hospitalisation costs was analysed with histograms and Q-Q plots. Data 
were tested for normality and they were not normally distributed (Kolmogorov-Smirnov 
test, p<0.001). 
Hospitalisation costs data were log- and square-root transformed and tests for normality 
were repeated, showing that the transformed data were not normally distributed 
(Kolmogorov-Smirnov test, p=0.001). Therefore, non-parametric tests were used to 
explore differences in costs of hospitalisation at 6 months post stroke between surviving 
patients in the 3 malnutrition risk categories. 
 
Table 4.6 demonstrates that the costs of hospitalisation were significantly different across 
nutrition risk categories (Kruskal-Wallis test, p<0.001 for GSTT NST and p=0.049 for 
MUST), and this association remained significant after taking in consideration the effect of 
age, gender, ethnicity, type and severity of stroke, using univariate analysis of variance on 
ranked data (p<0.001, for both NST). Age, severity and type of stroke were also significant 
predictors of hospitalisation costs (p<0.05, in both models). Furthermore, adding the stroke 
risk factors to the model did not alter the signiﬁcant association between risk of 
malnutrition and costs of hospitalisation (p<0.001) - appendix 4.18 a) and b). 
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Costs increased progressively with malnutrition risk category, from a median of less than 
£5000 in patients at low risk of malnutrition to more than £8000 in patients at high risk of 
malnutrition. When compared to individuals at low risk of malnutrition as classified by the 
GSTT NST, the median cost of hospitalisation was 80% higher for individuals at high risk 
of malnutrition and 27% higher for those at medium risk. 
 
Figures 4.9 and 4.10 illustrate a clear graded association between risk of malnutrition and 























































- results on ranked hospitalisation costs and adjusted for the effect of age, gender, 
ethnicity, type and severity of stroke 
GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool 




Fig. 4.9 – Median hospitalisation costs of patients at 6 months post-stroke, according to 




Fig. 4.10 – Hospitalisation costs of patients at 6 months post-stroke, according to risk of 























































Risk of malnutrition 
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Similar analyses were conducted for groups of BMI and WC, and there were no 
statistically significant differences in hospitalisation costs between patients in the 4 
categories of BMI (p=0.729) and WC (p=0.713). However, obese individuals presented 
the lowest costs (median of £5260) of all BMI groups, and those who were underweight 
posed the highest economic burden (median of £7544) – see appendix 4.19. 
 
A sensitivity analysis was carried out to understand the impact of removing 2% of the 
admission data, due to lack of information on costs. Analysis was repeated without the 35 
patients who had an excluded admission and the associations between risk of malnutrition 








d) Hospital readmissions 
 
Patients who survived and were readmitted to hospital during a period of 6 months post-
stroke were identified. The analyses showed that there were no statistically significant 
differences between rates of hospital readmissions for patients in the 3 malnutrition risk 
categories, although there was a (non significant) trend for a higher percentage of hospital 











Table 4.7 – Percentage of patients readmitted to hospital at 6 months post-stroke, 




to hospital  
Chi-square 




Low risk 303 58.7% 
0.233 Medium risk 45 64.4% 
High risk 100 68.0% 
MUST  
(n=442) 
Low risk 322 59.0% 
0.287 Medium risk 29 62.1% 
High risk 91 68.1% 
GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool 





Fig 4.11 – Percentage of patients readmitted to hospital at 6 months post-stroke, according 
to risk of malnutrition (data taken from table 4.7). 
GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool 



































GSTT NST MUST 
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Similar analyses were conducted for groups of BMI and WC, showing that there were no 
statistically significant differences in the proportion of patients readmitted to hospital at 6 
months post-stroke between the 4 categories of BMI (p=0.984) or WC (p=0.288). 
 
Given that the median number of hospital readmissions for the sample of patients who 
survived at 6 months was 1, data were also divided into 2 groups, i.e. group of patients 
who had 1 or no hospital readmissions and group of patients who had 2 or more hospital 
readmissions. Chi-square tests demonstrated, once again, that there were no significant 
differences across GSTT NST categories (p=0.120), MUST categories (p=0.266), BMI 







e) Stroke recurrence 
 
Stroke recurrence (n=17 cases) was identified from the diagnoses at hospital readmissions, 
during a period of 6 months, for those patients who survived. Excluding patients who died 
guarantees the exclusion of false negatives (i.e. a patient who died does not count as a 
patient who did not have a recurrent stroke). 
 
No statistically significant differences were found in stroke recurrence for patients who 
survived at 6 months, across BMI (p=0.909) and WC (p=0.829) groups. Surprisingly, 
obese patients were the group with the lowest rate of stroke recurrence (2.8 %) (see table 









Table. 4.8 - Percentage of surviving patients who were readmitted with a recurrent stroke 















Underweight  27 3.7 
0.909 
Normal weight  157 3.8 
Overweight 155 4.5 





1st quartile 107 2.8 
0.829 
2nd quartile 117 5.1 
3rd quartile 113 3.5 





















Fig 4.12 and fig. 4.13 - Percentage of surviving patients who were readmitted with a 




































































































Waist circumference quartiles 
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Similar analyses were conducted for both NST, showing that there were no statistically 
significant differences in stroke recurrence rates between patients in the 3 malnutrition risk 
categories (p=0.883 for GSTT NST and p=0.531 for MUST). 
 
Given that some patients may have been readmitted to hospital with a diagnosis of a 
recurrent stroke and may have died within 6 months post stroke, previous analyses were 
repeated taking into consideration all patients (i.e. without excluding those who had died at 
6 months). The number of patients with a recurrent event rose to 24. Nevertheless, results 
were identical, with no significant differences across BMI (p=0.877), WC (p=0.357), 





f) Comparison of the two NST with regards to their performance to predict 
post-stroke outcomes 
 
Both NST were compared for their ability to predict mortality, hospital stay and 
hospitalisation costs by using ROC curves (Zweig and Campbell, 1993). The ROC curves 
analyses of LOS and hospitalisation costs excluded the patients who died during the 
follow-up period. 
LOS and hospitalisation costs were classified into 2 groups: short LOS (≤ 18 days) and 
long LOS (> 18 days), as well as low (≤ £5890) and high hospitalisation costs (> £5890), 
using the median of the variables distribution as a cut-off point.  
 
The ROC curves obtained for each outcome are displayed in figure 4.14, and the areas 









GSTT NST and mortality                                         MUST and mortality 
GSTT NST and length of hospital stay                    MUST and length of hospital stay 
GSTT NST and hospitalisation costs                        MUST and hospitalisation costs 
Fig 4.14 – ROC curves of GSTT NST and MUST for mortality, length of hospital stay and 
hospitalisation costs.  
ROC = receiver operating characteristic, GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool, 
MUST = Malnutrition Universal Screening Tool 
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GSTT NST 0.778 0.629 0.609 
MUST 0.771 0.622 0.602 
 
GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool 
MUST = Malnutrition Universal Screening Tool 




The values of the areas under the ROC curves demonstrate that the screening tools have a 
fair accuracy, and the most effective tool in predicting outcomes is the one with the largest 
area under the ROC curve.  
For each outcome, the GSTT NST presented slightly higher values than MUST. Thus, 
GSTT NST has a slightly better predictive value, although it can be concluded that the 




Given the interesting prognostic value of the NSTs, it was further investigated: 
 
g) the characteristics of patients at high risk of malnutrition 
 
The characteristics believed to be related with risk of malnutrition are shown on the 
following tables (tables 4.10 and 4.11). Differences between groups were analysed using 




Table 4.10 – Characteristics of patients according to risk of malnutrition, as defined by the 
GSTT NST 
 
Low  Medium  High  p 
value risk risk risk 
Age, mean in years (SD)  
72.5 (13.9) 73.8 (13.4) 79.2 (12.2) <0.001 
          Range (minimum-maximum)                           22 - 95 30 - 98 25 - 99   
NIHSS score, mean (SD) 6.2 (4.9) 6.5 (4.5) 10.7 (6.3) <0.001 
            Range (minimum-maximum)                           0-27 1-20 0-25   
Gender, n       0.142 
    Male, n (%) 175 (55) 23 (44) 80 (47)   
    Female, n (%) 145 (45) 29 (56) 91 (53)   
Type of stroke, n       0.073 
    Ischaemic, n (%)  280 (87) 49 (94) 143 (84)   
    Haemorrhagic, n (%) 38 (12) 2 (4) 28 (16)   
    Subarachnoid haemorrhage, n (%) 2 (1 ) 1 (2) 0   
Living conditions prior to stroke       0.015 
    Home (unsupported), n (%) 77 (24) 13 (15) 5 (32)   
    Home (with support), n (%) 238 (74) 38 (73) 111 (65)   
    Institutionalized (care home), n (%) 5 (2) 0 5 (3)   
     Other, n (%) 0 1 (2) 0   
Chronic conditions related to 
malnutrition         
   Gastrointestinal diseases, n (%)         26 (8) 4 (7)  22 (13) 0.209 
   Cognitive dysfunction, n (%)                    18 (6) 2 (4) 17 (10) 0.131 
   Impaired mobility, n (%)        22 (7) 7 (14) 33 (19) <0.001 
Had a previous stroke 65 (20) 11 (21) 43 (25) 0.463 
Failed swallow screening test 63 (20) 11 (21) 111 (65) <0.001 
Numbers in parentheses indicate percentages for categorical data and SD (standard deviation) for 
continuous data; NIHSS = National Institutes of Health Stroke Scale 
 
 
Patients at high risk of malnutrition, as defined by the GSTT NST, were more likely to be 
older, to have a more severe stroke, to live at home with no support, to have impaired 




















Age, mean in years  








    Range (minimum-maximum)                           22 - 98 35 - 94 25 - 99   
NIHSS score, mean (SD) 6.2 (4.8) 5.7 (3.8) 11.3 (6.3) <0.001 
    Range (minimum-maximum)                           
0-27 1-18 0-25   
Gender, n       0.101 
    Male, n (%) 181(53) 24 (61) 70 (45)   
    Female, n (%) 161 (47) 15 (39) 86 (55)   
Type of stroke, n       0.001 
    Ischaemic, n (%)  303 (89) 32 (82) 132 (85)   
    Haemorrhagic, n (%) 38 (11) 5 (13) 24 (15)   
    Subarachnoid haemorrhage, n (%) 1 (0.3) 2 (5) 0   
Living conditions prior to stroke       0.005 
     Home (unsupported), n (%) 81 (24) 10 (26) 51 (33)   
     Home (with support), n (%) 255 (74) 28 (72) 101 (65)   
     Institutionalized (care home), n (%) 6 (2) 0 4 (2)   
     Other, n (%) 0 1 (2) 0   
Chronic conditions related to 
malnutrition 
        
   Gastrointestinal diseases, n (%)         27 (8) 2 (5)  22 (14) 0.057 
   Cognitive dysfunction, n (%)                    22 (6) 2 (5) 12 (8) 0.803 
   Impaired mobility, n (%)        28 (8) 3(8) 30 (19) 0.001 
Had a previous stroke 
71 (21) 8 (21) 38 (24) 0.652 
Failed swallow screening test 64 (19) 10 (26) 110 (61) <0.001 
Numbers in parentheses indicate percentages for categorical data and SD (standard deviation) for 
continuous data; NIHSS = National Institutes of Health Stroke Scale 
 
 Patients at high risk of malnutrition, as defined by the MUST, were more likely to be 
older, to have a more severe stroke, to have a haemorrhagic stroke, to live at home with no 
support, to have a gastrointestinal disease, to have impaired mobility (prior to stroke) and 






h) Mortality, LOS and hospitalisation costs for patients who unintentionally 
lost weight before stroke  
 
Knowing that the nutritional status of an individual who suffered a stroke can deteriorate as 
a consequence of the event (due to dysphagia, decreased alertness, physical impairment, 
etc., as previously discussed), the independent impact of unintentional weight loss prior to 
stroke (as an indicator of a poor nutritional status) on stroke outcomes was also 
investigated, at 6 months after admission.  
 
It was observed that 110 out of 543 patients (20%) unintentionally lost weight 3 to 6 
months before hospital admission. Patients were classified into different groups of 
unintentional weight loss according to the criteria used in both NST. Thus, there were 2 
groups for GSTT NST (“yes” or “no”) and 3 groups for MUST ( “<5%”, “5-10%” and 
“>10%”). 
 
The Chi-square test was used to compare rates of mortality, and Cox Proportional Hazards 
Models were used to compare risk of mortality (crude and adjusted HR) between groups 
with (and without) unplanned weight loss. Results are summarized in the following tables 
and figures (table 4.12 and figures 4.15 and 4.16), showing that patients who lost weight 
had a higher rate of mortality (p<0.001 for GSTT NST), and the higher the % of weight 
loss, the higher the rate of mortality (p<0.001 for MUST).  
The unadjusted (p<0.001 for both NST) and adjusted risk of mortality (p=0.005 for GSTT 
NST and p=0.001 for MUST) was also significantly higher for individuals who had an 











Table 4.12 - Rates of mortality and risk of mortality according to groups of unintentional 
weight loss, using univariate and multivariable Cox Proportional Hazards Models 
 






rates    
Univariate Cox 
Proportional 





Hazards Model    
(Chi-
square 







Guy's and St. 
Thomas' Nutrition 
Screening Tool  
543 p<0.001   p<0.001   p=0.005   
No 433 14.3% Reference group  Reference group  
Yes 110 30.0% 2.33 1.53-3.56 1.87 1.21-2.91  
Malnutrition 
Universal 
Screening Tool  
537 p<0.001   p<0.001   p=0.001   
<5% 445 13.9% Reference group  Reference group  
5-10% 43 30.2% 2.43 1.34-4.42  1.75 0.95-3.25  
>10% 49 40.8% 3.48 2.10-5.76  2.68 1.55-4.63  
a
 - results adjusted for the effect of age, gender, ethnicity, type of stroke, severity of stroke and 
stroke risk factors (hypertension, diabetes, dyslipidemia, smoking, IHD, heart failure, atrial 














Fig. 4.15 - Survival curves after stroke according to groups of unintentional weight loss (as 
classified by GSTT NST) 
 
Fig. 4.16 - Survival curves after stroke according to groups of unintentional weight loss (as 




Tables 4.13 and 4.14 summarise the differences on LOS and hospitalisation costs in 
patients who survived at 6 months, according to groups of unintentional weight loss. 
 
According to the GSTT NST, individuals who unintentionally lost weight prior to 
admission had a statistically significant longer LOS (p=0.004) and higher cost of 
hospitalisation (p=0.03) than those who did not (lose weight), and this association 
remained significant after taking into consideration the effect of age, gender, ethnicity, 
type and severity of stroke, using univariate analysis of variance on ranked data (p=0.002 
for LOS and p=0.017 for hospitalisation costs).  
According to MUST, the higher the percentage of weight loss prior to stroke, the longer 
the LOS and the  higher the hospitalisation costs at 6 months post stroke. This association 
was significant for LOS, before (p=0.019) and after (p=0.016) the adjustment for possible 
confounders, and there was a trend for significant association between percentage of 
unintentional weight loss and hospitalisation costs (p=0.066 for the unadjusted results and 
p=0.054 for the adjusted results). 
 
LOS increased progressively with the increase in percentage unintentional weight loss, 
from a median of 17 to 40 days, and the same pattern was observed for costs, starting with 
a median of £5506 in patients who had no unintentional weight loss (or less than 5%) to a 
median of £8416 for individuals who lost more than 10% of their usual weight prior to 
















Table 4.13 - Length of hospital stay of patients who survived 6 months, according to 
groups of unintentional weight loss (unadjusted and adjusted results) 

















            
 




No 371 17 2-194 
0.004 0.002 
Yes 77 37 2-119 
MUST  
(n=442) 
<5% 383 17 2-194 
0.019 0.016 5-10% 30 32 2-102 
>10% 29 40 2-119 
a
 - analysis of ranked LOS and adjusted for the effect of age, gender, ethnicity, type and severity of stroke 
GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool 
MUST = Malnutrition Universal Screening Tool 
 
 
Table 4.14 - Hospitalisation costs of patients who survived a 6 months, according to groups 
of unintentional weight loss (unadjusted and adjusted results) 
Method used  
to classify  












           























 - analysis of ranked hospitalisation costs and adjusted for the effect of age, gender, ethnicity, type and 
severity of stroke 
GSTT NST = Guy's and St. Thomas' Nutrition Screening Tool 




Although it was not the aim of this study to explore the reasons for the observed 
unintentional weight loss prior to stroke that affected 20 % of recruited patients, whenever 
possible the author collected this information, from multiple sources, including 
testimonials from all patients who lost weight, their relatives or carers and medical notes. 
Reasons for weight loss were then grouped into “disease-related” and 
“psychological/social”, and details can be found in appendix 4.20 (note that this is the 






4.5 - Discussion 
 
The aims of this study were to: 
A. determine the ability of MUST to independently predict negative outcomes in acute 
stroke patients, specifically mortality, LOS, readmissions and hospitalisation costs at 6 
months post stroke. 
B. determine whether the MUST or GSTT NST is the most effective NST in predicting 
negative outcomes in patients at 6 months post stroke. 
C. determine the association between BMI, central obesity and outcomes (i.e. mortality and 
recurrent stroke) at 6 months post-stroke. 
 
Aims A. and B. 
Regarding the first and second aims, it was observed that both NSTs can be used to predict 
risk of negative outcomes in stroke patients. Patients at high risk of malnutrition had a 
significantly higher risk of mortality, a longer LOS and greater costs of hospitalisation at 6 
months post stroke. Furthermore, the association between risk of malnutrition and the 
outcomes was statistically significant and graded: the greater the risk of malnutrition, the 
higher the risk of mortality, the longer the LOS and the greater the costs.  
The results of the ROC curves showed that the ability of both tools to predict negative 
outcomes was similar. However, MUST had the disadvantage of not being able to be 
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applied to the entire study population, as it was impossible to quantify weight loss in 6 
patients (out of 543). 
These results are consistent with previous studies conducted in other populations.  
In 2006, the MUST was applied to 150 consecutively admitted elderly patients, with a 
mean age of 85 years and a wide range of conditions (Stratton et al., 2006). The % of 
patients identified at high risk of malnutrition (41%) was greater than in the present study 
(30%), but the results were identical in terms of in-hospital mortality and LOS, as both 
rose significantly with increasing malnutrition risk category.  
In a recent study conducted in Singapore (Lim et al., 2012), 818 patients admitted to 16 
different wards had their nutritional status assessed by the Subjective Global Assessment 
(an assessment tool that takes into account information about weight changes, dietary 
intake, gastrointestinal symptoms, functional capacity, disease, subcutaneous fat, muscle 
wasting, oedema and ascites (Detsky et al., 1987)). Similar to the findings of the current 
study, malnutrition affected 29% of patients aged 18-74 years and was an independent 
predictor of mortality, LOS and hospitalisation costs. Looking at the example of mortality, 
in the Singapore-based study, malnutrition posed a 4-fold increased risk of death at 1-year 
follow-up, and in the London-based (present) study, patients at high risk of malnutrition 
had an approximately 6-fold increased risk of death at 6-month follow up (in the 
multivariable models of both NST).  
In the present study, costs of hospitalisation of individuals at high risk of malnutrition were 
80% higher than the costs of low risk patients.  This is a major contributor, when compared 
with other factors that have the potential to influence hospitalisation costs after stroke. For 
example, it has been shown that atrial fibrillation increases acute hospitalisation costs by 
23.5% (Brueggenjuergen et al., 2007), depression by 63% (Husaini et al., 2013), 
haemorrhagic strokes by 65% (vs. ischaemic strokes (Gioldasis et al., 2008)), and younger 
patients (18-44 years old vs. 45-64 years old) by 6% (Wang et al., 2014). 
Results of a retrospective cohort study conducted in 709 patients (with a wide range of 
diseases, selected from 25 Brazilian hospitals), also assessed by the Subjective Global 
Assessment, showed that malnourished patients (of which 26.3% were moderately or 
suspected malnourished and 7.9% were severely malnourished) incurred a 61% increase in 
hospitalisation costs (Correia and Waitzberg, 2003). Malnourished patients also had a 
significantly increased rate of mortality (12.4% vs. 4.7%) and a longer LOS (mean of 16.7 
days vs. 10.1 days) when compared with the well-nourished. It should be noted that the 
Subjective Global Assessment is a nutritional assessment method, while the present study 
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used nutrition screening methods, which are quicker and easier to apply, not requiring 
specific training in the area. Other studies that determined the hospitalisation costs of 
nutritionally vulnerable patients report costs 20% (Amaral et al., 2007) or 36% (Chima et 
al., 1997) higher, when compared to the costs of well nourished patients  . 
These different figures are probably related to the methodology used to determine the 
outcomes (e.g. the majority of these studies only analysed the outcomes related with the 
first admission, until discharge or death), with the tool used to categorise patients as 
malnourished or at risk of malnutrition, and also with the type of population (e.g. the LOS 
of stroke patients may be longer than general medical patients, due to the time required for 
rehabilitation). 
However, the results obtained in all these different studies are consistent. 
In the stroke population, a study has been conducted to evaluate the impact of malnutrition 
(undernutrition), as assessed by the Subjective Global Assessment, on outcomes (mortality 
and functional capacity) at 1 month after stroke (Davis et al., 2004). This tool identified 
only 16% of patients as being “undernourished”, which is approximately half of the 
proportion of patients identified at high risk of malnutrition by MUST or the GSTT. These 
“undernourished” patients were more likely to die and to have a poor functional outcome at 
1 month, but these associations were no longer significant after the adjustment for possible 
confounders. These results are slightly different from the results obtained in the present 
study, and this may be due to the differences in sample size (543 vs. 185 patients), follow-
up time (6 months vs. 1 month) or the tool used to assess nutritional status (risk) (MUST or 
GSTT NST vs. subjective global assessment, with the latter being a nutrition assessment 
tool and having a subjective nature).  
As mentioned in chapter 1, other studies have explored the prevalence and consequences of 
malnutrition after stroke using biochemical parameters, such as albumin, to classify 
patients as being malnourished (Davalos et al., 1996, Gariballa et al., 1998a, Yoo et al., 
2008). However, the limitations of using these parameters in the assessment of nutritional 
status were already pointed out in section 1.3 (e.g. not being specific to nutritional status) 
and, in fact, a recent consensus statement of renowned institutions does not propose any 
specific inflammatory markers for diagnostic purposes of adult malnutrition (White et al., 
2012). 
 
In the present study, there was a non-significant trend for a higher percentage of patients to 
be readmitted to hospital in the medium and high risk categories, similar to results obtained 
191 
 
in other populations (Lim et al., 2012, Chima et al., 1997). Although these non significant 
results do not support the study hypothesis it could be argued that spending more days in 
hospital (i.e. the length of the hospital admission) is a more meaningful outcome than the 
number of readmissions (or percentage of patients readmitted), as these can be as short as 1 
day.   
 
 
Characteristics of patients at high risk of malnutrition 
When the characteristics of patients at high risk of malnutrition (as defined by the MUST) 
were examined, it was found that these individuals were more likely to be older and to 
have a more severe stroke (as demonstrated before, in the stroke and non-stroke population 
(Yoo et al., 2008, Lim et al., 2012)), to have a haemorrhagic stroke (in line with the 
findings from a study that showed that undernourishment was significantly more prevalent 
in haemorrhagic strokes (Choi-Kwon et al., 1998)), to live at home with no support, to 
have a gastrointestinal disease (as shown before in the non-stroke (hospitalised) population 
(Chima et al., 1997)), to have impaired mobility (prior to stroke) and to fail the swallow 
screening test.  
There is a complex relationship between malnutrition, age and frailty, as frail patients are 
likely to be at high risk of malnutrition, to be older, and to have higher NIHSS scores 
(suggesting that they have more severe strokes). All these factors predict poor outcome. 
 
 
Outcomes of patients who unintentionally lost weight before stroke 
Some of the reasons for unintentional weight loss prior to stroke (which were collected 
from multiple sources of information) were presented in appendix 4.20. They show that 
unintentional weight loss is not only associated with a disease/occult pathology or 
untreated chronic disease such as cancer; instead, it may involve psychological and social 
reasons such as lack of interest in preparing own food, social isolation and depression due 
to the death of a close relative. In other words, malnutrition has multi-factorial causes, 
which need to be explored by health and social care professionals so they can provide 




In the current study approximately 20% of patients had unintentionally lost weight 3 to 6 
months before hospital admission and they had a significantly higher risk of mortality, a 
longer LOS and greater costs of hospitalisation, when compared to patients with no 
unintentional weight loss. Stratton and her colleagues (Stratton et al., 2006) also observed 
that weight loss of > 5% prior to admission affected 35% of hospitalised elderly patients 
and was a good predictor of mortality. Raslan and her colleagues (Raslan et al., 2010) also 
demonstrated that the 16.2% of hospitalised patients (with a wide range of diseases) who 
unintentionally lost more than 10% of their weight prior to admission stayed in hospital for 
a longer period of time. However, in contrast to the current study, LOS was only related 
with the first admission, excluding any other hospital readmissions within a certain period 
of time. 
 
In summary, these results show the value of screening for risk of malnutrition (including 
the question related to unintentional weight loss prior to stroke). MUST and GSTT NST 
can adequately identify stroke patients who are more likely to suffer worse outcomes and, 
consequently, those who are more likely to benefit from nutritional interventions.   
 
Furthermore, these tools can be very useful to support hospital administration. If 
malnourished patients are accurately diagnosed and coded as such, this correctly reflects 
the resources that the hospitals might spend on them, which can enhance the 
reimbursement that the hospital receives for the treatment of those patients (Funk and 
Ayton, 1995).  
Treatment costs for stroke account for approximately 5% of total NHS costs in the United 
Kingdom (Saka et al., 2009), and in the United States of America the total annual costs of 
stroke are projected to increase to $240.67 billion by 2030, an increase of 129% over the 
next 2 decades (Ovbiagele et al., 2013). The findings of this thesis show that patients at 
high risk of malnutrition cost 80% more than those at low risk, demonstrating that 








BMI, WC and mortality 
Regarding the third aim of the study, a significant difference was observed in the rates of 
mortality between patients across BMI and WC categories, at 6 months post-stroke, with 
the higher the BMI and the WC quartile, the lower the mortality rates.  
BMI was a statistically significant independent risk factor for mortality, both in the 
univariate and multivariable analysis while the impact of WC was only significant in the 
univariate analysis, suggesting that WC does not add any predictive value to this outcome.  
In the multivariable model, having the normal weight category as a reference group, being 
overweight was associated with a 43% decreased risk of death and with a 54% decreased 
risk for obese patients.  
These findings of a better survival in overweight/obese patients or those with a larger WC 
were similar to the analyses conducted in the subgroups of ischaemic strokes or patients 
aged 64 and older. Although surprising, they are also in line with the results from the 
present study regarding risk of malnutrition (given that underweight patients had the 
highest rates of mortality), with the results from previous studies (as discussed in the 
literature review presented in chapter 3) and with the results from the SLSR data (chapter 
3). 
The small differences between results in chapter 3 and 4 (e.g. U shaped relationship 
between BMI and mortality observed in chapter 3, but not in the present study) may be due 
different characteristics of the populations. The first study included only first strokes, with 
a mean age of 68.5 +/- 15 years, and a follow-up period of up to 8 years, while the 
population of the present study included first and recurrent strokes, was older (with a mean 
age of 74.7 +/- 14 years) and their outcomes were evaluated only at 6 months. 
Additionally, the amount of missing data regarding the record of BMI were minimal in the 
present study, in comparison to the 47% observed on the SLSR study, and in the present 
study there were no missing data regarding covariates (e.g. NIHSS score), preventing 
patients from being excluded from the multivariable analyses. In the present study, all the 
data were systematically and consistently collected by only one researcher. 
 
BMI, WC and stroke recurrence 
When the second outcome was analysed (stroke recurrence), no significant differences 
were found on stroke recurrence rates in patients who survived at 6 months, across BMI 
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and WC groups. It was expected that obese patients would experience more readmissions 
for recurrent stroke but, surprisingly, the rate of stroke recurrence for this group was no 
higher than for the others.  
As mentioned in the introduction of this chapter (section 4.1), a few studies have evaluated 
the impact of BMI on stroke recurrence: 
a) similar to the present findings, a study conducted in 20246 patients older than 55 years 
with an ischaemic stroke and followed for 2.5 years,  showed that being overweight and 
obese was not associated with increased recurrent stroke (risk), although the reference 
category was the “lean group” defined by a BMI < 25Kg/m2 (Ovbiagele et al., 2011).  
b) in the same way, in a sub-analysis of an intervention study with 1521 patients who had a 
stroke or a TIA, recurrent strokes at 2.5 years were non-significantly lower in obese 
patients (Doehner et al., 2013).  
c) the largest study that included this outcome is the Danish Stroke Register, with 29326 
patients with a record of BMI who were followed for a similar period of time (mean of 2.6 
years). The authors demonstrated that risk of readmission for recurrent stroke was 
significantly lower in obese patients than in normal weight patients (HR = 0.84 (C.I. 95% 
0.72-0.92)) (Andersen and Olsen, 2013). 
d) a study with 2785 first-ever stroke patients and with a longer follow-up period (mean of 
3.9 years) showed that stroke recurrence was similar among BMI groups. Similarly to 
Ovbiagele’s study, underweight and normal weight patients were combined in one BMI 
category (< 25Kg/m
2
) (Vemmos et al., 2011).  
Data from these 4 studies, in conjunction with the present study, suggest that obese stroke 
patients are not at increased risk of developing a recurrent stroke, and a protective effect of 
obesity may be observed in larger samples. Nonetheless, the 4 studies described above 
have limitations that were pointed out in section 4.1. 
To the best of the author’s knowledge, there are no published data exploring the 
association between WC (or any other marker of abdominal obesity) in stroke patients and 
the risk of stroke recurrence. The present study demonstrates that a larger WC is not 
associated with an increased risk of a recurrent stroke. In fact, patients in the second 
quartile of WC (91.6-100 cm for men/ 85-94 cm for women) presented the highest rate of 






The rationale behind the “obesity paradox” 
 
The biological mechanisms that explain the observed paradoxical associations between 
BMI, WC and outcomes have not yet been determined.  
However, as mentioned before, it was suggested that the ideal BMI for healthy populations 
may be different from the ideal BMI for populations with a chronic disease (including 
stroke). It is possible that the fat stores of obese patients make them more resistant to the 
catabolic progressions of their disease (usually a disease associated with wasting and 
cachexia, as explained in section 3.1). 
 
Some individuals will struggle to meet their nutrition and hydration requirements post 
stroke and approximately a quarter of the survivors will have a significant weight loss at 4 
months and 1 year post-stroke (Joonsson et al., 2008). As explained in section 1.3 
“malnutrition and stroke”, there are several factors that can contribute to the deterioration 
of nutritional status and dehydration post-stroke, such as swallowing and chewing 
difficulties, motor and sensory impairment, GI dismotility, communication deficits and the 
poor nutritional composition of MTD (particularly deficient in energy and proteins). In this 
context, the body fat stores of overweight and obese patients may provide a survival 
advantage over those who are normal weight or underweight (or those that, even being 
overweight or obese, unintentionally lose a clinically significant amount of weight prior to 
stroke).  
 
In a study that aimed to scrutinise the “obesity paradox” in patients with chronic heart 
failure, it was observed that only obese patients had balanced muscle protein metabolism 
(i.e. a balance between protein synthesis and degradation) (Aquilani et al., 2012). 
Clinically, an unbalanced protein metabolism is associated with several comorbidities (e.g. 
reduced immunological capacity and tissue integrity) (Aquilani et al., 2012). The results of 
this study may also be extended to patients with a stroke, although research in this 
population is needed. 
 
It should also be noted that fat tissue has relevant beneficial effects, for example, in the 
protection against bone fractures (Laet et al., 2005), infectious complications and pressure 
ulcers (Bouillanne et al., 2009). Additionally, Anderson and Olsen found that a higher BMI 
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in stroke patients was associated with positive health indicators, such as non-smoking and 
nondrinking, suggesting that these positive lifestyles aspects may help to explain the 
paradoxical survival of obese stroke patients (Andersen and Olsen, 2013). 
 
The link between severity of stroke, brain lesion and this “obesity paradox” is less clear, 
but some studies suggest that obese patients have less severe strokes and die less from 
neurological damage (Vemmos et al., 2011, Ryu et al., 2011).  
When Vemmos and colleagues explored the different causes of death of 2785 patients with 
ischaemic and haemorrhagic first-ever strokes, the obese individuals had the lowest rate of 
mortality from neurological damage (3.2%) when compared with the overweight (7.5%) 
and normal weight (8.9%) groups (p=0.0001) (Vemmos et al., 2011). Surprisingly, the 
differences on rates of mortality from cardiovascular deaths were not statistically 
significant across BMI categories (p=0.115). 
Ryu and his colleagues found that BMI was inversely associated with the NIHSS score in 
1592 ischaemic strokes. Thus, patients with a low BMI had more severe strokes (and were 
more likely to have strokes due to cardioembolism) and patients with a high BMI had less 
severe strokes (and had more strokes due to small-vessel occlusion) (Ryu et al., 2011).  
These findings could contribute to the explanation of the obesity paradox and explain the 
importance of the adjustment for stroke severity in studies exploring the association 




Primary versus secondary prevention of stroke – interpretation of the 
available data 
 
While some authors do not accept the existence of an “obesity paradox”, claiming that it is 
simply an epidemiological association and supporting the view that the intervention for 
obesity will reduce the burden of stroke and it should start in the hyper-acute period after 
stroke (Kernan et al., 2013), other authors claim that not all patients classified as 
overweight  or obese (grade 1), particularly those with chronic diseases, can be assumed to 
require weight loss treatment (Heymsfield and Cefalu, 2013), and no data are available to 
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support recommendations to reduce body weight in (obese) patients after stroke 
(Scherbakov et al., 2011).  
The results of the present study (chapter 4) suggest, once again, that a distinction needs to 
be made between the guidelines for primary and secondary prevention of stroke. It is well 
established that, in the healthy population, excess body fat increases the risk of mortality 
and the risk of stroke. This applies not only to BMI (Strazzullo et al., 2010, Wang et al., 
2013, Calle et al., 1999, Berrington de Gonzalez et al., 2010) but also to several markers of 
abdominal obesity, such as WC (Winter et al., 2008, Suk et al., 2003, Bodenant et al., 
2011, Jacobs et al., 2010, Pischon et al., 2008). However, when the outcomes are assessed 
in those who have had a stroke, being obese or having a larger WC is associated with a 
better survival and does not increase (or can even decrease) the risk of a recurrent stroke. 
In other words, being overweight or obese may impact patients with stroke differently than 




The main merits of this study are the relatively large sample size, where one researcher 
(author) recruited all patients, collected all the baseline information and consistently 
analysed all the outcome data, that was available for the entire study population. 
Additionally, it captures any hospital admission that occurred anywhere in England, during 
the 6 month follow-up period. Many studies of the impact of malnutrition only looked at 
the outcomes of the first admission, not being able to report any outcome after the hospital 
discharge (Correia and Waitzberg, 2003, Raslan et al., 2010) and, to our knowledge, none 
of the published studies in the area of malnutrition were able to capture hospital 
readmissions at a national level. Lim et al admit that, because they were not able to 
monitor the study patients readmitted to other hospitals, an underestimation of the 
readmission rates may have occurred (Lim et al., 2012). 
HES was the system chosen to capture hospital readmission and potential recurrent strokes.  
In a study that aimed to validate self-reported strokes in a longitudinal UK cohort, HES 
was the most efficient method of validation, when compared with manual extraction from 
hospital notes and corresponding with GPs (Britton et al., 2012). HES had the additional 
advantage of not requiring patient contact after discharge.  
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Moreover, the current study included patients without limitations of age (>18 years), 
gender or stroke severity, and did not exclude patients who lacked capacity to consent to 
participate or patients with severe communication problems, which is very common in the 
acute stage after stroke. In these cases, the researcher always tried to contact and meet with 
their next of kin (sometimes after working hours), who would be able to provide assent and 
information relevant for the study (e.g. usual weight and unintentional weight loss in the 
last months). This is particularly important to avoid a selection bias, which has been 
reported in national registries of strokes. For example, the Registry of the Canadian Stroke 
Network reported that the participation rate never exceeded half of the eligible patients (Tu 
et al., 2004), while the equivalent participation rates for the present study were 95% (or 
91% if we include the patients who were not weighed due to the severity of their illness).  
For the 21 patients who were not weighed within the first 3 days after stroke due to the 
severity of their illness, as they were not considered for any active treatment, the poor 
outcome of these patients is more likely to have been related to stroke severity (including 
cases of patients who were found at home, unresponsive, a few days after the stroke), and 
less likely to be associated with their nutritional status. Furthermore, the characteristics of 
the patients included in the study are in line with published figures (Carroll et al., 2001, 
RCP, 2012), such as the percentage of patients who had an ischaemic stroke (87 %) and the 
proportion of patients aged 65 and older (80%), This indicates that the study sample was 
representative of the stroke population in the U.K., suggesting minimal risk of selection 
bias.  
Another positive and exclusive aspect of this study (when compared to all other studies 
exploring the association between BMI and mortality) is that it took into consideration 
indicators of a poor nutritional status, such as unintentional weight loss in the period 
preceding the baseline data collection (previous 3 to 6 months). Individuals who are 
normal weight, overweight or obese may also be at risk of malnutrition if, for example, the 
person presents a recent involuntary weight loss. BMI is an indicator of a chronic protein-
energy status but recent unintentional weight loss reflects acute changes in nutritional 
status (Elia, 2000). In the present study, patients who lost weight before having a stroke 
were more likely to die and more likely to have a longer LOS and be more costly, 
independent of age, gender, ethnicity, type of stroke, severity of stroke and stroke risk 





The major limitations of this study were the lack of information regarding changes in body 
weight during follow-up and regarding the proportion of patients who were referred to a 
dietitian, as well as the type or length of any nutritional intervention they may have 
received (thus, dietetic intervention is an unmeasured confounder). In fact, this is an area 
that deserves further investigation. As mentioned in the “Methods” section (Baseline data 
collection - page 147), both tools were applied by the same person (the author) to avoid 
missing data as, in the vast majority of the cases, the NST was not fully completed by the 
staff (statement based on observation while collecting data). Thus, although I screened all 
the patients for my study (using 2 NST), it is very unlikely that all patients were screened 
by the nursing staff using the locally applied NST. Furthermore, of those who were 
screened by the nursing staff and considered at high risk of malnutrition, I do not how 
many were referred to a dietitian, and of those who were referred, I do not know how many 
received any intervention, neither the type nor the length of the nutritional intervention 
(with appropriate measures of prescription and compliance). In this study, these data would 
be extremely difficult to collect because of the current organisation of the stroke services in 
London, i.e., if I recruit a patient in the hyper-acute Stroke Unit of Princess Royal 
University Hospital (within 2 days post stroke) and he/she is then transferred to his local 
Stroke Unit (which may be Lewisham Hospital in London or a neuro-rehabilitation unit in 
Yorkshire) on the 3rd day post-stroke, I am not able to collect information regarding 
dietetic referral or potential intervention that the patient may have received in his/her local 
unit and after being discharged from hospital. 
As discussed before, in “Chapter 1: Introduction / 1.1) Malnutrition / Potential benefits of 
nutritional intervention (page 25)”, there are different types of nutritional interventions and 
these can result in a number of benefits, potentially changing the outcomes that I am 
measuring.  
An ideal study would be conducted in a stroke unit that has no nutritional screening in 
place or any type of dietetic input to provide nutritional support, eliminating the effect that 
nutritional interventions can have on outcomes.  
Nonetheless, it should be noted that even in places where nutritional screening exists and 
dietetic input is available, the system fails to adequately recognise and treat malnutrition. 
In 2007, Lamb and his colleagues conducted a cross-sectional study in adults under the 
specialities of general medicine, general surgery, orthopaedics and critical care of an acute 
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hospital in North-East England, to measure the compliance with policy on screening for 
malnutrition (by ward staff) and further dietetic referral. In a single day, 328 inpatients met 
the inclusion criteria, of which only 226 (69%) had the local NST applied. Of these, 31 
(14%) were identified as being at high risk of malnutrition, and of these, only 14 (45%) 
were appropriately referred for dietetic advice. Furthermore, when the researchers assessed 
the remaining 102 unscreened patients, they found that 14 (14%) patients were also at high 
risk of malnutrition, i.e. these patients were unrecognised by ward staff and should also 
have been referred for dietetic intervention (Lamb et al., 2009). Other authors have 
highlighted the significant proportion of malnourished patients that often go unrecognised 
and, therefore, untreated (McWhirter and Pennington, 1994, Lim et al., 2012) and it is 
likely that the same problem will apply to this study.     
 
Another limitation is related to the patients who had a stroke and died before hospital 
arrival were not included in the analysis. This is a difficult limitation to overcome, and was 
present in the majority of the studies that explored the association between BMI and 
mortality post-stroke (Vemmos et al., 2011, Doehner et al., 2013, Olsen et al., 2008). 
Similarly, HES does not capture strokes that did not result in hospitalisation or that did not 
occur in England. 
This study had the advantage of including a parameter that is rarely measured, the WC, 
which is considered the best surrogate method of visceral adiposity across a wide age range 
(Onat et al., 2004). In a few patients with larger WC, the difference between WC of 
individuals standing up and lying down was greater than 2 cm. This is a potential limitation 
of the methods used to determine WC in bedbound patients. However, the alternative of 
excluding patients who were bedbound would probably create a strong selection bias. 
Hence, the risk of having a minor error associated with the measurements of WC in all 
recruited patients seems to be more acceptable than the risk of excluding a significant part 
of recruited patients due to their inability to (safely) stand up.  
Furthermore, it would be interesting to analyse functional outcomes, such as the degree of 
disability or dependence for activities of daily living in relation to BMI. The present study 
was not designed to capture this information, i.e. it was agreed that patients would not be 
contacted post recruitment in order to maximise the number of patients recruited. In a 
future study, short-term and long-term indicators of poor functional outcome measured by, 
for example, the modified Rankin Scale and the Barthel Index (Sulter et al., 1999), would 
help to address this question. Dohener and his colleagues analysed the association between 
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body mass index and a combined endpoint of mortality and severe functional disability (as 
defined by modified Rankin scale > 3 or Barthel Index < 60) in 1374 patients at 30 months 
post-stroke or TIA (Doehner et al., 2013). They found that, after adjusting for potential 
confounders, obese (and overweight) patients had a significantly lower risk of this 
combined endpoint, when compared to the normal weight (reference) group. However, this 
study presents several limitations, such as, being a subanalysis of an intervention study, 
BMI data was available for only 34% of study participants, inclusion of TIAs and lack of 
separated multivariable analysis for functional disability. Thus, future studies are needed to 
address this question adequately.  
 
In the present study, causes of death were not investigated because: 
- the source of information to obtain mortality data, i.e. Summary Care Records, provides 
the date of death (when applicable) but not cause of death 
- even if cause of death was available, the relatively small sample size of this study would 
not allow for a stratified analysis by cause of death (the same problem was raised and 
discussed for ethnicity, in section “results” of chapter 3, where the sample size is slightly 
bigger). However, as stated before in the discussion of chapter 3, a South Korean study 
with 34132 acute ischaemic strokes conducted a stratified analysis by cause of death 
(divided by “cancer”, “vascular” and “other”), and found that the inverse association 
between BMI and mortality remains preserved in the multivariable cause-specific analyses 
(Kim et al., 2012). This study suggests that the association between BMI and mortality is 
independent of cause of death (as well as age). Another study explored the different causes 
of death (neurological damage, infection, cardiovascular, recurrent stroke, malignancy and 
other causes) in different BMI groups of 2785 patients with ischaemic and haemorrhagic 
first-ever strokes. Cause-specific rates of mortality were not significantly different across 
BMI categories, except for 2 causes of death (recurrent strokes and neurological damage, 
p=0.0001 and p=0.037 respectively) where the lower death rates were attributed to the 
obese group (Vemmos et al., 2011).   
 
Finally, the 6-month follow-up time of this study was relatively short (due to time 
constraints imposed by the PhD programme), and it would be interesting to see whether the 
long-term outcomes remain similar. Other authors have reported that survival rates at 1 
week, 1 month and 10 years post-stroke remain significantly lower over time for 
overweight and obese (first ever stroke) patients, when compared with the normal weight 
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group (Vemmos et al., 2011), but we do not know whether this applies to all the outcome 
measured in the present study, in a multiethnic population of first and recurrent strokes. 
 
 
A checklist used to report standards for observational studies (STROBE, i.e. 
STrengthening the Reporting of OBservational studies in Epidemiology (von Elm et al., 





4.6 - Conclusion  
Patients at high risk of malnutrition (as identified by MUST or GSTT NST) have a 
significantly increased risk of mortality, a longer LOS and a greater cost of hospitalisation, 
at 6 months post stroke.  
Whether nutritional interventions provided in hospital are sufficient to improve outcomes 
in these patients remains to be clarified, as well as the best timing and type of feeding 
routes. 
The author of this thesis collaborated in the process to develop the 4th edition of the 
“National clinical guidelines for stroke” (RCP, 2012), created by the Royal College of 
Physicians Intercollegiate Stroke Working Party, where key aspects of the nutritional 
support of stroke patients at risk of malnutrition were systematically reviewed with the aim 
of providing evidence-based guidelines for use in clinical practice (Gomes et al., 2014). 
As part of this work, a systematic review entitled “Oral nutritional supplements in patients 
at risk of malnutrition who have had a stroke” was undertaken. Searches were conducted 
through to 31
st
 October 2011 using five electronic databases (Embase, Medline, Cinahl, 
Cochrane Library and Web of Science), and 1084 abstracts were retrieved of which no 
studies met all the inclusion criteria. It was concluded that, to that date, there was a lack of 
good quality evidence supporting the role of ONS in the management of patients who are 
malnourished or at risk of malnutrition following acute stroke.  These results were 
presented as an oral communication at the 21
st
 European Stroke Conference (appendix G). 
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The limited data available suggest the need for adequately powered randomised controlled 
trials, using validated screening procedures, to investigate the effects of oral nutritional 
supplements on clinical, nutritional and cost outcomes.  
Further research is also needed on the most effective types and duration of nutritional 
support. Given that malnutrition may take a considerable amount of time (e.g. several 
months) to develop, studies that examine the effect of short term nutritional interventions 
(sometimes confined to hospital admission) are not allowing enough time to treat any pre-
existing nutritional deficiencies or to make a difference on outcomes.   
Alongside hospital-based interventions for those patients who are admitted already 
malnourished, early or preventative nutritional interventions in the community (i.e., 
strategies to improve nutritional status of the population at risk for stroke) may be needed, 
either for people living at home or institutionalised. For instance, some authors suggest that 
the combination of physical exercise and nutritional supplementation should be considered, 
due to its potential to counteract muscle weakness (i.e. increase muscle power and 
functional gains) in frail elderly individuals (Bonnefoy et al., 2003). 
 
 
As mentioned previously, guidelines on secondary prevention of stroke recommend 
patients who are overweight or obese should be advised to lose weight (RCP, 2012, AHA, 
2009).  
The results of the present study showed that being obese and having a larger WC was 
associated with reduced mortality and does not increase the risk of a recurrent stroke. This, 
in conjunction with a growing body of evidence that supports “the obesity paradox” after 
stroke (as demonstrated in section 3.1), may emphasise the need to amend the current 
guidelines. However these are observational studies, which identify associations, not 
causality. Future research could include randomised controlled trials of interventions for 






















































Summary of achievements and findings of this thesis 
 
In the first study (chapter 2), the predictive validity of the GSTT NST was tested in 
hospitalised elderly care and stroke patients. 
Results demonstrated that patients at high risk of malnutrition had a significantly increased 
rate of mortality (at 1 month, 3 months, 6 months and 1 year) and a tendency for a longer 
LOS, when compared to patients at medium and low risk. This suggested that the NST can 
be used to predict negative outcomes in the elderly and stroke hospitalised population, 
although more research was needed to make definitive conclusions, given the small 
number of stroke patients included in this sample (n=25). Therefore, an adequately 
powered study was designed to investigate the predictive validity of this tool and another 
recommended tool (MUST) in patients who have had a stroke (chapter 4). 
 
Given the emerging evidence of a paradoxical survival in obese stroke patients, a literature 
review was conducted to capture and compare all the published studies that explored the 
association between BMI and mortality in patients who suffered a stroke. 
Several studies were identified with ischaemic and haemorrhagic strokes, with different 
groups of age, with first and recurrent strokes, in various countries with different cut-offs 
to define BMI groups. All of them had limitations and further investigation was needed, 
especially in multi-ethnic populations, such as the population of London.  
An ongoing population-based register (which covers a multiethnic population of 234 533 
inhabitants and records strokes that occurred in South London), was used as the source of 
data for the second study (chapter 3), to determine the association between BMI and 
mortality after a first-ever stroke.   
After adjusting for possible confounders and having the normal weight category as 
reference group, the risk of mortality (up to 8 years) was higher for the underweight and 
lower for the overweight category. BMI was an independent significant risk factor for 
mortality in a multiethnic population of individuals who had a stroke for the first time.  
 
This “obesity paradox” needed to be scrutinised and justified the evaluation of other 
relevant outcomes, such as the risk of having a recurrent stroke, as well as other indicators 
of nutritional status and distribution of body fat. The third study was, therefore, designed to 
investigate this (chapter 4). 
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The relationship between BMI, WC, risk of malnutrition and outcomes at 6 months post 
stroke was prospectively analysed. 550 patients were recruited and assessed within 72h of 
admission to two London-based hospitals.  
Results showed that patients at high risk of malnutrition (as identified by MUST or GSTT) 
had a significantly increased risk of mortality, a longer LOS and a greater cost of 
hospitalisation, at 6 months post stroke, independent of age, gender, ethnicity, type of 
stroke, severity of stroke and stroke risk factors.  The results also showed that the higher 
the BMI and the WC quartile, the lower the rate of mortality, and there were no significant 
associations between BMI or WC and stroke recurrence. 
Further research is needed to determine whether nutritional support (including type and 
duration) improves the poor outcomes of those patients identified as at high risk of 
malnutrition. 
 
A systematic review entitled “ONS in patients at risk of malnutrition who have had a 
stroke” was also conducted (as part of a review of national clinical guidelines on stroke 
care) and it was concluded that there is a lack of good quality evidence supporting the role 




Original aspects of this thesis 
 
In Chapter 3, I was able to identify, summarise and analyse all the existing published 
studies that have explored the association between BMI and mortality post stroke. After 
showing the clinical heterogeneity and the limitations of these studies (included the lack of 
studies conducted in a multiethnic population), my prospective study was the first to 
demonstrate that BMI is a statistically significant independent risk factor for mortality in a 
multiethnic population of individuals who had a first stroke. These results account for the 
correct distinction between underweight and normal weight patients and apply to both 
early (6 months) and late (up to 8 years) follow-up times, as well as to total and ischaemic 
strokes and to patients aged under 65 years or 65 and over, and included the adjustment for 
the effect of ethnicity. This is another important piece of information that can be added to 
the growing body of evidence that supports the “obesity paradox” post stroke. 
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Chapter 4 described a study that, for the first time, was able to: 
- validate a nutrition screening tool for stroke patients, which was an area identified as 
lacking a strong evidence base 
- show that risk of malnutrition, assessed by these tools, is a statistically significant 
predictor of mortality, LOS and hospitalisation costs at 6 months post-stroke, 
independently of age, gender, ethnicity, type of stroke, severity of stroke and stroke risk 
factors 
- determine the proportion of patients who presented unintentional weight loss prior to 
stroke and demonstrate that the isolated effect of this unintentional weight loss (an 
indicator of risk of malnutrition) is also a statistically significant predictor of mortality, 
LOS and hospitalisation costs at 6 months post-stroke 
The methodology used to determine LOS and hospitalisation costs is unique in this study 
as it captures national data, i.e., any hospital admission that occurred anywhere in England, 
during the 6 month follow-up period. Other studies have determined these outcomes based 
simply on the first admission or on readmissions that occurred to the same hospital 
- use several markers of nutritional status (BMI, WC, risk of malnutrition, unintentional 
weight loss prior to stroke) for every recruited patient, measured by a single researcher, 
and also a variety of outcomes (mortality, stroke recurrence, LOS, hospitalisation costs and 
hospital readmissions). Many authors that explored the association between BMI and 
mortality admitted that the main limitation of their studies is the lack of measures of 
distribution of body fat or other indicators of nutritional status.  
Several studies conducted in the stroke population have explored the association between 
BMI and mortality, and a few have looked at the relationship between BMI and stroke 
recurrence, but no published studies have assessed the effect of abdominal obesity (e.g. 
measured by WC) on mortality or stroke recurrence. The current study explored all these 
associations, and did it with a methodology that is notably superior to the ones reported by 
all the other studies. I would like to highlight that, as opposed to other published studies, in 
the present study a single researcher was responsible for all recruitment (and managed to 
recruit 95% of all eligible patients), collected all the baseline information and consistently 
analysed all the outcome data that was available for the entire study population. 
Thus, this high quality study was the first to show the results on a combination of 
exposures and outcomes in a multiethnic population with first and recurrent, ischaemic and 
haemorrhagic strokes. It showed that, the higher the BMI (divided by 4 categories, with an 
adequate distinction between underweight and normal weight) and the WC quartile, the 
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lower the rate of mortality (although WC was not a significant predictor of mortality in the 
multivariable analysis), and there were no significant associations between BMI or WC 
and stroke recurrence. Equally, overweight and obese patients were not more likely to have 
a longer LOS, or to cost more or to have more hospital readmissions. All these results also 
reinforce the idea of the “obesity paradox” after stroke, and show that WC does not add 
any predictive value for stroke outcomes (as opposed to what is suggested by primary 
prevention studies). 
 
The data from my studies will be important to inform the design of future RCT. For 
example, now that we know how to identify those who are at high risk of malnutrition 
(using a validated screening tool for the stroke population) and are more likely to have 
poor outcomes (mortality, LOS, costs), the next step is to investigate whether we can 
change these outcomes by providing adequate nutritional support. 
As mentioned before, there is lack of good quality evidence supporting the role of 
nutritional interventions (e.g. ONS) in the management of acute stroke patients that are 
malnourished or at risk of malnutrition, and the reason for the lack of beneficial effects of 
some of these interventions may be related with the incorrect identification (i.e. use of non 




Contributions and final remarks 
 
The health system has the responsibility of giving accurate advice and information to 
patients, and helping healthcare professionals to deliver targeted interventions. In addition, 
there is a continuous need to evaluate healthcare practices using evidence-based methods.  
 
Firstly, this thesis contributed to the evaluation of nutrition screening practices and the 
results reinforced the importance of screening stroke patients.  
In fact, a recent cohort study (with more than 36000 ischaemic stroke patients) that 
explored the association between process of care received and 30-day mortality in 
England, highlights the importance of nutrition screening and adequate nutrition after acute 
stroke (Bray et al., 2013). Among several bundles of care, authors identified two bundles 
that were associated with reduced mortality: nutrition screening and formal swallow 
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assessment within 72 hours where appropriate, and antiplatelet therapy where appropriate 
and adequate fluid and nutrition for the first 72 hours.  
In 2003, an audit evaluated the outcomes of 2 groups of acute stroke patients (n=200 
patients each): one group admitted before implementation of guidelines for nutrition 
support and the other group admitted after implementation. These guidelines included 
recommendations for screening for nutritional risk, dysphagia and other impairments that 
affect eating. Several significant improvements were observed, including lower rates of 
chest infection, aspiration pneumonia and/or sepsis in the post-implementation group, and 
a significant reduction in the number of patients for whom nutritional support decision 
making was deferred beyond 5 days of admission (Perry and McLaren, 2003). 
Further studies are needed to evaluate the individual process measures (in particular the 
individual effects of screening and nutritional support) in more detail, as in both studies 
changes cannot be attributed to individual components. 
 
Secondly, this thesis also contributed to the evaluation of practices imposing “ideal” BMI 
ranges in stroke patients and the potential need to shift emphasis from BMI to WC.  
The idea of the “obesity paradox” in a stroke population may not be easily accepted by 
some members of the scientific community, although this is not the first or only 
paradoxical association to be reported. It should be noted that, besides the growing body of 
evidence supporting the “obesity paradox” - not only in stroke and wasting diseases but 
also in cardiovascular diseases, such as coronary artery disease (Uretsky et al., 2007) or 
diabetes type II (Doehner et al., 2012) - other paradoxical associations have also been 
reported in the stroke population. For example, some studies found a better prognosis 
(including mortality) in ischaemic stroke patients who had higher serum cholesterol levels 
after the event (Vauthey et al., 2000, Zuliani et al., 2004).  
As suggested before, it is possible that a distinction needs to be made between the 









Future research recommendations 
The better outcomes of patients who are overweight and obese or have a larger WC 
suggest that current guidelines on weight management of these patients may need to be 
amended, however future randomised controlled trials of interventions for weight 
reduction (or diet modification) on secondary prevention of stroke are needed. 
 
These randomised controlled trials would need to be well designed and adequately 
powered to determine the effect of weight reduction on several outcomes of overweight 
and obese patients who have suffered a stroke. 
In an ideal study, overweight and obese acute stroke patients would be allocated either to 
the control group (which would aim to maintain weight but would receive advice to 
improve the nutritional profile of their diet) or to the intervention group (which would also 
receive advice to improve the nutritional profile of the diet but would aim for weight 
reduction, which would be planned, balanced and supervised by an experienced qualified 
professional). The duration of the trial (intervention and follow-up) would need to be at 
least 1 year, and during this period, both groups would have monthly contact with the 
people delivering the intervention (via clinics or telephone) to reinforce compliance to the 
diet and to encourage the participant to achieve or maintain the nutritional targets. 
The treatment received to control other risk factors (e.g. anticoagulation and antiplatelet 
therapy, smoking cessation plans, etc.) should be similar in both groups.  
Primary outcomes would be mortality, functional outcomes and recurrent stroke; 
secondary outcomes would be nutritional outcomes and quality of life. 
Ideally, the intervention group would allow for a combination of strategies that would 
better fit the participant, who would receive an individualised plan designed to sustain a 
long-term weight loss (blinding to patients and people administering treatment would not 
be possible). The control group would aim to follow a diet with no caloric restriction but 
with an improved nutritional profile, such as salt reduction, replacement of saturated fat 
with mono and unsaturated fats, decrease of animal protein and increase of plant protein 
from pulses and nuts. This comparison has the advantage of distinguishing the effect of 
weight reduction per se from the effect of dietary modification (with no weight loss) on 
outcomes, but it is a complex project that would require feasibility testing and pilot work.  
The definition of the inclusion criteria would also be a crucial step in this trial. One would 
argue that it would be ideal to include patients fed via nasogastric tubes, since it is easy to 
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control the caloric (and nutrient) intake for these patients and we should be able to 
extrapolate the results to the entire overweight and obese stroke population. However, 
when the nasogastric tube is removed, it is possible (and often observed) that an 
unintentional weight loss may occur (particularly if the patient requires texture 
modification of the diet). Thus, it would better to include only overweight and obese 
patients who have an intact swallowing function and can follow a normal diet. The 
intervention could start immediately after stroke for those who meet the inclusion criteria 
(including no swallowing difficulties). For those with dysphagia, recruitment and the 
beginning of intervention could be delayed for 2 weeks after stroke (when a swallowing 
improvement is expected for the majority of patients with potential for recovery).   
Another difficulty includes the possible occurrence of a significant weight reduction in the 
control group. Thus, participants in the control group should also be weighed by the end of 
the trial to allow for a comparison with the weight reduction obtained in the intervention 
group. 
Compliance and attrition rates are a common problem in long-term dietary intervention 
trials. Therefore the number of patients recruited should be higher than necessary to 
account for this issue and financial compensation should be considered to maximise 
compliance. 
 
A further recommendation to improve the quality of future research is related with the 
assessment of height, weight and BMI in stroke trials and registers. 
The proportion of patients whose BMI is not assessed, even when weight and height were 
explicitly stated to be routinely collected, varies from approximately 50% in national 
stroke registers (SRP, 2001-2003, Olsen et al., 2008) to 66% (Doehner et al., 2013) or 80%  
(Dennis et al., 2006) in clinical trials.  Given the emerging impact of BMI on post-stroke 
outcomes and the need to avoid selection bias, regular assessment of these measurements 
in stroke trials and registers, as well as in clinical settings should be recommended. 
In the SLSR, it would be important to amend the protocol of data collection regarding 
weight and BMI. The following recommendations are made: 
- SLSR researchers/fieldworkers should have an active role in collecting weight and height 
measurements from patients able to stand up, after receiving appropriate training 
- SLSR researchers/fieldworkers should be able to use simple and quick alternative 
measurements to estimate height, such as, ulna length. “Method used to measure height” 
should be another variable added to the data collection sheet 
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- wall fixed stadiometers should be made available in every ward/room where the SLSR 
data is collected  
- it would be the responsibility of the nursing staff to weigh bedbound patients, therefore 
nurse coordinators should emphasise the need to weigh any patient within 72h (and assure 
that regular audits are conducted to measure compliance). 
 
While there is a growing interest of researchers and clinicians in exploring the associations 
between BMI and mortality or stroke recurrence, due to the “obesity paradox” effect, little 
is known about the functional outcomes of overweight and obese patients (Doehner et al., 
2013). 
Additionally, there is a paucity of data on health outcomes from the patient’s perspective, 
such as quality of life and patient satisfaction and the association between malnutrition and 
quality of life after a stroke has not yet been explored. 
Quality of life can be profoundly affected by a stroke (Muren et al., 2008)  and it was 
suggested that malnutrition, through different ways, could lead to an impairment of quality 
of life in elderly patients (Jones, 2006); however, the association between this condition 
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Appendix 2.1 – “Nutrition Screening Tool currently used at Guy´s and St Thomas´ 

















































Appendix 3.1 – Medline full search strategy  
 
1 exp Stroke/ 
2 (stroke$ or post?stroke$).ti,ab. 
3 ((cerebro$ or brain or cerebral$) adj3 (infarct$ or accident$ or h?emorrhage)).ti,ab. 
4 subarachnoid h?emorrhage.ti,ab. 
5 1 or 2 or 3 or 4 
6 exp Body Mass Index/ 
7 exp Obesity/ 
8 body mass index.ti,ab. 
9 (obese or obesity or "obesity paradox").ti,ab. 
10 6 or 7 or 8 or 9 
11 (mortality or death or survival).ti,ab. 
12 5 and 10 and 11 
13 exp Animal Experimentation/ 
14 Animals/ 
15 exp Rodentia/ 
16 13 or 14 or 15 























Appendix 3.2 - Multivariable Cox Proportional Hazards Model showing the effect of 
different variables on 8-year mortality (using ethnicity divided into 3 groups) 
 HR 95% CI p value 
BMI  groups 
     Underweight 
     Normal weight (reference) 











Type of stroke 
   Ischaemic 
   Haemorrhagic 
      Subarachnoid haemorrhage 














Age (per 1-year increase) 1.06 1.05-1.08 <0.001 
Ethnicity 
   White 
   Black  












Gender (female) 0.79 0.59-1.05 0.099 
NIHSS score (per 1-unit increase) 1.07 1.05-1.09 <0.001 
Living conditions prior to stroke 
     Home 
     Institutionalized 

























































BMI = body mass index; NIHSS = National Institutes of Health Stroke Scale; CCF = congestive cardiac 











Appendix 3.3 - Multivariable Cox Proportional Hazards Model showing the effect of 
different variables on 8-year mortality, adding smoking as a risk factor.  
 HR 95% CI p value 
BMI  groups 
     Underweight 
     Normal weight (reference) 











Type of stroke 
   Ischaemic 
   Haemorrhagic 
      Subarachnoid haemorrhage 














Age (per 1-year increase) 1.07 1.05-1.08 <0.001 
Ethnicity 
   White 
   Black Caribbean 
   Black African 
   Black other    
















Gender (female) 0.82 0.61-1.09 0.177 
NIHSS score (per 1-unit increase) 1.07 1.05-1.09 <0.001 
Living conditions prior to stroke 
     Home 
     Institutionalized 




























































BMI = body mass index; NIHSS = National Institutes of Health Stroke Scale; CCF = congestive cardiac 
failure; TIA = transient ischaemic attack; HR = hazard ratio. 
 
 
*Note: from the 856 patients with available BMI data, 301 (35.2%) never smoked, 286 
(33.4%) were ex-smokers, 232 (27.1%) were current smokers and 37 (4.3%) were 






























The association between nutritional status and outcomes after a 
stroke 
REC Reference Number: 11/YH/0054 
 
Can you help with a research project? 
We would like to invite you to take part in a research project.  Before you decide 
we would like you to understand why the research is being carried out and what it 
would involve for you. 
 
One of our team will go through the information booklet with you and answer any 
questions you have.  This should take about 10 – 15 minutes.   
 






What is the purpose of the study?   
The main purpose of the study is to understand if nutritional status is associated 
with how well people recover after a stroke.  
We know overweight people are more likely to have a stroke but we do not know 
how this influences their recovery after a stroke. 
We also know that a person who is thin or has lost weight tends to recover more 
slowly from many illnesses, but we do not know whether this applies also to 
people who have had a stroke.  
 
We intend to: 
 
 identify people with a poor nutritional status (thin or losing weight) and see if 
they have worse outcomes than people with a better nutritional status 
 
 see if the body weight and the distribution of fat increases or decreases the 
risk of death and the risk of having another stroke 
 
 see if a poor nutritional status affects the hospital costs  
 
 
Why have I been invited? 
You have been invited to take part in this study because we are looking for adults 
who have had a stroke and have been admitted on the Stroke Units of St. 






Do I have to take part? 
It is up to you to decide if you want to take part in the research. We will describe 
the study and go through this information booklet with you.   
 
If you agree to take part, we will then ask you to sign a consent form. 
 
You are free to refuse or to withdraw at any time, without giving a reason. This will 
not affect any of the care you receive. 
 
 
Who are the researchers? 
The research will be conducted by a team based at St Thomas’ Hospital and 
King’s College London University: 
 
Dr Elizabeth Weekes, Lead Research Dietitian 
Ms Filomena Gomes, Dietitian and PhD student 
Prof. Peter Emery, Head of Department of Nutrition and Dietetics 
 
The Chief Investigator is Dr Elizabeth Weekes and this research is being 
conducted as part of a PhD program for Ms Gomes. 
 
 
Where will the research take place? 
The research will start while you are in hospital and will continue for 6 months after 
you have been admitted to hospital. 
 
However, you will only be contacted once, while you are in hospital. The follow-up 
data (regarding your outcomes during these 6 months) will be obtained from a 
national data warehouse containing details of all admissions to NHS hospitals in 
England. 
  
What will happen to me if I take part? 
If you agree to take part in this study, the researcher (dietitian or research nurse) 
will take some measurements and ask you (or your carer) some questions that are 
related to your nutritional status.  
You will also be weighed and your height will be measured as part of routine 
clinical care.  If it is not possible for you to stand safely we will obtain information 
about your weight and height from you, your carers or your medical notes. We will 
also ask you about your appetite and weight loss in the previous 3 to 6 months. It 
will take no more than 5 - 10 minutes to make these measurements and collect 
this information. 
 
The researcher will also measure your waist circumference (with a tape measure 
around your waist) twice, with you standing (if possible) and lying down on the 
bed. If you cannot stand, it will only be measured with you comfortably lying down 
on the bed. 
The researcher will then look at your medical records in order to obtain details 
about type and severity of stroke, medical history and other details such as age, 




What will happen after my discharge from hospital? 
In order to complete this study we will need to know how well you are recovering 6 
months after the stroke.  
We will collect information about your outcome from a national data warehouse 
known as the “Hospital Episode Statistics” (HES). The HES contains details of all 
hospital admissions to NHS hospital in England including admission and discharge 
dates, length of hospital stay, diagnosis and survival. 
Therefore, as long as you give your consent, we will legally obtain this information 




What do I need to do? 
Once you have left hospital we will not contact you again to obtain more 
information from you. 
 
 
Why is this research important? 
This research is important because it will help us to understand: 
 
 if it is possible to identify people who are likely to recover more slowly from 
a stroke because they are thin or have lost weight 
 whether a particular body shape (including amount and distribution of fat in 
the body) is protective or harmful after a stroke 
 whether a patient who is thin or has lost weight costs more to treat in the 
NHS than someone who is well-nourished  
 
 
Are there any benefits to taking part? 
We cannot promise the study will help you, but the information we get from this 
research may help to improve health care practices in the future and consequently 
help to improve outcomes of patients who have had a stroke.  
 
Your medical treatment will not be affected by taking part in this study. We do not 
expect the study to cause you any pain, discomfort or distress. 
 
 
What will happen when the research is finished? 
A summary of the results will be available and we will send you a copy if you 
request it. 
The results of the research will be published in reports and will be presented at 
conferences.  The research may also be used for teaching purposes. 
 
Any information presented about you will be done in a way so that you cannot be 










What will happen if I don’t want to carry on in the study? 
You are free to stop the research at any time and you do not have to give a reason 
why.  We will not collect any more information about you after that time. 
 
If you stop the research before the study is finished, we would like your permission 
to use the information we have already collected. 
 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to 
the researchers. They will do their best to answer your questions. Their contact 
details are on the last page of this booklet. 
 
If you remain unhappy and wish to complain formally, you can do this by 
contacting the Patient Advice and Liaison Service (PALS). 
Patient Advice and Liaison Service  
KIC, Ground Floor, North Wing,  
St Thomas’ Hospital,  
Westminster Bridge Road,  
London SE1 7EH 
Tel: 0207 188 8801 or 0207 188 8803 
Email: pals@gstt.nhs.uk 
 
Patient Advice and Liaison Service 
King's College Hospital 
Denmark Hill 
London, SE5 9RS 
Tel: 020 3299 3625 / 020 3299 3601 
Email: kch-tr.PALS@nhs.net. 
  
This trial is sponsored by Guy’s and St Thomas’ NHS Foundation Trust. All 
professional staff involved in the study hold professional indemnity to work within 
Guy’s and St Thomas’ NHS Foundation Trust.  In the event that you are harmed 
during the research and this is due to negligence then you may have grounds for 
legal action for compensation against Guy’s and St Thomas NHS Trust but you 
may have to pay your legal costs.  The normal NHS complaints mechanisms are 
still available to you. 
 
 
What will happen to the information we collect? 
The Chief Investigator (Dr Elizabeth Weekes) will be responsible for ensuring that 
all the information we collect about you during the study will be kept strictly 
confidential.   
 
All the information we collect and receive (after obtaining the required approvals) 
will be stored on a password protected computer, specifically purchased for this 
purpose. Only members of the research team will have access to information we 




Any information about you which leaves the hospital will have your personal 




Contact details  
If you have any questions about the study please talk to one of the researchers: 
 
Chief Investigator 
Dr Elizabeth Weekes 
Clinical Expert in Disease-Related Malnutrition and Research Lead 
Department of Nutrition and Dietetics 
St Thomas’ Hospital 
Westminster Bridge Road 
London 
SE1 7EH 
Tel: 0207 188 2014 (direct line) 
E-mail: elizabeth.weekes@gstt.nhs.uk 
 
Ms Filomena Gomes,  
Dietitian and PhD student 
Diabetes and Nutritional Sciences Division 
School of Medicine 
King's College London 
Franklin Wilkins Building - Room 4.46 
150 Stamford Street 
London SE1 9NH 
Tel: 020 7848 4594 
E-mail: filomena.gomes@kcl.ac.uk 
 
Prof Peter Emery 
Head of Department of Nutrition and Dietetics 
King's College London 
Franklin-Wilkins Building 
150 Stamford Street 





















































































Appendix 4.9 – Malnutrition universal Screening Tool 










Appendix 4.10 – Fields requested to Hospital Episode Statistics 
 
 
The following fields were requested for all episodes occurring in 2011/12 and 2012/13: 
 
- Patient unique identifier  
- Date of admission 
- Method of admission 
- Date of discharge 
- Destination on discharge 
- Method of discharge  
- Bed days within the year 
- Beginning of spell 
- Date episode ended 
- Date episode started 
- Duration of spell 
- End of spell 
- Episode duration 
- Episode order 
- Episode status 
- Episode type 
- Hospital provider spell number 
- Ward type at start of episode 
- Discharge ready date 
- All diagnoses codes 
- Primary diagnoses  
- Dominant procedure  
- NHS-generated Healthcare Resource Group code 
- NHS-generated Healthcare Resource Group code version number 
- SUS generated core spell Healthcare Resource Group 
- SUS generated Healthcare Resource Group 
- SUS generated Healthcare Resource Group version number 





Appendix 4.11  
 
a)  Multivariable Cox Proportional Hazards Model showing the effect of different 
variables on 6-month mortality, including BMI: 
 
  HR 95% CI p value 
BMI  groups     0.057 
     Underweight 0.82 0.41-1.65 0.58 
     Normal weight (reference) ----- ----- ----- 
     Overweight 0.57 0.33-0.97  0.038 
     Obese 0.46 0.24-0.88   0.02 
Age 1.06 1.03-1.09 <0.001 
Gender  1.27 0.82-1.97 0.288 
Ethnicity  0.80 0.54-1.19 0.271 
Type of stroke 1.27 0.69-2.31 0.429 
Severity of stroke 1.13 1.09-1.16 <0.001 
Risk factors        
Hypertension 1.82 1.07-3.09 0.026 
Diabetes 1.36 0.78-2.32 0.268 
Dyslipidemia 0.64 0.39-1.06 0.082 
Smoking 1.79 0.84-3.84 0.134 
IHD 1.94 1.15-3.26 0.013 
Heart failure 4.02 1.92-8.44 <0.001 
Atrial fibrillation 1.05 0.67-1.64 0.835 
Previous TIA 1.15 0.61-2.18 0.658 













b)  Multivariable Cox Proportional Hazards Model showing the effect of different 
variables on 6-month mortality, including WC: 
 
  HR 95% CI p value 
WC quartiles     0.107 
1st quartile (reference) ----- ----- ----- 
2nd quartile   0.64 0.37-1.09 0.103 
3rd quartile   0.60 0.33-1.06 0.080 
4th quartile   0.52 0.29-0.94 0.031 
Age 1.07 1.04-1.09 <0.001 
Gender  1.24 0.81-1.90 0.325 
Ethnicity  0.80 0.54-1.19 0.278 
Type of stroke 1.30 0.72-2.37 0.388 
Severity of stroke 1.13 1.09-1.17 <0.001 
Risk factors        
Hypertension 1.78 1.05-3.03 0.033 
Diabetes 1.30 0.76-2.21 0.335 
Dyslipidemia 0.67 0.41-1.09 0.111 
Smoking 1.79 0.83-3.88 0.140 
IHD 1.74 1.05-2.89 0.033 
Heart failure 3.56 1.72-7.36 0.001 
Atrial fibrillation 1.06 0.68-1.65 0.794 
Previous TIA 1.17 0.62-2.20 0.621 












c) Multivariable Cox Proportional Hazards Model showing the effect of different 
variables on 6-month mortality, including risk of malnutrition as determined by the 
GSTT NST: 
 
  HR 95% CI p value 
Risk of malnutrition     <0.001 
Low risk ----- ----- ----- 
Medium risk 2.1 0.87-5.09  0.099 
High risk 5.99 3.42-10.50   <0.001 
Age 1.06 1.03-1.09 <0.001 
Gender  1.25 0.81-1.92 0.314 
Ethnicity  0.79 0.54-1.17 0.237 
Type of stroke 1.31 0.72-2.42 0.378 
Severity of stroke 1.09 1.06-1.13 <0.001 
Risk factors        
Hypertension 1.95 1.14-3.33 0.014 
Diabetes 1.36 0.79-2.32 0.257 
Dyslipidemia 0.72 0.43-1.18 0.190 
Smoking 1.52 0.69-3.32 0.298 
IHD 1.73 1.04-2.88 0.035 
Heart failure 3.28 1.60-6.73 0.001 
Atrial fibrillation 1.10 0.71-1.70 0.678 
Previous TIA 1.39 0.73-2.62 0.315 


















d) Multivariable Cox Proportional Hazards Model showing the effect of different 




  HR 95% CI p value 
Risk of malnutrition     <0.001 
Low risk ----- ----- ----- 
Medium risk 3.77 1.71-8.31  0.001 
High risk 5.58 3.24-9.64   <0.001 
Age 1.06 1.03-1.09 <0.001 
Gender  1.31 0.85-2.02 0.229 
Ethnicity  0.89 0.61-1.30 0.540 
Type of stroke 1.21 0.67-2.20 0.529 
Severity of stroke 1.09 1.05-1.13 <0.001 
Risk factors        
Hypertension 2.23 1.31-3.82 0.003 
Diabetes 1.34 0.79-2.28 0.270 
Dyslipidemia 0.70 0.42-1.15 0.154 
Smoking 1.72 0.77-3.85 0.188 
IHD 1.79 1.07-2.97 0.026 
Heart failure 3.19 1.54-6.62 0.002 
Atrial fibrillation 1.13 0.73-1.76 0.584 
Previous TIA 1.49 0.79-2.83 0.220 












Appendix 4.12 – Rates of mortality and risk of mortality according to groups of BMI 
and quartiles of WC, using univariate and multivariable Cox Proportional Hazards 
Models, for the subgroup of patients with ischaemic strokes. 
 
 n  
Mortality 
rates    
Univariate Cox 
Proportional 
Hazards Model   
Multivariable* Cox 
Proportional 
Hazards Model    
(Chi-
square 
test)   
Hazard 
ratio  
95% CI    
Hazard 
ratio   
95% CI    
Body Mass Index 
categories   
472 p=0.003 p=0.001   p=0.100 
Underweight   
33 30.3% 1.25 0.64-2.54  0.85 0.41-1.78 
(<18.5 kg/m
2
)   
Normal weight   
175 23.4% Reference group  Reference group  
(18.5-24.9 kg/m
2
)   
Overweight   
157 12.1% 0.48 0.28-0.82  0.57 0.32-1.02 
(25-29.9 kg/m
2
)   
Obesity   
107 11.2% 0.43 0.23-0.82 0.49 0.25-0.95   
(>30 kg/m
2




471 p=0.172 p=0.176 p=0.257 
1st quartile    121 24.0% Reference group  Reference group  
2nd quartile   124 16.1% 0.65 0.37-1.15  0.7 0.39-1.25 
3rd quartile   117 14.5% 0.58 0.32-1.06 0.62 0.33-1.15 
4th quartile   109 14.7% 0.57 0.31-1.05 0.56 0.30-1.06 
*adjusted for age, gender, ethnicity, type and severity of stroke (NIHSS score) + 9 stroke 
risk factors: HT, diabetes, dyslipidemia, smoking, IHD, heart failure, AF, previous TIA 







Appendix 4.13 – Rates of mortality and risk of mortality according to groups of risk 
of malnutrition, using univariate and multivariable Cox Proportional Hazards 




rates    
Univariate Cox 
Proportional 





Hazards Model    
(Chi-
square 
test)   
Hazard 
Ratio 
95% CI    
Hazard 
Ratio   
95% CI    
Guy's and St. 
Thomas' 
Nutrition 
Screening Tool  
472 p<0.001   p<0.001   p<0.001   
Low risk   280 5.7% Reference group  Reference group  
Medium risk   49 12.2% 2.25 0.88-5.74  1.85 0.72-4.74  
High risk   143 42.0% 9.57 5.51-16.62  5.56 3.08-10.03  
Malnutrition 
Universal 
Screening Tool  
467 p<0.001   p<0.001   p<0.001   
Low risk   303 5.9% Reference group  Reference group  
Medium risk   32 25.0% 4.75 2.06-10.92  3.69 1.58-8.63 
High risk   132 42.4% 9.31 5.47-15.84  5.64 3.17-10.11 
a
 - adjusted for age, gender, ethnicity, type and severity of stroke (NIHSS score) + 9 stroke 
risk factors: HT, diabetes, dyslipidemia, smoking, IHD, heart failure, AF, previous TIA 











Appendix 4.14 - Rates of mortality and risk of mortality according to groups of BMI 
and quartiles of WC, using univariate and multivariable Cox Proportional Hazards 
Models, for the subgroup of patients aged 65 and older. 
 
 n  
Mortality 
rates    
Univariate Cox 
Proportional 





Hazards Model    
(Chi-
square 
test)   
Hazard 
ratio  
95% CI    
Hazard 
ratio   
95% CI    
Body Mass Index 
categories   
434 p=0.020 p=0.021 p=0.181 
Underweight   
33 33.3% 1.26 0.65-2.44 0.9 0.44-1.81 
(<18.5 kg/m
2
)   
Normal weight   
179 25.7% Reference group  Reference group  
(18.5-24.9 kg/m
2
)   
Overweight   
139 15.8% 0.56 0.34-0.94  0.66 0.38-1.15 
(25-29.9 kg/m
2
)   
Obesity   
83 14.5% 0.51 0.27-0.95 0.51 0.26-0.99   
(>30 kg/m
2




433 p=0.145 p=0.133 p=0.291 
1st quartile    117 28.2% Reference group  Reference group  
2nd quartile   108 20.4% 0.69 0.40-1.18  0.71 0.41-1.22 
3rd quartile   111 17.1% 0.57 0.32-1.00 0.66 0.37-1.22 
4th quartile   97 17.5% 0.57 0.32-1.02 0.58 0.31-1.07 
a
 - adjusted for age, gender, ethnicity, type and severity of stroke (NIHSS score) + 9 stroke 
risk factors: HT, diabetes, dyslipidemia, smoking, IHD, heart failure, AF, previous TIA 





Appendix 4.15 - Rates of mortality and risk of mortality according to groups of risk 
of malnutrition, using univariate and multivariable Cox Proportional Hazards 




rates    
Univariate Cox 
Proportional 





Hazards Model    
(Chi-
square 
test)   
Hazard 
Ratio 
95% CI    
Hazard 
Ratio   
95% CI    
Guy's and St. 
Thomas' Nutrition 
Screening Tool  
434 p<0.001   p<0.001   p<0.001   
Low risk   238 5.7% Reference group  Reference group  
Medium risk   40 12.2% 1.8 0.67-4.89  1.49 0.55-4.05  
High risk   156 42.0% 8.28 4.87-14.09  5.46 3.10-9.61 
Malnutrition 
Universal 
Screening Tool  
429 p<0.001   p<0.001   p<0.001   
Low risk   255 5.9% Reference group  Reference group  
Medium risk   34 25.0% 3.9 1.76-8.61  3.39 1.47-7.79 
High risk   140 42.4% 8.09 4.84-13.52  5.4 3.08-9.47 
a
 - adjusted for age, gender, ethnicity, type and severity of stroke (NIHSS score) + 9 stroke 
risk factors: HT, diabetes, dyslipidemia, smoking, IHD, heart failure, AF, previous TIA 


















Appendix 4.16  
 
a) Association between risk of malnutrition as defined by the GSTT NST and ranked 
length of hospital stay, adjusted for the effect of several covariates (univariate 
analysis of variance) 
 
Predictor variable F p value 
Risk of malnutrition 
(GSTT NST score) 
17.96 <0.001 
Gender 0.10 0.753 
Ethnicity  0.31 0.578 
Severity of stroke 121.45 <0.001 
Type of stroke 16.11 <0.001 
Age 9.72 0.002 
Hypertension 0.68 0.409 
Diabetes 5.61 0.018 
Dyslipidemia 0.00 0.962 
Smoking 3.21 0.074 
IHD 0.50 0.479 
Heart failure 1.95 0.163 
Atrial fibrillation 0.01 0.938 















b) Association between risk of malnutrition as defined by the MUST and ranked 
length of hospital stay, adjusted for the effect of several covariates (univariate 
analysis of variance) 
 
Predictor variable F p value 
Risk of malnutrition 
(MUST score) 
18.40 <0.001 
Gender 0.14 0.708 
Ethnicity  0.06 0.800 
Severity of stroke 115.77 <0.001 
Type of stroke 13.43 <0.001 
Age 8.07 0.005 
Hypertension 1.04 0.309 
Diabetes 5.63 0.018 
Dyslipidemia 0.06 0.805 
Smoking 3.12 0.078 
IHD 0.96 0.327 
Heart failure 3.92 0.048 
Atrial fibrillation 0.03 0.872 
















Appendix 4.17 - Length of hospital stay of patients who survived a 6 months, 
according to groups of BMI and quartiles of WC (unadjusted and adjusted results) 
 













Underweight  27 20 2-194 
0.348 0.439 
Normal weight  157 24 2-165 
Overweight 155 18 2-174 
Obese 109 17 2-167 
WC 
(n=447) 
1st quartile 107 19 2-194 
0.655 0.896 
2nd quartile 117 15 2-155 
3rd quartile 113 18 2-174 
4th quartile 110 22 2-167 
a

































a) Association between risk of malnutrition as defined by the GSTT NST and ranked 
hospitalisation costs, adjusted for the effect of several covariates (univariate analysis 
of variance) 
 
Predictor variable F 
p 
value 
Risk of malnutrition 
(GSTT NST score) 
9.03 <0.001 
Gender 1.70 0.193 
Ethnicity  0.83 0.362 
Severity of stroke 81.19 <0.001 
Type of stroke 6.94 0.009 
Age 2.90 0.089 
Hypertension 0.15 0.698 
Diabetes 4.24 0.040 
Dyslipidemia 0.61 0.435 
Smoking 0.80 0.373 
IHD 0.33 0.569 
Heart failure 4.80 0.029 
Atrial fibrillation 0.64 0.423 













b) Association between risk of malnutrition as defined by the MUST and ranked 
hospitalisation costs, adjusted for the effect of several covariates (univariate analysis 
of variance) 
 
Predictor variable F 
p 
value 
Risk of malnutrition 
(MUST score) 
9.52 <0.001 
Gender 1.65 0.199 
Ethnicity  0.19 0.660 
Severity of stroke 77.66 <0.001 
Type of stroke 5.24 0.023 
Age 2.44 0.119 
Hypertension 0.28 0.596 
Diabetes 4.79 0.029 
Dyslipidemia 0.31 0.575 
Smoking 0.46 0.498 
IHD 0.81 0.368 
Heart failure 6.44 0.012 
Atrial fibrillation 1.01 0.316 




















Appendix 4.19 - Hospitalisation costs of patients at 6 months post-stroke, according to 
groups of BMI and quartiles of WC 
 
 









































































Appendix 4.20 - Reasons for pre-stroke unintentional weight loss, as reported by 
patients, their relatives/carers and medical notes  
 
a) Disease-related reasons:  
“Swallowing problems since last stroke” 
“Swallowing problems since throat cancer” 
“Due to my illness” 
“Stomach upset for months” 
“She has gradually becoming less mobile and does not prepare her meals”  
“Sometimes does not eat for days at time due to binge drinking” 
“Due to excessive alcohol intake” 
“I have been anxious about eating and opening my bowels (because of my diverticular 
disease)” 
“I have been hospitalized for a long period of time” 
 “Due to recent frequent hospital admissions” (testimonial from a patient with a high fall 
risk) 
“Due to diarrhoea as a consequence of antibiotic use for a chest infection in a recent 
hospital admission”  
“Due to gastric surgery and pneumonia in the last 3 months” 
“Vomiting and eating too little, no appetite during 2 weeks before being admitted to 
hospital; doctors suspected of food poisoning” 
 
b) Psychological and social reasons: 
“I lost the will to live” 
“I didn’t feel hungry” 
 “I eat to survive. Eating is boring and time consuming” 
“Foods taste the same; I do not bother to cook anymore” 
“Food tastes different” 
“I lost interest about food and I was not feeling hungry” 
“I used to have a huge appetite but now I lost interest about food” 
 “Due to stress, family problems” 
 “My wife died last month” 
“Because of the death of my husband” 
“Due to by husband illness; I am worried and I have been carrying for him” 
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“Due to depression” 
“I was at unemployed, at home for several months. I was worried and had a small 
appetite”  
“The cognitive decline of my father led to a decrease in dietary intake in the last year” 
“My mother’s fridge is empty, with ready meals (bought by family) left all around the 























Appendix 4.21 - Checklist used to report standards for observational studies (STROBE, i.e. 
STrengthening the Reporting of OBservational studies in Epidemiology) applied to the 
study described in chapter 4 
 









 Title and abstract 1 (a) Indicate the study’s design with a commonly used term 





(b) Provide in the abstract an informative and balanced 
summary of what was done and what was found 
Page 4  
Introduction    
Background/rationale 2 Explain the scientific background and rationale for the 





Objectives 3 State specific objectives, including any prespecified 
hypotheses 
Page 141  
Methods    
Study design 4 Present key elements of study design early in the paper Pages 142 
and 151 
 
Setting 5 Describe the setting, locations, and relevant dates, 





Participants 6 (a) Give the eligibility criteria, and the sources and 





(b) For matched studies, give matching criteria and number 
of exposed and unexposed 
N.A.  
Variables 7 Clearly define all outcomes, exposures, predictors, 
potential confounders, and effect modifiers. Give 








as part of 
these 
corrections 
in table 1.4. 











8*  For each variable of interest, give sources of data and 
details of methods of assessment (measurement). Describe 












in page 148. 
Details of 
these efforts 






Study size 10 Explain how the study size was arrived at Page 153  
Quantitative 
variables 
11 Explain how quantitative variables were handled in the 
analyses. If applicable, describe which groupings were 






Statistical methods 12 (a) Describe all statistical methods, including those used to 
control for confounding 
Page 152  
(b) Describe any methods used to examine subgroups and 
interactions 
Page 153  
(c) Explain how missing data were addressed Page  157, 
159-160 
 
(d) If applicable, explain how loss to follow-up was 
addressed 
N.A.  








Results    
Participants 13* (a) Report numbers of individuals at each stage of study—
eg numbers potentially eligible, examined for eligibility, 
confirmed eligible, included in the study, completing 




(b) Give reasons for non-participation at each stage Pages 154-
156 
 
(c) Consider use of a flow diagram Page 156  
Descriptive data 14* (a) Give characteristics of study participants (eg 
demographic, clinical, social) and information on 




(b) Indicate number of participants with missing data for 
each variable of interest 
Page 157  








period of 6 
months 
 








Main results 16 (a) Give unadjusted estimates and, if applicable, 
confounder-adjusted estimates and their precision (eg, 95% 
confidence interval). Make clear which confounders were 














as part of 
these 
corrections 
in table 1.4. 
(b) Report category boundaries when continuous variables 
were categorized 
Page 161  
(c) If relevant, consider translating estimates of relative risk 
into absolute risk for a meaningful time period 
N.A.  
Other analyses 17 Report other analyses done—eg analyses of subgroups and 








Discussion    
Key results 18 Summarise key results with reference to study objectives Pages 188-
194 
 
Limitations 19 Discuss limitations of the study, taking into account 
sources of potential bias or imprecision. Discuss both 




Interpretation 20 Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity of analyses, results 









Other information    
Funding 22 Give the source of funding and the role of the funders for 
the present study and, if applicable, for the original study 
on which the present article is based 
Page 6  
 



















Appendices of published abstracts – A to J 
 
 
A – Gomes, F., Emery, P. W., Weekes, C. E. 2014. Abstract 63: Risk Of Malnutrition On 
Admission Predicts Mortality, Length Of Hospital Stay And Hospitalisation Costs At 6 
Months Post Stroke. Stroke, 45:A63. 




Malnutrition is related with poor outcomes after stroke which justifies the need for 
screening to identify and treat nutritionally vulnerable patients; however, no nutrition 
screening tool has been validated for this population. 
This study aimed to establish the predictive validity of the Malnutrition Universal 
Screening Tool (MUST) in stroke patients, using several outcomes: mortality, cumulative 
length of hospital stay (LOS) and hospitalisation costs at 6 months post stroke. 
 
METHODS 
Patients were recruited from consecutive admissions at 2 hyper-acute stroke units in 
London and were screened for their risk of malnutrition (low, medium and high) according 
to MUST. Outcomes were obtained for each patient through a national database that 
contains details of all hospital admissions. 
 
RESULTS 
Of 543 recruited patients, 537 were screened within 72h of admission with MUST, 51% 
were males and 87% had an ischaemic stroke, with a mean age of 74.7years (range 22-99). 
Results (see table) showed a strong positive association between risk of malnutrition and 
mortality rate (Chi square test, p<0.001), which remained significant after adjustment for 
possible confounders (Multivariable Cox Proportional Hazards Model, p<0.001). For 
patients who survived, there was a strong positive association between the risk of 
malnutrition and both LOS and hospitalisation costs (Kruskal-Wallis test, p<0.001 and 
p=0.049, respectively), which again remained significant after adjustment for possible 
confounders (univariate analysis of variance, p<0.001 and p=0.001, respectively). 
 
CONCLUSION 
Risk of malnutrition (as assessed by MUST) is an independent strong predictor of 
mortality, LOS and hospitalisation costs at 6 months post stroke, supporting the routine 















B - Gomes, F., Emery, P. W., Weekes, C. E. 2014. Abstract T P142: Mortality And Stroke 
Recurrence In Obese Stroke Patients: The Obesity Paradox In a London-Based Population. 
Stroke, 45:ATP142. 




Several studies have shown a paradoxical association between body mass index (BMI) and 
mortality after stroke. However, the association between BMI, waist circumference (WC) 
and mortality and stroke recurrence is unclear. 
This study aimed to determine the associations between BMI, WC and mortality and stroke 
recurrence at 6 months post stroke. 
 
METHODS 
Patients were recruited from consecutive admissions at 2 hyper-acute stroke units in 
London and were classified into 4 categories of BMI (underweight, normal weight, 
overweight and obese) and quartiles of WC. Outcomes were obtained for each patient 
through a national database that contains details of all hospital admissions. 
Chi-square tests were used to compare mortality and stroke recurrence rates. Cox 
Proportional Hazards Models were used to compare mortality risk and survival curves 
between different BMI categories and WC quartiles. 
 
RESULTS 
Of 543 recruited patients, 51% were males and 87% had an ischaemic stroke, with a mean 
age of 74.7 years (range 22-99). 
There were significant inverse associations between BMI and WC and risk of mortality at 
6-months post-stroke (see table) (p=0.001 and p=0.04, respectively). After adjusting for 
possible confounders (age, ethnicity, gender, severity and type of stroke, stroke risk 
factors), these associations were attenuated (p=0.06 for BMI and p=0.11 for WC). 
No significant differences were found in stroke recurrence rates between BMI groups 
(underweight 3.7%, normal weight 3.8%, overweight 4.5%, obese 2.8%; p=0.91) or WC 
quartiles (Q1 2.8%, Q2 5.1%, Q3 3.5%, Q4 3.6%; p=0.83). 
 
CONCLUSION 
After a stroke, being obese and having a larger waist circumference was associated with 























Appendix C - Gomes, F., Emery, P. W., Weekes, C. E. 2013. Weight loss prior to stroke is 
associated with increased mortality and length of hospital stay at 6 months post-stroke. 
International Journal of Stroke. 8(Suppl 3):39. 
Poster presented at the UK Stroke Forum Conference 2013 (Harrogate, 2013) 
 
Introduction: 
Malnutrition is associated with poor outcomes post-stroke. Weight loss after stroke has 
been identified as a common concern that needs close observation (Jonsson et al, 2008), 
but the impact of weight loss before stroke on outcomes is not yet known. 
 
Method:  
Patients were recruited from consecutive admissions at 2 hyper-acute stroke units in 
London and screened for their risk of malnutrition using 2 nutrition screening tools. These 
included a question on unintentional weight loss in the previous 3-6 months. 
NHS summary care records and data from the Hospital Episode Statistics were reviewed to 




Of 543 patients recruited, 51% were males and 87% had an ischaemic stroke, with a mean 
age of 74.7years (range 22–99). 
20% of patients had unintentionally lost weight before stroke and this group had a 
significantly higher rate of mortality (Chi-square test p<0.001) and a significantly higher 
LOS (Mann-Whitney test, p=0.004) when compared with the group with no weight loss, 
even after adjustment for possible confounders (age, gender, ethnicity, type and severity of 
stroke). 
A wide range of reasons for weight loss were identified by patients and carers and from 
medical notes, including disease-related, psychological and social reasons. 
 
Conclusion:  
Weight loss prior to stroke, which affects one in five patients, appears to be an important 
component of the relationship between malnutrition and poor clinical outcome after stroke. 

















Appendix D - Gomes, F., Emery, P. W., Weekes, C. E. 2013. Risk of malnutrition, Body 
Mass Index and Waist Circumference as predictors of mortality after stroke. 




Several recent studies have shown a paradoxical association between Body Mass Index 
(BMI) and mortality after stroke. This better survival of overweight and obese patients 
needs to be scrutinized. 
The aim of this study is to compare the associations between BMI, waist circumference 
(WC), risk of malnutrition and mortality at 6 months after a stroke. 
 
Methods 
Patients were recruited from consecutive admissions at 2 hyper-acute stroke units based in 
London and, after assessment, they were divided into 4 categories of BMI (underweight, 
normal weight, overweight and obese), quartiles of WC and 3 groups of risk of 
malnutrition (low, medium and high, according to two nutrition screening tools). 
NHS summary care records were reviewed to obtain mortality data for each patient at 6 
months post admission. 
Chi-square tests were used to compare mortality rates and Cox Proportional Hazards 
Models were used to compare mortality risk and survival curves between different BMI 
categories, WC quartiles and nutritional risk groups. 
 
Results 
Of 543 recruited patients, 51% were males and 87% had an ischaemic stroke, with a mean 
age of 74.7years (range 22–99). 
As shown on table 1 (attached), there were significant inverse associations between BMI 
and WC and risk of mortality at 6-months post-stroke, i.e., the higher the BMI category 
and the WC quartile, the lower the risk of mortality (p=0.002 and p=0.042, respectively).  
However, after adjustment for possible confounders (age, ethnicity, gender, severity and 
type of stroke), the significant associations disappeared (p=0.259 and p=0.197, 
respectively). For both nutrition screening tools, the higher the risk of malnutrition, the 
higher the risk of mortality (p<0.001) and this association remained significant after the 
adjustment for possible confounders (p<0.001).  
 
Conclusion 






















Hazards Model  
HR  95%CI  HR  95%CI  
Body Mass Index 
categories (p 
values) 

























11.5% 0.43 0.24-0.79 0.61 0.33-1.124 
Waist 
Circumference 
Quartiles (p values) 
542 p=0.042 p=0.042 p=0.197 
1st quartile  
(<88cm) 
146 25.3% Reference group Reference group 
2nd quartile 
(89 - 98cm) 
143 16.1% 0.61 0.36-1.02 0.61 0.36-1.06 
3rd quartile 
(99 – 108cm) 
118 14.4% 0.54 0.30-0.95 0.62 0.34-1.14 
4th quartile 
(>109cm) 
135 14.1% 0.51 0.29-0.89 0.59 0.33-1.07 
Guy's and St. 
Thomas' Nutrition 
Screening Tool  
(p values) 
543 p<0.001 p<0.001 p<0.001 
Low risk 320 5.6% Reference group Reference group 
Medium risk 52 13.5% 2.5 1.05-5.99 2.07 0.86-4.97 
High risk 171 41.5% 9.64 5.74-16.18 5.59 3.25-9.64 
Malnutrition 
Universal 
Screening Tool   
(p values) 
537 p<0.001 p<0.001 p<0.001 
Low risk 342 6.1% Reference group Reference group 
Medium risk 39 25.6% 4.65 2.19-9.89 3.51 1.63-7.63 
High risk 156 41.7% 8.82 5.39-14.44 4.92 2.91-8.33 




Appendix E - Aubrey, V. C., Gomes, F., Weekes, C. E. 2013. Nutrition screening tools 
can predict outcomes at one month in patients who have had a stroke. 
Cerebrovascular Diseases; 35(Suppl. 3):171. 
 
Background Nutrition screening tools (NSTs) are routinely used to identify patients 
requiring further nutritional assessment and possible intervention. This study tested the 
predictive validity of two NSTs in acute stroke patients.  
 
Method Patients admitted to St Thomas’ Hospital with acute stroke were assessed using 
two NSTs; MUST (Elia, 2003) and Guy’s & St Thomas’ (GST) (Weekes et al 2004) if they 
were in hospital more than 3 days.  Both tools assessed BMI, recent weight loss and dietary 
intake.  Outcome data (mortality, discharge destination and length of hospital stay (LOS)) 
were collected retrospectively from hospital records at one month post stroke. The tools 
categorised patients into low, medium or high risk of malnutrition.  Low/medium risk 
category was combined for comparison with the high-risk category.  Statistical analyses 
were conducted using Fisher’s Exact test and logistic regression (SPSS v18.0). 
 
Results 158 patients were recruited; 79 (50 %) male; mean age 72.4 (SD 13.8) years; 
NIHSS score 10.2 (SD 6.4). Eighteen patients were excluded from the analysis; lack of 
discharge information (n = 14); MUST incomplete (n = 4).  Using MUST there were 
significant relationships for mortality (p = 0.000) and LOS (p=0.033) with increased 
patient deaths and longer LOS in the high-risk category. No significant relationship was 
observed for discharge destination (p=0.09).  Using GST there were significant 
relationships between risk category and mortality, LOS and discharge destination (Table 
1).  Patients in the high-risk category had poorer outcomes.  For both tools the 
relationships remained significant after adjustment for age, gender and stroke severity (log 
regression, p< 0.05).  
 











LOS in weeks 
(n=158) 
 (p=0.021)* 

































 *Fisher’s Exact test 
Conclusion Both MUST and GST reliably predict poor outcomes in stroke patients at one 
month. Research is needed to determine if nutrition interventions implemented following 
nutrition screening result in better outcomes in high-risk patients who have had a stroke.   
 
Elia M (2003) BAPEN 




Appendix F - Aubrey, V. C., Gomes, F., Weekes, C. E. 2013. Concurrent validity of two 




There is a continued high prevalence and lack of recognition of malnutrition in hospitals. 
Nutrition screening tools (NSTs) are used to identify those at risk of malnutrition who may 
benefit from intervention. This study was used to assess the concurrent validity of two 
NSTs in stroke patients.   
 
Method 
Patients admitted to St Thomas’ Hospital with acute stroke were assessed using two NSTs; 
MUST (Elia, 2003) and Guy’s & St Thomas’ (GST) (Weekes et al 2004) if they were in 
hospital more than 3 days. Both tools include three variables (BMI, weight loss and nil by 
mouth over 5 days).  MUST requires calculation of % weight loss whereas the GST simply 
requires a record of weight loss with no requirement to calculate % change.  An extra 
variable (decreased appetite) is included in GST.  Both tools assign patients to one of three 
categories (low, medium or high risk of malnutrition).  Agreement between the methods 
was tested using the Kappa statistic, a chance corrected measure of agreement where  > 
0.6 represents good agreement (Landis & Koch 1977).  Statistical tests were conducted 
using SPSS (v 18). 
 
Results  
NSTs were completed for all subjects using GST (n = 158) and 154 (97 %) using MUST 
due to missing information for % weight loss.  Data were analysed on 154 patients; 77 
males (50%); mean age 72.3 (SD 13.9) years; BMI 25.7 (SD 6.1) kg/m
2
; NIHSS score 10.2 
(SD 6.4). There was complete agreement between the tools in 132 patients (85.7%) and 
chance corrected agreement between the tools was good ( = 0.746, SE 0.046) (see Table 
1). Although agreement between the tools was good, the GST classified more patients in 
the higher risk categories. 
 
Table 1: Concurrent validity of two NSTs 






 Low 72 10  2 
MUST Medium 4 2 4 




This study suggests good concurrent validity between the MUST and GST screening tools. 
Completion of MUST was not possible in a small proportion of cases. Agreement between 
these tools suggests either MUST or GST can be used to assess nutritional risk status in 
acute stroke patients.  
 
Elia M (2003) BAPEN 
Landis JR & Koch GG (1977) Biometrics 33: 159-74   
Weekes CE et al (2004) Clinical Nutrition, 23:1104-12 
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Appendix G - Gomes, F., Hookway, C., Emery, P. W., Weekes, C. E. 2012. A systematic 
review of the evidence for oral nutritional supplements in patients at risk of 
malnutrition who have had a stroke. Cerebrovascular Diseases, 33(Suppl.2):1-2.  
 
In the management of malnutrition in the elderly, oral nutritional supplements (ONS) 
significantly reduce mortality and complications in undernourished patients (body mass 
index < 20 kg/m
2
 or with recent weight loss and/or reduced dietary intake) (Milne et al., 
2009. Protein and energy supplementation in elderly people at risk from malnutrition. 
Cochrane Database of Systematic Reviews).  The aim of this systematic review was to 
evaluate the effect of ONS in acute stroke patients identified as malnourished or at risk of 
malnutrition using a validated screening procedure. 
 
Inclusion criteria: randomised controlled trials (RCTs) comparing ONS with usual diet in 
adults aged > 16 years with a confirmed diagnosis of acute stroke and identified as 
malnourished or at risk of malnutrition using a validated screening procedure.  Outcome 
measures: mortality; morbidity; nutritional status; functional status; quality of life.  The 
following databases were searched: Cochrane Library; Medline; Embase; Web of Science; 
CINAHL.  All retrieved titles were reviewed by one author and potentially relevant studies 
were assessed independently by two reviewers against the inclusion criteria.  Any 
differences were resolved by discussion and where necessary by consultation with a third 
reviewer.  Quality review of all selected trials was conducted by two independent 
reviewers. 
 
1,084 abstracts were retrieved of which no studies met all the inclusion criteria.  Five 
RCTs met some criteria, but were excluded for one or more of the following reasons: 
included adequately nourished patients; nutrition risk status not assessed at baseline; 
included tube-fed patients; compared routine with intensive ONS. 
 
Currently there is a lack of good quality evidence supporting the role of ONS in the 



















Appendix H - Gomes, F., Feeney, A., Prior, R., Weekes, C. E., Emery, P. W. 2012 
Predictive validity of a nutrition screening tool: clinical outcomes at one year. Age and 
Ageing. 41 (suppl 1):43-43. 
 
Introduction 
A nutrition screening tool (NST) identifies patients who are at risk of malnutrition and may 
require intervention.  The aim of this study was to establish the predictive validity of an 
NST (Weekes et al, Clinical Nutrition, 2004, 23:1104-12) in stroke and elderly care 




We aimed to recruit all patients admitted to the stroke unit and three elderly care wards 
over two months. Following screening, patients were categorised as being at low, medium 
or high risk of malnutrition.  Hospital records were reviewed retrospectively to establish 
cumulative LOS and mortality at one year after admission.   
 
Results 
Of 208 patients who were admitted, 182 (88%) were screened; mean age was 75 years 




Mortality at 1 year 
(n=182) 
Chi-square test p<0.001) 
LOS at 1 year  
(n=138) 





















There was a statistically significant difference in mortality rate between NST risk 
categories, with more deaths in the high risk patients (45%). This association remained 
significant (p<0.001) after adjustment for the effects of age and sex (logistic regression). 
LOS at one year for those who survived was not significantly different between groups 
although LOS in the high risk group tended to be longer.  Age had a significant effect on 




This NST can be used to predict mortality but not LOS at one year in stroke and elderly 




Appendix I - Gomes, F., Crichton, S., Wolfe, C., Emery, P. W., Weekes, C. E. 2011. 
Association between BMI and mortality after first-ever ischaemic stroke. 
Cerebrovascular Diseases, 31(suppl 2):1–322. 
 
Background:  
The available data regarding the relationship between Body Mass Index (BMI) and 
mortality after stroke are still limited. We retrospectively studied the association between 
BMI and 1-year mortality after acute first-ever ischemic strokes. 
 
Methods:  
Records of patients who entered the South London Stroke Register (an ongoing population 
based stroke register recording first stroke in South London) between January 2004 and 
December 2008 were examined. Official records were obtained of all deaths within a year 
after a stroke. Kaplan Meier methods were used to estimate survival in the first year after 
stroke across BMI categories and survival functions were compared using log rank tests. A 
multivariable Cox Proportional Hazards Model was used to compare risk of mortality 
between different categories of BMI after adjusting for possible confounders (age, gender, 
ethnicity and severity of stroke). 
 
Results:  
From a total of 1178 patients, 640 (54%) had a record of BMI; of these, 482 (75.3%) 
patients had ischemic strokes. This group was divided into 4 categories of BMI: 6.6% were 
underweight (<18.5Kg/m
2
), 36.9% were normal weight (18.5-24.9Kg/m
2
), 32.4% were 
overweight (25-29.9Kg/m
2
) and 24.1% were obese (≥30kg/m2). There was a significant 
difference in survival rates between the 4 BMI categories (68.8% underweight, 78.7% 
normal, 89.1% overweight, 81% obesity (p=0.010)). In a multivariable analysis, there was 
a significant difference in the risk of mortality across BMI categories (p=0.022).With the 
normal weight category as reference group, the risk of mortality was higher for the 
underweight (hazard ratio, (HR) 1.380, 95%CI, 0.794-2.399) and obese categories (HR 




The decreased mortality rate in the overweight group is in line with previous findings (e.g. 















Appendix J - Gomes, F., Feeney, A., Prior, R., Weekes, C. E., Emery, P. W. 2011. 
Predictive validity of the Nutrition Screening Tool currently used in St. Thomas 
Hospital. Sinapse, 11(1):106-107. 
 
Introdução 
Os indivíduos idosos e doentes no pós-AVC são particularmente susceptíveis à depleção 
nutricional e suas graves consequências. Uma ferramenta de rastreio do risco nutricional 
ajuda a identificar indivíduos desnutridos, de forma a que possam ser reencaminhados para 
uma avaliação nutricional e, caso necessário, intervenção nutricional. Estas ferramentas 
devem ser capazes de prever resultados clínicos negativos (validade preditiva) e, quando 
validadas, são apropriadas para determinada população ou patologia. 
A ferramenta de rastreio nutricional em vigor no St Thomas Hospital (FSTH) foi 
previamente validada em algumas populações mas não em doente idosos hospitalizados e 
doentes com AVC. 
Objectivo: Avaliar a validade preditiva da FSTH em doentes idosos hospitalizados e 
doentes com AVC. 
Metodologia 
208 doentes admitidos em 3 enfermarias para idosos e na unidade de AVCs do St Thomas 
Hospital foram incluídos no estudo. Sempre que a FSTH foi aplicada pela equipa de 
enfermagem, os doentes foram divididos em diferentes categorias de risco nutritional 
(baixo, médio ou alto) de acordo com o resultado obtido pela ferramenta. Posteriormente, 
os registos clínicos informatizados foram consultados para estabelecer os resultados 
clínicos negativos (tempo de internamento hospitalar e mortalidade) para cada um dos 
doentes, 1 e 6 meses depois da admissão hospitalar. 
Resultados 
Apenas 183 doentes (88%) foram rastreados e destes, 32% foram identificados com 
elevado risco nutricional. 
Verificou-se uma diferença estatisticamente significativa na taxa de mortalidade entre as 
várias categorias de risco nutricional (teste do Qui-Quadrado, p=0,027 ao 1º mês e 
p=0,004 ao 6º mês), sendo a taxa do grupo de alto risco 4 vezes superior à taxa dos doentes 
com médio e baixo risco nutricional. A idade e sexo não afectaram esta relação (usando 
regressão logística).  
Verificou-se também uma diferença estatisticamente significativa (teste de Kruskall-
Wallis, p=0.034) no tempo de internamento um mês depois da admissão, sendo este tempo 
maior na categoria de alto risco nutricional (16 dias versus 14.5 e 12 dias nos grupos de 
médio e baixo risco, respectivamente). Esta relação foi atenuada depois de se ajustarem os 
resultados para o efeito da idade (usando a análise de variância, p=0.128). 
Aos 6 meses manteve-se a mesma tendência de um maior tempo de internamento no grupo 
de alto risco nutricional, embora a diferença não seja significativa (teste de Kruskall-
Wallis, p=0.675). 
Conclusões  
Os resultados sugerem que esta ferramenta de rastreio nutricional poder ser usada para 
prever os resultados clínicos negativos em doentes idosos hospitalizados e doentes com 
AVC. Contudo, é necessária mais investigação.  
 
Compromissos 
Bolsa de Doutoramento financiada pela Fundação para a Ciência e a Tecnologia 
(referência SFRH / BD / 65259 / 2009). 
